Preeclampsia is a pregnancy disorder that contributes substantially to maternal and fetal morbidity and mortality worldwide. Apoptosis has been implicated in its pathogenesis, particularly in placental dysfunction. Caspase-3, an executioner caspase, mediates the final stage of apoptotic signaling; however, its role in preeclampsia remains incompletely defined. This systematic review evaluated observational evidence on placental caspase-3 expression in preeclampsia. PubMed, Scopus, and ScienceDirect were systematically searched on June 21, 2024. Eligible studies were human observational studies that assessed caspase-3 expression in placental tissue from pregnancies complicated by preeclampsia. Risk of bias was evaluated using the Newcastle-Ottawa Scale and the Risk of Bias Assessment Tool for Nonrandomized Studies 2.0 (RoBANS 2.0). Data were synthesized qualitatively because of substantial methodological heterogeneity. Twelve studies (n=736 pregnancies) were included. All assessed caspase-3 expression in placental tissue obtained after delivery. Most reported higher caspase-3 expression in preeclamptic placentas than in normotensive controls; two studies suggested higher expression in early-onset and severe preeclampsia. However, the studies varied substantially in diagnostic subtypes, measurement methods (including immunohistochemistry scoring systems, Western blotting, and enzyme-linked immunosorbent assay), and control of confounding variables. Observational evidence consistently indicates increased placental caspase-3 expression in preeclampsia, supporting enhanced apoptotic activity in affected placentas. However, because measurements were performed after delivery and caspase-3 is a downstream executioner caspase, current evidence supports its use as a marker of established placental injury. Further mechanistic and longitudinal studies are needed.
@article{lukas2026placental,
title = {Placental caspase-3 expression in preeclampsia: a systematic review of observational evidence},
author = {Lukas, Graciella Angelica and Prabowo, Wisnu and Rahma, Annisa Aghnia and Suhartono, Maurilla Iascha and Fatahillah, Hidayat and Pradana, Hikam Yanwar and Ilyas, Muhana Fawwazy and Wijayanto, Matthew Aldo},
journal = {Obstetrics \& Gynecology Science},
year = {2026},
month = {nov},
volume = {69},
number = {6},
pages = {391-403},
doi = {10.5468/ogs.25360},
url = {https://doi.org/10.5468/ogs.25360}
}
Background/Objectives The global aging population is growing rapidly, especially in Southeast Asia and Indonesia. This demographic shift poses significant challenges for urban planning and public health, as older adults face barriers to accessing essential services and engaging in their communities. This study assesses the age-friendliness of urban environments in Indonesia by evaluating the psychometric properties of an Indonesian-language version of the Age-Friendly Cities and Communities Questionnaire (AFCCQ) and comparing perceived age-friendliness across urban categories. Methods A cross-sectional survey using the Indonesian version of the AFCCQ was conducted between 7 January and 3 February 2025. The AFCCQ covers nine domains: housing, social participation, respect and social inclusion, civic participation and employment, communication and information, community support and health services, outdoor spaces and buildings, transportation, and financial status. Validity was assessed using item–total Spearman correlations and exploratory factor analysis; reliability was assessed using Cronbach’s α. Differences in domain scores across five urban categories were examined using the Kruskal–Wallis test with Bonferroni adjustment across the nine domain-level tests (α = 0.05/9 = 0.0056). Results The study involved 505 community-dwelling older adults aged ≥60 years, with a mean age of 69.4 years; 81.6% were female. The average AFCCQ score was 14.96 ± 10.46. Overall Cronbach’s α was 0.90. The KMO value was 0.83 and Bartlett’s test was significant (χ²(253) = 13,374.41, p < 0.001); the first unrotated component accounted for 35.92% of the variance, although 7 components had eigenvalues greater than 1. Nominally significant differences across city categories were observed in housing, social participation, and transportation (p < 0.05); none remained significant after Bonferroni adjustment for nine domain-level comparisons. These comparisons are reported as exploratory. Conclusion The study indicates that the Indonesian AFCCQ has acceptable internal consistency. Item-level convergence was weak for the two respect and social inclusion items, and the exploratory factor analysis did not reproduce the nine-domain structure. Exploratory differences across urban categories suggest that perceived age-friendliness may vary by city size, particularly for housing, social participation, and transportation, and provide a basis for further investigation in representative samples. Confirmatory factor analysis and formal test–retest assessment in an independent Indonesian sample remain necessary.
@article{sari2026assessing,
title = {Assessing age-friendly urban environments in Indonesia: Validation of the Indonesian age-friendly cities and communities questionnaire (AFCCQ) and differences across urban city categories},
author = {Sari, Nina Kemala and Stepvia and Ilyas, Muhana Fawwazy},
journal = {PLOS One},
year = {2026},
month = {oct},
volume = {21},
number = {10},
pages = {e0358251},
doi = {10.1371/journal.pone.0358251},
url = {https://doi.org/10.1371/journal.pone.0358251}
}
Background This study evaluated whether hypoxia-conditoned allogeneic Schwann-like cells (SLCs) or their secretome augment peripheral nerve regeneration after acute sciatic nerve injury in rats by assessing biologic and functional outcomes. Methods In this in-vivo experiment, Wistar rats (Rattus norvegicus) underwent sciatic nerve transection and repair and were assigned to control (suture only), hypoxic allogeneic SLC, or hypoxic SLC-secretome groups. SLCs were generated from adipose-derived mesenchymal stem cells using the Kingham protocol with 10% platelet-rich plasma and 1% hypoxic preconditioning. HIF-1α was evaluated by immunohistochemistry; TGF-β and VEGF by ELISA; CD-31, NCAM, α-SMA, and NeuN by qRT-PCR at weeks 3 and 6; and motor recovery by sciatic function index (SFI) from weeks 0–6. Results HIF-1α staining was stronger in both intervention groups than in controls and was more prominent at week 6 than week 3. At week 3, three-group differences were significant for TGF-β ( p =0.002), α-SMA ( p <0.001), CD-31 ( p =0.003), NCAM ( p <0.001), and NeuN ( p =0.050), but not VEGF ( p =0.235). At week 6, TGF-β, α-SMA, CD-31, NCAM, and NeuN all differed significantly (all p <0.001), whereas VEGF remained non-significant ( p =0.323). From week 2 to week 6, SFI differed significantly among groups (all p ≤0.001), with both interventions outperforming control; the secretome group showed the strongest recovery trend. Conclusion In this acute rat PNI model, hypoxic-conditioned allogeneic SLCs and their secretome were associated with improved motor recovery (higher SFI) and a biomarker profile consistent with a more supportive repair environment (higher TGF-β, HIF-1α/NCAM/CD-31; lower α-SMA) versus suturing alone. These findings are associative and do not establish causality.
@article{sumarwoto2026augmentation,
title = {Augmentation of peripheral nerve regeneration by hypoxic allogenic Schwann-like cells and secretome in acute nerve injury of Rattus norvegicus},
author = {Sumarwoto, Tito and Romaniyanto and Suroto, Heri and Utomo, Dwikora Novembri and Prakoeswa, Cita Rosita Sigit and Tinduh, Damayanti and Notobroto, Hari Basuki and Arfian, Nur and Rantam, Fedik Abdul and Rhatomy, Sholahuddin and Ilyas, Muhana Fawwazy and Mahyudin, Ferdiansyah},
journal = {Stem Cell Research \& Therapy},
year = {2026},
month = {sep},
doi = {10.1186/s13287-026-05274-0},
url = {https://doi.org/10.1186/s13287-026-05274-0}
}
Introduction . Umbilical ventriculoperitoneal (VP) shunt migration is a rare complication of VP shunt placement for hydrocephalus, with an estimated incidence of 5.8%. It can closely mimic other umbilical pathologies, such as a patent urachus, leading to diagnostic challenges. Clinical case . We report a case of a 14-month-old boy with hydrocephalus who presented with persistent clear umbilical fluid leakage. Initial ultrasound and computed tomography scan findings suggested a patent urachus due to the tenting of the superior bladder towards the umbilicus. Intraoperative exploration revealed that the urachus was obliterated and that the leakage was due to the migration of the VP shunt catheter into the umbilicus. The patient then underwent a VP shunt revision, which led to the complete resolution of symptoms within two weeks. Conclusion . Umbilical VP shunt migration is a rare but significant complication that can mimic a patent urachus. This case underscores the importance of considering VP shunt complications in similar presentations and highlights the need for additional diagnostic tools, such as voiding cystourethrogram or sinogram, to ensure accurate preoperative diagnosis.
@article{budiyanto2026diagnostic,
title = {Diagnostic challenge in identifying umbilical ventriculoperitoneal shunt migration mimicking patent urachus: a case report},
author = {Budiyanto, S. N. and Ilyas, M. F. and Budiyanto, T.},
journal = {Urology Herald},
year = {2026},
month = {jul},
volume = {14},
number = {2},
pages = {112-117},
doi = {10.21886/2308-6424-2026-14-2-112-117},
url = {https://doi.org/10.21886/2308-6424-2026-14-2-112-117}
}
Background: Traumatic brain injury (TBI) is a leading cause of neurological morbidity and mortality worldwide, with a disproportionate burden in low- and middle-income countries, including Indonesia. Prognostic assessment continues to rely on clinical scales such as the Glasgow Coma Scale (GCS) and on computed tomography, both of which have limited availability or variable performance in resource-constrained settings. Circulating microRNAs (miRNAs) are small non-coding RNAs notable for their stability in blood and quantifiability using widely available reverse transcription quantitative polymerase chain reaction (RT-qPCR) techniques, and they have emerged as candidate prognostic biomarkers after TBI. Objectives: This narrative review synthesizes current evidence on circulating miRNAs as non-invasive prognostic biomarkers in TBI and examines translational and implementation considerations within the Indonesian and broader low-resource neurosurgical context. Methods: A structured literature search was conducted in PubMed, Scopus, Google Scholar, and Cochrane for English-language human studies published between 2015 and 2024, using the keywords “microRNA”, “traumatic brain injury”, “prognosis”, and “biomarker”. After PRISMA-based screening, 32 studies were retained for narrative synthesis and complemented by foundational methodological references and high-quality reviews. Results: miR-21, miR-146a, miR-155, and miR-124, together with additional candidates such as miR-16, miR-92a, miR-93, miR-191, miR-499, miR-206 and miR-549a-3p, recurrently appeared across studies as associated with injury severity and neurological outcome measured by GCS, Glasgow Outcome Scale (GOS), or its Extended version (GOSE). Multi-miRNA panels generally outperformed individual miRNAs, and models integrating miRNAs with clinical variables reported higher discriminative performance than conventional single protein biomarkers alone. Across studies, the early post-injury window of approximately 24 to 72 hours appeared most informative for prognostication. Major barriers to translation include pre-analytical variability, the absence of consensus normalization strategies, and heterogeneity in analytical platforms and reporting. Conclusions: Circulating miRNAs represent a mechanistically grounded and logistically feasible candidate biomarker class for non-invasive TBI prognostication. Clinical translation will require multicenter validation, consensus pre-analytical and analytical standards, and phased implementation pathways adapted to local infrastructure. In Indonesia, leveraging the molecular diagnostic capacity expanded during the COVID-19 response could accelerate feasibility testing and early-phase clinical validation.
@article{yefri2026circulating,
title = {Circulating MicroRNA as a Non-Invasive Prognostic Biomarker in Traumatic Brain Injury: A Narrative Review of Current Evidence and Translational Considerations for Resource-Limited Settings},
author = {Yefri, Rezka Fadillah and Ilyas, Muhana Fawwazy and Wardhana, Aji Wahyu and Kurniawan, Azhar Farisyabdi and Prasetya, Mustaqim and Arham, Abrar},
journal = {Asian Australasian Neuro and Health Science Journal (AANHS-J)},
year = {2026},
month = {may},
volume = {8},
number = {01},
pages = {21-35},
doi = {10.32734/aanhs-j.v8i01.25356},
url = {https://doi.org/10.32734/aanhs-j.v8i01.25356}
}
Background Insomnia is a prevalent sleep disorder among older adults, associated with fatigue, cognitive decline, and poor physical and mental health. Concise instruments such as the Insomnia Severity Index (ISI) are valuable for screening and evaluation. This study aimed to validate the Indonesian version of the ISI in older adults. Methods This study used a cross-sectional survey conducted in multiple health centers and hospitals. The ISI was adapted into Indonesian following the Consensus-based Standards for the Selection of Health Measurement Instruments guidelines. Construct validity was examined using Exploratory Factor Analysis, while reliability was assessed using Cronbach’s alpha and intraclass correlation coefficients (ICC). Results A total of 510 older adults (mean age 69.3 years, 81.4% female) participated. Item–total correlations were strong ( r ≥ 0.75, p < 0.01), supporting internal consistency. Factor analysis confirmed a unidimensional structure (Kaiser-Meyer-Olkin = 0.92; Bartlett’s test p < 0.01). The ISI showed excellent reliability (Cronbach’s alpha = 0.96; ICC = 0.96). Conclusion This study demonstrates that the ISI is a valid and reliable instrument for evaluating perceived insomnia severity among older adults in Indonesia. Its ease of use and strong psychometric properties make it an invaluable tool for healthcare practitioners in routine screening and clinical practice.
@article{sari2026validity,
title = {Validity and reliability of Insomnia Severity Index among older adults in Indonesia},
author = {Sari, Nina Kemala and Stepvia and Ilyas, Muhana Fawwazy},
journal = {PeerJ},
year = {2026},
month = {apr},
volume = {14},
pages = {e20473},
doi = {10.7717/peerj.20473},
url = {https://doi.org/10.7717/peerj.20473}
}
Introduction: Papillary thyroid microcarcinoma (PTMC) is the most common subtype of thyroid cancer, generally associated with a favorable prognosis. Radiofrequency ablation (RFA) is emerging as a minimally invasive alternative to surgery, particularly for patients unsuitable for active surveillance and surgery. This report presents the first documented case of RFA for PTMC in Indonesia. Case report: A 40-year-old woman presented with a palpable thyroid nodule on the right side of her neck. Thyroid ultrasound and thyroid core needle biopsy confirmed PTMC. The patient underwent RFA using a 5-mm probe tip and 50-Watt power, employing the “moving shot” technique. The procedure was successful, with no reported complications. Follow-up assessments showed a significant reduction in tumor volume of 95.38%, from 0.264 ml to 0.012 ml, with no signs of progression at 12 months. Discussion: RFA provides a minimally invasive alternative to active surveillance with advantages, giving patient definitive treatment. Compare to surgery, this treatment have advantage such as shorter procedure time, lower procedural costs, reduced blood loss, and preservation of thyroid function, leading to faster recovery. However, wider adoption in Indonesia remains limited by the need for trained operators and access to advanced ultrasonography equipment. Strengthening workforce training, improving infrastructure, and generating long-term outcome data are essential for broader implementation. Conclusion: This case highlights RFA as a safe and effective treatment for PTMC, particularly for patients who do not wish to undergo active surveillance management for low risk thyroid cancer. Further studies are necessary to assess its long-term efficacy and feasibility.
@article{yarso2026first,
title = {First successful radiofrequency ablation for papillary thyroid microcarcinoma in Indonesia: a case report},
author = {Yarso, Kristanto Yuli and Ilyas, Muhana Fawwazy and Adli, Mohamad Rifki and Wahyudi, Akmal Zhahir},
journal = {International Journal of Surgery Case Reports},
year = {2026},
month = {feb},
volume = {138},
number = {3},
pages = {514-520},
doi = {10.1097/rc9.0000000000000159},
url = {https://doi.org/10.1097/rc9.0000000000000159}
}
The aim of this study was to map the global somatotype research trends using a bibliometric analysis. The method employed a bibliometric analysis of data sourced from the Scopus database, yielding 2,438 relevant studies authored by 7,609 individuals. To analyze these data, VOSviewer and Biblioshiny were employed to visualize publication trends, key authors, institutions, journals, and keywords. Key findings include a significant research focus in "Medicine" (39.6%) and "Health Professions" (13.1%), with emerging interdisciplinary opportunities in "Psychology" and "Engineering." Notable research themes include "somatotype components", "BMI", and "body image", with emerging studies focusing on 3D human models and artificial neural networks. Despite these advancements, international collaboration remains limited, mainly among industrialized nations. Additionally, the analysis highlights the critical role of somatotype in sports science for optimizing athlete performance and talent identification. Furthermore, new technologies, such as 3D scanning and machine learning, promise advancements in somatotype assessment. Future research should focus on enhancing validity and reliability by integrating advanced technologies and fostering international collaboration to overcome scientific isolation. In conclusion, somatotype research has significantly evolved, with concentrated efforts in medicine and health professions and expanding interdisciplinary collaborations. This study provides valuable insights, emphasizing the need for technological advancements and greater global collaboration.
@article{ghozali2026scientific,
title = {Scientific mapping of somatotype research publications: A bibliometric analysis (1944–2023)},
author = {Ghozali, Dhoni Akbar and Budiono, Enrico Ananda and Ilyas, Muhana Fawwazy and Hidayat, Saiful and Bakti, Ananda Perwira},
journal = {SPORT TK-Revista EuroAmericana de Ciencias del Deporte},
year = {2026},
month = {feb},
volume = {15},
pages = {4},
doi = {10.6018/sportk.634281},
url = {https://doi.org/10.6018/sportk.634281}
}
@article{prakoeswa2026comprehensive,
title = {Comprehensive Analysis of Mice Models for Leprosy Pathogenesis, Immunological Responses, and Therapeutic Interventions: A Systematic Review},
author = {Prakoeswa, Flora Ramona Sigit and Asaduddin, Aiman Hilmi and Pondang, Josafat and Yanuarsyah, Farhan Dhio and Tristan, Christopher Daniel and Ilyas, Muhana Fawwazy and Pramuningtyas, Ratih},
journal = {Infection \& Chemotherapy},
year = {2026},
volume = {58},
pages = {e47},
doi = {10.3947/ic.2026.0018},
url = {https://doi.org/10.3947/ic.2026.0018}
}
@article{stark2025global,
title = {Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023},
author = {Stark, Benjamin A. and DeCleene, Nicole K. and Desai, Emily C. and Hsu, Johnathan M. and Johnson, Catherine O. and Lara-Castor, Laura and LeGrand, Kate E. and A, Prof Bhoomadevi and Aalipour, Mohammad Amin and Aalruz, Hasan and Abafita, Bedru J. and Abaraogu, Ukachukwu O. and Abavisani, Mohammad and Abbas, Nasir and Abbasi, Madineh and Abbasian, Mohammadreza and Abbastabar, Hedayat and Magied, Abdallah H.A. Abd Al and ElHafeez, Samar Abd and Abdelalim, Prof Ahmed and Abdelfattah, Omar M. and Abdel-Hameed, Prof Reda and Abdelnabi, Mahmoud and Abdel-Rahman, Prof Wael M and Abdi, Parsa and Abdisa, Wakgari Mosisa and Abdissa, Daba and Abdous, Arman and Abdullah, Mujahid and Abdullahi, Auwal and Abdykerimova, Kulmira and Abebe, Mesfin and Abedi, Aidin and Abedi, Armita and Abejew, Asrat Agalu and Abhilash, E.S. and Abiodun, Olugbenga Olusola and Abiodun, Prof Olumide and Kasem, Rahim Abo and Aboagye, Richard Gyan and Abohashem, Shady and Abolhassani, Hassan and Abonie, Ulric Sena and Aborode, Abdullahi Tunde and Abourashed, Nagah Mohamed and Abramov, Dmitry and Abreu, Lucas Guimarães and Abtahi, Dariush and Farha, Rana Kamal Abu and Abubakar, Aminu Kende Kende and Abubakar, Ibrahim Jatau and Abu-Elala, Nermeen and Abu-Gharbieh, Eman and Abukhadijah, Hana J. and Aburuz, Salahdein and Abushanab, Dina and Acharya, Anirudh Balakrishna and Acharya, Apurba and Acharya, Swetha and Achore, Meshack and Adal, Ousman and Adams, Lisa C. and Adamu, Lawan Hassan and Adão, Rui and Addo, Isaac Yeboah and Adebayo, Oladimeji Muritala and Adebisi, Tajudeen Adesanmi and Adedia, David and Adedokun, Kamoru Ademola and Adegbile, Oluwatobi E. and Adegboye, Oyelola A. and Adegoke, Nurudeen A. and Adekanmbi, Victor and Adeleke, Olumide Thomas and Adetunji, Charles Oluwaseun and Adeyomoye, Olorunsola Israel and Adha, Rishan and Adhikari, Kishor and Adhikary, Ripon Kumar and Adikusuma, Wirawan and Parvar, Tanin Adl and Adnan, Mohd and Adnani, Qorinah Estiningtyas Sakilah and Adoma, Prince Owusu and Adzigbli, Leticia Akua and Adzrago, David and Afifi, Ahmed M. and Afolabi, Habeeb Abiodun and Afrashteh, Fatemeh and Afrooghe, Arya and Afzal, Muhammad Sohail and Afzal, Saira and Agampodi, Suneth Buddhika and Agarwal, Dhiraj Motilal and Agarwal, Gina and Agarwal, Prerna and Ageru, Temesgen Anjulo and Aggarwal, Navidha and Aghajanian, Sepehr and Sobrinho, César Agostinis and Agyemang-Duah, Williams and Ahadi, Mahsa and Ahammed, Benojir and Ahinkorah, Bright Opoku and Ahmad, Aqeel and Ahmad, Fuzail and Ahmad, Khurshid and Ahmad, Muayyad M. and Ahmad, Sajjad and Ahmad, Shoaib and Ahmad, Tauseef and Ahmadzadeh, Koohyar and Ahmed, Ali and Ahmed, Anisuddin and Ahmed, Ayman and Ahmed, Gasha Salih and Ahmed, Haroon and Ahmed, Junaid and Ahmed, Luai A. and Ahmed, Mehrunnisha Sharif and Ahmed, Meqdad Saleh and Ahmed, Muktar Beshir and Ahmed, Mushood and Ahmed, Naveed and Ahmed, Nesredin and Ahmed, Shabbir and Ahmed, Syed Anees and Ajakwe, Simeon Okechukwu and Ajami, Marjan and Aji, Budi and Akalu, Yonas and Akeju, Oluwasefunmi and Akhigbe, Roland Eghoghosoa and Akhmedullin, Ruslan and Akindele, Mukadas Oyeniran and Akinosoglou, Karolina and Akiska, Yagiz Matthew and Akkaif, Mohammed Ahmed and Akram, Hammad and Akrami, Ashley E. and Awaidy, Salah Al and Hamad, Hanadi Al and Hasan, Syed Mahfuz Al and Omari, Omar Al and Qadire, Mohammad Al and Thaher, Yazan Al and Zoubi, Mohammad Ahmmad Mahmoud Al and Al-Ajlouni, Yazan and Alalwan, Tariq A. and Al-Aly, Ziyad and Alam, Khurshid and Alam, Mohammad Khursheed and Alam, Mostafa and Alam, Zufishan and Al-amer, Rasmieh Mustafa and Alansari, Amani and Alanzi, Turki M. and Alarifi, Abdullah and Al-Ashwal, Fahmi Y. and Alavi, Rashid and Albashtawy, Mohammed and Al-Daken, Laila Ismael and Aldawsari, Khalifah A. and Aldhahir, Abdulelah Mastour and Aldossary, Mohammed S. and Aleidi, Shereen M. and Alemayehu, Bezawit Abeje and Alemayehu, Tekletsadik Tekleslassie and Alemi, Hediyeh and Algammal, Prof Abdelazeem M and Al-Gheethi, Adel Ali Saeed and Alhajri, Noora and Alhalaiqa, Fadwa Naji and Al-Hanawi, Mohammed Khaled and Alharrasi, Maryam and Alhumaidi, Ashraf and Ali, Akhtar and Ali, Endale Alemayehu and Ali, Kamran and Ali, Mohammad Daud and Ali, Mohammed Usman and Ali, Rafat and Ali, Sameer A. and Ali, Syed Shujait and Ali, Syed Yusuf and Al-Ibraheem, Akram and Al-Iede, Montaha and Alif, Sheikh Mohammad and Rokny, Hamid Alinejad and Al-Jabi, Samah W. and Aljawadi, Mohammad Hasan and Aljofan, Mohamad and Aljunid, Syed Mohamed and Alkhatib, Ahmad and Alkousheh, Hazim and Alla, François and Al-Mamun, Md and Al-Marwani, Sabah and Almasri, Nihad A. and Almazan, Joseph Uy and Almidani, Omar and Almobayed, Amr and Alnaeem, Mohmmad Minwer and Al-Naqeb, Ghanya Naji and Alniss, Hasan Yaser and Alomari, Mahmoud A. and Alosta, Mohammad R. and Alqahtani, Jaber S. and Alqudimat, Mohammad R. and Alrawashdeh, Ahmad and Alrimawi, Intima and Alrousan, Sahel Majed and Alsabri, Mohammed A. and Alsakarneh, Saqr and Alshehri, Mansour Abdullah and Altaany, Zaid and Altaf, Awais and Al-Tammemi, Alaa B. and Al-Tawfiq, Jaffar A. and Alvis-Guzman, Nelson and Alvis-Zakzuk, Nelson J. and Alwafi, Hassan and Al-Wardat, Mohammad and Al-Worafi, Yaser Mohammed and Aly, Hany and AlZahmi, Amal and Alzahrani, Hosam and Alzoubi, Abdallah and Alzoubi, Karem H. and Al-Zubayer, Md Akib and Amafah, Ekiyor Joseph and Amafah, Joy and Amani-Beni, Reza and Amanollahi, Mobina and Amaravadi, Sampath Kumar and Amegah, Adeladza Kofi and Amegbor, Prince M. and Amenah, Michel Adurayi and Amidi, Bardia and Amin, Tarek Tawfik and Amindarolzarbi, Alireza and Amini-Rarani, Mostafa and Amini-Salehi, Ehsan and Aminorroaya, Arya and Aminzare, Majid and Amiri, Sohrab and Ammirati, Enrico and Amobonye, Ayodeji and Ampon-Wireko, Sabina and Amu, Hubert and Amugsi, Dickson A. and Amusa, Ganiyu Adeniyi and Anagnostakis, Filippos and Ananda, Roshan A. and Anaraki, Nazanin and Ancuceanu, Robert and Anderlini, Deanna and Anderson, David B. and Anderson, Jason A. and Andrei, Catalina Liliana and Ang, Song Peng and Angappan, Santhalakshmi and Anh, Nguyen Hoang and Anil, Abhishek and Ansari, Sumbul and Ansariadi and Anteneh, Rahel Mulatie and Anuoluwa, Boluwatife Stephen and Anuoluwa, Iyadunni Adesola and Anvari, Saeid and Anwar, Saleha and Anwar, Sumadi Lukman and Anwer, Razique and Anyasodor, Anayochukwu Edward and Appiah, Francis and Arab, Juan Pablo and Arabloo, Jalal and Arafa, Elshaimaa A. and Arafat, Mosab and Aravkin, Aleksandr Y. and Areda, Demelash and Aremu, Olatunde and Torre, Jorge Arias de la and Armocida, Benedetta and Arockiaraj, Jesu and Arooj, Mahwish and Arshadi, Mahdi and Artamonov, Anton A. and Arumugam, Ashokan and Asaduzzaman, Muhammad and Asdaq, Syed Mohammed Basheeruddin and Asefa, Shewatatek Melaku Melaku and Asgary, Amirhossein and Asghari-Jafarabadi, Mohammad and Ashagre, Alebachew Fasil and Ashames, Akram and Ashfaq, Muhammad and Ashraf, Hamza and Ashraf, Muhammad Abdul Basit and Ashraf, Tahira and ashrafi, mitra and Aslam, Muhammad Shahzad and Asrat, Anemaw A. and Asri, Yuni and Assefa, Dereje Zewdu and Assembekov, Batyrbek and Astell-Burt, Prof Thomas and Athari, Seyyed Shamsadin and Atout, Maha Moh'd Wahbi and Atreya, Alok and Atta, Julie Alaere and Aurangzeb, Khursheed and Ausloos, Marcel and Avula, Sreekant and Awedew, Atalel Fentahun and Awoke, Mamaru Ayenew and Awotidebe, Adedapo Wasiu and Awoyomi, Oluwabusayo Olufunke and Axame, Wisdom Kudzo and Ayele, Belete Achamyelew and Ayyad, Mohammed and Azadnajafabad, Sina and Azadnia, Arian and Azami, Hiva and Azarboo, Alireza and Azhar, Masood and Aziz, Mohd Yusmaidie and Aziz, Sadat Abdulla and Azizan, Amin and Azizi, Hosein and Azzam, Ahmed Y. and Azzolino, Domenico and Babatope, Abisola Esther and Babu, Abraham Samuel and Babu, Giridhara Rathnaiah and Badar, Muhammad and Badran, Alaa Aboelnour and Bagga, Arvind and Baghcheghi, Nayereh and Bagheri, Nasser and Bagheri, Sara and Baghizadeh, Elahe and Baghizadeh, Fereshteh and Baghizadeh, Sana and Taghanaki, Pegah Bahrami and Bahreini, Razieh and Bai, Ruhai and Bains, Lovenish and Bakkannavar, Shankar M. and Bako, Abdulaziz T. and Balakrishnan, Senthilkumar and Balasubramanian, Madhan and Balcha, Wondu Feyisa and Baldereschi, Marzia and Balkis, Maher and Baloch, Farhala and Balogun, Saliu A. and Hasankhani, Mohammadreza Balooch and Baltatu, Ovidiu Constantin and Bam, Kiran and Banda, Kondwani Joseph and Bandaru, Praneeth Kumar Reddy and Banik, Palash Chandra and Banik, Rajon and Bansal, Hansi and Bansal, Kannu and Barati, Shirin and Barbic, Franca and Bardhan, Mainak and Barengo, Noel C. and Barker-Collo, Suzanne Lyn and Barqawi, Hiba Jawdat and Barteit, Sandra and Barua, Lingkan and Bashar, MD Abu and Bashir, Shahid and Bashiri, Azadeh and Aliabadi, Somaye Bashiri and Basri, Rehana and Bastan, Mohammad-Mahdi and Basu, Saurav and Batra, Kavita and Bauckneht, Matteo and Bayat, Mahdis and Bayat, Reza and Bayih, Mulat Tirfie and Bayisa, Feyisa Shasho and Beeraka, Narasimha M. and Behnoush, Amir Hossein and Bekele, Alehegn and Belayneh, Asnake Gashaw and Belete, Abebe Gedefaw and Belete, Abel Cherkos and Bilgin, Gokce Belge and Bello, Bashir and Bello, Olorunjuwon Omolaja and Bello, Umar Muhammad and Belo, Luis and Belsti, Yitayeh and Benfor, Bright and Bennett, Derrick A. and Bensenor, Isabela M. and Tune, Samiun Nazrin Bente Kamal and Benziger, Catherine P. and Bera, Om Prakash and Berezvai, Zombor and Bergami, Maria and Berhe, Kenfe Tesfay and Berhie, Alemshet Yirga and Berihun, Abiye Assefa and Bermudez, Amiel Nazer C and Bernstein, Robert S. and Bhadoria, Ajeet Singh and Bhagavathula, Akshaya Srikanth and Bhandari, Buna and Bhardwaj, Nikha and Bhardwaj, Pankaj and Bhaskar, Sonu and Bhattacharjee, Priyadarshini and Bhattacharjee, Shuvarthi and Bhatti, Gurjit Kaur and Bhatti, Jasvinder Singh and Bhatti, Rajbir and Bhuyan, Soumitra S. and Biadgilign, Sibhatu Kassa and Bilgin, Can and Bilgin, Cem and Birck, Marina G. and Birhan, Mekuriaw Mesfin and Birru, Eshetie Melese and Biswas, Bijit and Biswas, Mohammad Shahangir and Biswas, Monirujjaman and Biswas, Raaj Kishore and Bizzozero-Peroni, Bruno and Bjørge, Tone and Bodhare, Trupti and Bodunrin, Aadam Olalekan and Bogale, Sitotaw Kerie and Bohn, Lucimere and Bolarinwa, Obasanjo Afolabi and Boloor, Archith and Hashemi, Milad Bonakdar and Bonakdarhashemi, Moein and Basara, Berrak Bora and Borhany, Hamed and Borran, Mina and Bosoka, Samuel Adolf and Carvajal, Alejandro Botero and Boyko, Edward J. and Bozic, Marija M. and Braithwaite, Dejana and Brant, Luisa C. and Brauer, Michael and Breitner, Susanne and Brenner, Hermann and Bressem, Keno K. and Britton, Gabrielle and Bugiardini, Raffaele and Bui, Linh Phuong and Bulamu, Norma B. and Bulto, Lemma N. and Burhan, Asmat and Burley, Claire V. and Burns, Richard A. and Busch, Felix and Bustanji, Yasser and Butt, Nadeem Shafique and Butt, Zahid A. and J, Sanjay C. and Cabral, Lucas Scotta and Cairns, Rose and Barsbay, Mehtap Çakmak and Calina, Daniela and Cámera, Luis Alberto and Campos, Luciana Aparecida and Campos-Nonato, Ismael and Canales, Robert A. and Cao, Si and Capodici, Angelo and Caravaca-Morera, Jaime Alonso and Cárdenas, Rosario and Carletti, Claudia and Carreras, Giulia and Carugno, Andrea and Carvalho, Felix and Carvalho, Márcia and Carvalho-e-Silva, Ana Paula and Castaldelli-Maia, Joao Mauricio and Catapano, Alberico L. and Cattaruzza, Maria Sofia and Cegolon, Luca and Cembranel, Francieli and Cenderadewi, Muthia and Cenko, Edina and Cerin, Ester and Cerovac, Anis and Cerrai, Sonia and Chadwick, Joshua and Shivamadhu, Madhu Chakkere and Chakraborty, Aditya and Chakraborty, Chiranjib and Chakraborty, Sandip and Chan, Jeffrey Shi Kai and Chandika, Rama Mohan and Chandradasa, Miyuru and Bellur, Vinay Chandramouli and Chandrasekar, Eeshwar K. and Chang, Qinghua and Charan, Jaykaran and Chattu, Vijay Kumar and Chaudhary, Anis Ahmad and Chaudhuri, Sirshendu and Chavoshi, Mohammadreza and Chen, An-Tian and Chen, Guangjin and Chen, Haiyan and Chen, Hana and Chen, Haowei and Chen, Meng Xuan and Chen, Simiao and Chen, Xiang and Cheung, Ka Ching and Chew, Derek S. and Chew, Nicholas WS. and Chhabra, Ravindresh and Chi, Gerald and Chichagi, Fatemeh and Chimoriya, Ritesh and Ching, Patrick R. and Chiriacò, Martina and Chirinos-Caceres, Jesus Lorenzo and Chitheer, Abdulaal and Cho, So Mi Jemma and Cho, William C.S. and Chong, Bryan and Chong, Yuen Yu and Chopra, Hitesh and Chopra, Shivani and Chou, Hou In and Choudhari, Sonali Gajanan and Chowdhury, Enayet Karim and Chowdhury, Rajiv and Chowdhury, Sreshtha and Christensen, Hanne and Christopher, Devasahayam J. and Chu, Dinh-Toi and Chukwu, Isaac Sunday and Chung, Sheng-Chia and Chung, Sunghyun and Cioffi, Iolanda and Cohen, Aaron J. and Columbus, Alyssa and Conde, Joao and Congly, Stephen E. and Conrad, Nathalie and Conti, Sara and Cortesi, Paolo Angelo and Cosma, Claudia and Costa, Vera Marisa and Criqui, Michael H. and Cruz-Martins, Natalia and Silva, Alanna Gomes da and Dababo, Nour and Dabbagh, Ali and Dabo, Bashir and Dadras, Omid and Dai, Xiaochen and Dai, Zhaoli and Dalakoti, Mayank and Damasceno, Albertino Antonio Moura and D'Amico, Emanuele and Danaei, Bardia and Dandona, Lalit and Dandona, Rakhi and Dang, Anh Kim and D'Anna, Lucio and Danpanichkul, Pojsakorn and Danso, Samuel E. and Darcho, Samuel Demissie and Darouei, Bahar and Soltani, Reza Darvishi Cheshmeh and Das, Saswati and Dashtkoohi, Mohadese and Davletov, Dimash and Davletov, Kairat and Dayasiri, Kavinda and Hoz, Fernando Pio De la and Deb, Novonil and Dehadrai, Aniket and Bo', Cristian Del and Riccio, Marco Del and Delsoz, Mohammad and Demeke, Dessalegn and Deng, Ke and Denova-Gutiérrez, Edgar and Molla, Meseret Derbew and Dergaa, Ismail and Derseh, Hunegnaw Almaw and Dervišević, Emina and Desai, Hardik Dineshbhai and Desai, Rupak and Desta, Abraham Aregay and Deuba, Keshab and Devarakonda, Pradeep Kumar and Devegowda, Devananda and Dewan, Syed Masudur Rahman and Dhali, Arkadeep and Dhama, Kuldeep and Dhamija, Prof Rajinder K K and Dhimal, Meghnath and Dhungel, Bibha and Bella, Stefano Di and Pumpo, Marcello Di and Silva, Diana Dias da and Diaz, Luis Antonio and Dima, Adriana and Ding, Xueting and Do, Huyen and Do, Thao Huynh Phuong and Júnior, Orlando Luiz Luiz do Amaral do Amaral and Doegah, Phidelia Theresa and Dohare, Sushil and Dokova, Klara Georgieva and Dondi, Francesco and D'Oria, Mario and Dorostkar, Fariba and Santos, Wendel Mombaque dos and Doshi, Ojas Prakashbhai and Dowou, Robert Kokou and Dresse, Menayit Tamrat and Dsouza, Viola Savy and Du, Mi and Dube, John and Dumbili, Emeka W. and Duncan, Bruce B. and Dunne, Jennifer and Duraes, Andre Rodrigues and Durojaiye, Oyewole Christopher and Dutta, Siddhartha and Dutta, Sulagna and E’mar, Abdel Rahman and Ebohon, Osamudiamen and Ebraheim, Lamiaa Labieb Mahmoud and Ebrahimi, Alireza and Ebrahimi, Mohammad Hossein and Ebrahimi, Rasoul and Ebrahimi, Sara and Edinur, Hisham Atan and Efendi, Ferry and Eftekhari, Behrad and Eghbali, Foolad and Eghdami, Shayan and Sedeh, Ashkan Eighaei and Eini, Ebrahim and Ekholuenetale, Michael and Ekundayo, Temitope Cyrus and Arab, Rabie Adel El and Morsi, Doaa Abdel Wahab El and Zaki, Maysaa El Sayed and Eladl, Mohamed Ahmed and Elagali, Ahmed Elabbas Mustafa and Elalfy, Aya and El-Ashker, Said and El-Dahiyat, Faris and Elgendy, Islam Y. and Elhadi, Muhammed and El-Huneidi, Waseem and Elkannishy, Sherif and Elmonem, Mohamed A. and Elmoselhi, Adel B. and Elnaem, Mohamed Hassan and Elsohaby, Ibrahim and Eltahir, Mohd Elmagzoub and Zeydi, Amir Emami and Emeto, Theophilus I. and Emran, Talha Bin and Eshraghi, Reza and Eskandari, Khalil and Eskandarieh, Sharareh and Eyawo, Oghenowede and Fabin, Natalia and Fadavian, Heidar and Fagbamigbe, Adeniyi Francis and Fahim, Ayesha and Fahimi, Saman and Fahira, Aamir and Faiz, Razana and Fakhradiyev, Ildar Ravisovich and Falzone, Luca and Fan, Qiping and Farahani, Alireza and Farahmand, Mohammad and Faraji, Seyed Nooreddin and Faramarzpour, Mahsa and Faraon, Emerito Jose Aquino and Fareed, Mohammad and Farina, Jacopo and Faris, MoezAlIslam Ezzat Mahmoud and Faro, Andre and Farooq, Syed Muhammad Yousaf and Farooqui, Maryam and Farrokhpour, Hossein and Farshad, Fatemeh and Farsi, Farima and Fatima, Zareen and Fazeli, Pooria and Feili, Afrooz and Feizkhah, Alireza and Fekadu, Ginenus and Feng, Xiaoqi and Fereshtehnejad, Seyed-Mohammad and Fernandez-Jimenez, Rodrigo and Feroze, Abdullah H. and Ferrara, Pietro and Ferreira, Nuno and Feter, Natan and Feyisa, Bikila Regassa and Fiorilla, Claudio and Fischer, Florian and Fleszar, Laura and Flor, Luisa S. and Fogacci, Federica and Foigt, Nataliya A. and Fonzo, Marco and Fornari, Arianna and Fornari, Carla and Forray, Alina Ioana and Fortuna, Daniela and Foschi, Matteo and Fotouhi, Maryam and Francis-Oliviero, Florence and Fukumoto, Takeshi and Fux, Blima and Gaal, Peter Andras and Gadeka, Dominic Dormenyo and Gafane-Matemane, Lebo Francina and Gaidhane, Abhay Motiramji and Gaipov, Abduzhappar and Gajdács, Márió and Gakidou, Emmanuela and Galali, Yaseen and Gallus, Silvano and Ganesan, Balasankar and Gangachannaiah, Shivaprakash and Gao, Xiang and Garcia, Fernando Barroga and Garcia-Azorin, David and Garg, Ravindra Kumar and Garg, Vinod Kumar and Garlasco, Jacopo and Gasevic, Danijela and Gautam, Prem and Gautam, Rupesh K. and Ge, Hong-Han and Gebre, Feven Sahle and Gebregergis, Miglas Welay and Gebremariam, Alemayehu Digssie Digssie and Gebremedhin, Amanuel Tesfay and Gebremichael, Bereket and Gelaw, Asmare Yitayeh and Geleta, Leta Adugna and Matin, Ali Gerami and Geremew, Gebremariam Wulie and Getahun, Genanew K. and Gete, Kalab Yigermal and Ghadimi, Delaram J. and Ghadirian, Fataneh and Ghaffari, Kazem and Jolfayi, Amir Ghaffari and Ghahramani, Sulmaz and Ghajar, Alireza and Ghamkhar, Arin and Gheshlagh, Reza Ghanei and Assl, Shakiba Ghasemi and Seproo, Faeze Ghasemi and Ghazy, Ramy Mohamed and Gheno, Gloria and Ghimire, Sailaja and Ghith, Nermin and Ghorbani, Zeinab and Gil, Artyom Urievich and Gilani, Syed Abdullah and Gilani, Syed Amir and Gilbertson, Nora M. and Gill, Tiffany K. and Gillum, Richard F. and Girmay, Alem Abera and Girombelli, Alessandro and Glasstetter, Logan M. and Glushkova, Ekaterina Vladimirovna and Gnedovskaya, Elena V. and Göbölös, Laszlo and Goel, Amit and Goh, Lay Hoon and Gohari, Kimiya and Gohil, Megha Nishith and Goldust, Mohamad and Goleij, Pouya and Golinelli, Davide and Golkar, Mohsen and Gomes-Neto, Mansueto and Goodarzian, MReza and Goshu, Abel Tibebu and Goulart, Alessandra C. and Gregorio, Ernesto Ramos and Grivna, Michal and Grover, Ashna and Guadie, Habtamu Alganeh and Guan, Shi-Yang and Guan, Zhongyang and Guarducci, Giovanni and Gubari, Mohammed Ibrahim Mohialdeen and Guha, Avirup and Guicciardi, Stefano and Gulati, Sheffali and Gulati, Snigdha and Gunawardane, Damitha Asanga and Gunturu, Sasidhar and Guo, Qianyu and Guo, Xingzhi and Guo, Zheng and Guo, Zhifeng and Gupta, Anish Kumar and Gupta, Bhawna and Gupta, Himanshu and Gupta, Lalit and Gupta, Rahul and Gupta, Rajeev and Gupta, Sapna and Gupta, Vivek Kumar and Gutiérrez-Murillo, Roberth Steven and Guzman-Esquivel, Jose and Habibzadeh, Adrina and Habibzadeh, Farrokh and Habteyes, Abrham Tesfaye Tesfaye and Habteyohannes, Awoke Derbie and Hadei, Mostafa and Hadi, Najah R. and Hadian, Zahra and Haghdoost, Faraidoon and Haghmorad, Dariush and Haghtalab, Arian and Haile, Demewoz and Hailu, Haimanot Ewnetu and Haj-Mirzaian, Arvin and Halder, Pritam and Halim, Sobia Ahsan and Halwani, Rabih and Hamad, Islam M. and Hamdy, Nadia M. and Hamidi, Samer and Hamilton, Erin B. and Hammoud, Ahmad and Hamza, Mohammad and Hamza, Umar Sabiu and Hanif, Asif and Hanifi, Nasrin and Hankey, Graeme J. and Hanna, Fahad and Haque, Moon Moon and Haque, Obaid I. and Hareru, Habtamu Endashaw and Haro, Josep Maria and Has, Eka Mishbahatul Marah and Hasaballah, Ahmed I. and Hasan, Faizul and Hasan, Md Kamrul and Hasani, Hamidreza and Dehkordi, Ali Hasanpour- and Hashemian, Maryam and Hashempour, Zahra and Hashempur, Mohammad Hashem and Hashim, Nada Tawfig and Hasnain, Md Saquib and Hassan, Amr and Hassan, Ikrama Ibrahim and Hassan, Md Imtaiyaz and Hassan, Muhammad and Hassan, Shoaib and Wada, Yusuf Wada Hassan and Tabatabaei, Mahgol Sadat Hassan Zadeh and Hassankhani, Hadi and Haubold, Johannes and Havmoeller, Rasmus J. and Hawat, Angie and Hay, Simon I. and He, Guohua and He, Jiawei and He, Qiang and Hebert, Jeffrey J. and Heidari, Golnaz and Heidari, Mohammad and Gorji, Mohammad Ali Heidari and Hemmati, Mehdi and Hesami, Hamed and Hewage, Sumudu Avanthi and Heydari, Majid and Heydari, Mojtaba and Hezam, Kamal and Hikibu, Mitiku Desalegn and Hiraike, Yuta and Holla, Ramesh and Hong, Young-Rock and Hopkins, Ashley Mark and Hoseinzadeh, Mehdi and Hossain, Alamgir and Hossain, Lubna and Hossain, Md Belal and Hossain, Md Mahbub and Hossain, Md Sabbir and Hossain, Mohammad Bellal and mohammadi, negin sadat hosseini and Hosseinzadeh, Hassan and Hostiuc, Mihaela and Hostiuc, Sorin and Hotwani, Priya and Hoven, Hanno and Hsairi, Mohamed and Hu, Ben and Hu, Chengxi and Huang, Junjie and Huang, Yu-Song and Huang, Zunnan and Hundie, Tsegaye Gebreyes and Hushmandi, Kiavash and Hussain, Javid and Hussain, M Azhar and Hussein, Dursa and Husseiny, Mohamed Ibrahim and Hwang, Bing-Fang and Iavicoli, Ivo and Ibitoye, Segun Emmanuel and Ibrahim, Khalid S. and Ibrahim, Ramzi and Ibrahim, Umar Idris and Ikeda, Nayu and Ikiroma, Adalia and Ilesanmi, Olayinka Stephen and Ilic, Irena M. and Ilic, Milena D. and Ilyas, Muhana Fawwazy and Imam, Mohammad Tarique and Immurana, Mustapha and Imoh, Lucius Chidiebere and Inok, Arit and Iqhrammullah, Muhammad and Isa, Mustafa Alhaji and Iskandar, Benni and Iskander, Teresa R. and Islam, Md Fakrul and Islam, Md Rabiul and Islam, Md Sahidul and Islam, Md Saiful and Islam, Md Shariful and Islam, Rakibul M. and Ismail, Faisal and Ismail, Nahlah Elkudssiah and Ismoldayev, Yerlan and Iso, Hiroyasu and Isola, Gaetano and Issa, Ramzy and Ituka, Mosimah Charles and Iwagami, Masao and Iyasu, Assefa N. and Jaafari, Jalil and Jacob, Louis and Jafari-Khounigh, Ali and Jaffar, Shabbar and Jaganathan, Vennila and Jaganathasamy, Nagaraj and Jahan, Shafkat and Jahangiri, Soodeh and Jahani, Shima and Jahrami, Haitham and Jain, Akhil and Jain, Ayushi and Jain, Pragati and Jairoun, Ammar Abdulrahman and Jaiswal, Swati and Jakovljevic, Mihajlo and Jaliliyan, Ali and Jalloh, Mohamed and Jamal, Armaan and Jamal, Qazi Mohammad Sajid and Jamali, Navid and Jameie, Melika and Jamshidi, Masoud and Janardhanan, Rajiv and Javadi, Nilofer and Javaid, Syed Sarmad and Javankiani, Sepide and Javanmardi, Anita and Jayanna, Krishnamurthy and Jayapal, Sathish Kumar and Jayaram, Shubha and Jayasinghe, Ruwan Duminda and Jayatilleke, Achala Upendra and Jeong, Seogsong and Jeswani, Bijay Mukesh and Jha, Anil K. and Ji, Zixiang and Jiang, Min and Jin, Wenyi and Jokar, Mohammad and Jonas, Jost B. and Joo, Tamas and Jor, Abu and Jose, Jobin and Jose, Jobinse and Joseph, Nitin and Joshua, Charity Ehimwenma and Josten, Kripa and Joukar, Farahnaz and Jozwiak, Jacek Jerzy and Jürisson, Mikk and Juweid, Malik E. and Kaambwa, Billingsley and Kabir, Ali and Kabir, Zubair and Kadashetti, Vidya and Kader, Avan and Kader, Md Lutful and Kadir, Dler Hussein and Kaibullayeva, Jamilya and Kakkar, Ashish Kumar and Kalankesh, Leila R. and Kalra, Sanjay and Kamal, Manoj and Kamarajah, Sivesh Kathir and Kamath, Ashwin and Kamel, Ibrahim and Kamireddy, Arun and Kamyari, Naser and Kamyshnyi, Oleksandr and Kan, Haidong and Kanaan, Mona and Kanaan, Saddam Fuad and Kankam, Samuel Berchi and Kanmodi, Kehinde Kazeem and Kansal, Sushil Kumar and Kantar, Rami S. and Kar, Sujita Kumar and Karagiannidis, Efstratios and Karakasis, Paschalis and Karami, Jafar and Karch, André and Kariman, Arian and Karimi, Aliasghar and Karimtabar, Hajar and Karki, Prabin and Karobari, Mohmed Isaqali and Karpiński, Tomasz M. and Kasa, Ayele Semachew and Kasozi, Derrick and Kasraei, Hengameh and Kassa, Tigabu Hailu and Kassar, Ahmad M. and Kassebaum, Nicholas J. and Kattea, Mohammad Obadah and Kazemian, Sina and Kedir, Shemsu and Keivanlou, Mohammad-Hossein and Kelly, Jaimon Terence and Kempegowda, Swetha N. and Keshwani, Ariz and Kesse-Guyot, Emmanuelle and Keykhaei, Mohammad and Khadembashiri, Mohamad Mehdi and Khadembashiri, Mohammad Amin and Khademi, Reza and Khader, Yousef Saleh and Khaing, Inn Kynn and Khajuria, Himanshu and Khaksar, Mohammad Ali and Khalid, Nauman and Khalil, Anees Ahmed and Khalili, Pantea and khalis, Mohamed and Khan, Ajmal and Khan, Asaduzzaman and Khan, Faiz Ullah and Khan, Fayaz and Khan, Iman Waheed and Khan, Maseer and Khan, Md Abdullah Saeed and Khan, Moien AB. and Khan, Muhammad Hamza and Khan, Muhammad Mueed and Khan, Muhammad Umer and Khan, Salman Ali and Khan, Serab and Khan, Sumaiya Khan and Khan, Ubaid and Khan, Yusuf Saleem and Khanal, Vishnu and Khashim, Zenith and Khatab, Prof Khaled and Khatatbeh, Moawiah Mohammad and Khatib, Mahalaqua Nazli and Kashani, Hamid Reza Khayat and Khazaei, Afshin and Kheirallah, Khalid A. and Zarandi, Peyman Kheirandish and Kheradmand, Daniel and Khidri, Feriha Fatima and Khokhar, Manoj and Khokhar, Sunil Kumar and Khoshrou, Alireza and Khoshvaght, Parisa and Khosla, Atulya Aman and Khosravi, Ahmad and Khosravi, Majid and Khosravi, Sepehr and Khosrowjerdi, Mahmood and Khuman, P Ratan and Kifle, Zemene Demelash and Kim, Jinho and Kim, Kwanghyun and Kim, Sungroul and Kim, Yun Jin and Kimokoti, Ruth W. and Kinfu, Yohannes and Kisa, Adnan and Kisa, Sezer and Kivimäki, Mika and KM, Shivakumar and Kobyliak, Nazarii and Kogi, Robert and Kohansal, Erfan and Kokkorakis, Michail and Kolahi, Ali-Asghar and Kolte, Dhaval and Kompani, Farzad and Koohestani, Hamid Reza and Koren, Gerbrand and Kormoker, Tapos and Korshunov, Vladimir Andreevich and Korzh, Oleksii and Koscik, Michal and Kostev, Karel and Kothari, Nikhil and Kothari, Yash Lalit and Kotnis, Ashwin Laxmikant and Koul, Parvaiz A. and Laxminarayana, Sindhura Lakshmi Koulmane and Kretchy, James-Paul and Krishan, Kewal and Krishna, Varun and Król, Zbigniew J. and Kua, Chong-Han and Kuchay, Raja Amir Hassan and Bicer, Burcu Kucuk and Kuddus, Mohammed and Kukreti, Shikha and Kulimbet, Mukhtar and Kulkarni, Vishnutheertha and Kumar, Ashish and Kumar, Dewesh and Kumar, G Anil and Kumar, Kamal and Kumar, Manasi and Kumar, Mukesh and Kumar, Narendar and Kumar, Nithin and Kumar, Rakesh and Kumar, Tushar and Kumar, Vijay and Kundu, Amartya and Kunutsor, Setor K. and Kurmi, Om P. and Kurniasari, Maria Dyah and Kusnali, Asep and Kustanti, Christina Yeni Yeni and Kusuma, Dian and Kuttybayev, Assylkhan and Kwong, Wai Hang Patrick and Kytö, Ville and C, Pallavi L. and Vecchia, Carlo La and Lahariya, Chandrakant and Lai, Daphne Teck Ching and Lakanova, Balzhan and Lallukka, Tea and Lám, Judit and Lanfranchi, Francesco and Lasrado, Savita and Latif, Areeba and Lau, Kenney Ki Lee and Lawal, Basira Kankia and Lawan, Aliyu and Le, Huyen Thi Thanh and Le, Thao Thi Thu and Le, Thoa and Le, Trang Diep Thanh and Le, Trang Thi Bich and Leasher, Janet L. and Lee, Ivan and Lee, Paul H. and Lee, Seung Won and Lee, Wei-Chen and Leivaditis, Vasileios and Leonardi, Matilde and Leong, Elvynna and Letafatkar, Negin and Li, An and Li, Daisong and Li, Jiaying and Li, Jie and Li, Ming-Chieh and Li, Wei and Li, Weilong and Li, Wenjie and Li, Yichong and Li, Zhaolong Adrian and Li, Zhihui and Lim, Lee-Ling and Lim, Stephen S. and Lin, Jialing and Lin, Queran and Lin, Ro-Ting and Lindholm, Daniel and Liu, Gang and Liu, Haipeng and Liu, Xiaofeng and Liu, Xuefeng and Liu, Zhe and Llanaj, Erand and Lohner, Valerie and Lonimath, Ashwini and López-Gil, José Francisco and Lopukhov, Platon D. and Lorenzovici, László and Lorkowski, Stefan and Lotufo, Paulo A. and Lourembam, Surbala Devi and Lucchetti, Giancarlo and Lugo, Alessandra and Luo, Peng and Lutambi, Angelina M. and Lv, Hengliang and Lv, Lei and Lwin, Kaung Suu and Lytras, Dimitrios and Lytras, Miltiadis D. and Lytvyak, Ellina and Ma, Kevin Sheng-Kai and Ma, Zheng Feei and Mabrok, Mahmoud and Machoy, Monika and Madadi, Firoozeh and Madinezad, Seyed Ataollah and Madureira-Carvalho, Aurea Marilia and Maffia, Pasquale and Gómez, Javier A. Magaña and Maghazachi, Azzam A. and Mahalingam, Sasikumar and Mahalleh, Mehrdad and Mahalwar, Gauranga and Mahamed, Abdulahi Abdiwali and Mahamed, Samatar Abshir and Mahasha, Phetole Walter and Mahjoob, Monireh and Mahmood, Nozad Hussein and Mahmoudi, Elham and Mahmoudi, Farhad and Maiti, Rituparna and Majmundar, Vidit D. and Malagón-Rojas, Jeadran N. and Rad, Elaheh Malakan and Malekzadeh, Reza and Malhotra, Hardeep Singh and Malik, Ahmad Azam and Malik, Muhammad Sajeel Ahmed and Malik, Shahid and Malik, Tabarak and Malta, Deborah Carvalho and Mangdow, Mustapha and Manirambona, Emery and Manjani, Lokesh and Manla, Yosef and Mannan, Fahmida and Mannethodi, Kamaruddeen and Mansoor, Farheen and Mansouri, Vahid and Mansourian, Marjan and Mansournia, Mohammad Ali and Manu, Emmanuel and Maqsood, Sajid and Marasini, Bishnu P. and Marateb, Hamid Reza and Marino, Mirko and Marks-Hultström, Michael and Marques, Adilson and Martinez-Piedra, Ramon and Martins-Melo, Francisco Rogerlândio and Martorell, Miquel and März, Winfried and Marzo, Roy Rillera and Marzouk, Sammer and Masi, Stefano and Masoudi, Alireza and Masrouri, Soroush and Matei, Clara N. and Mathangasinghe, Yasith and Mathew, Don and Mathur, Medha and Mathur, Neeta and Matozinhos, Fernanda Penido and Mattiello, Rita and Mattoo, Khurshid A. and Maude, Richard James and Maugeri, Andrea and Mazidi, Mohsen and Mazzaglia, Giampiero and McPhail, Steven M. and Salas, María Paz Medel and Mehboob, Riffat and Mehmood, Asim and Mehravar, Fatemeh and Mehrotra, Ravi and Mehta, Vini and Meto, Tesfahun Mekene and Mekonnen, Berhanu Abebaw and Mekonnen, Eskedar Getie and Meles, Hadush Negash and Melisa, Septi and Memish, Ziad Ahmed and Mendoza, Walter and Menezes, Godfred Antony and Menezes, Ritesh G. and Mengesha, Endalkachew Worku and Mengistie, Emiru Ayalew and Mentis, Alexios-Fotios A and Mercogliano, Michelangelo and Meretoja, Atte and Mestrovic, Tomislav and Mettananda, Chamila Dinushi Kukulege and Mettananda, Sachith and Metwally, Mohamed and Miezah, Dennis and Miller, Ted R. and Minervini, Giuseppe and Ming, Wai-kit and Mini, G.K. and Mirdamadi, Arian and Mirdamadi, Niloofar and Mirghafourvand, Mojgan and Mirrakhimov, Erkin M. and Mirzaei, Roya and Mishra, Amaresh and Mishra, Archana and Mishra, Shivangi and Mishra, Vinaytosh and Mithra, Prasanna and Mittal, Chaitanya and Mobayen, Mohammadreza and Modi, Natansh Deepak and Mogessie, Yidnek and Mohamed, Abdalla Z. and Mohamed, Ahmed Ismail and Mohamed, Heba M. and Mohamed, Hebatalla and Mohamed, Jama and Mohamed, Mona Gamal and Mohamed, Nouh Saad and Mohammad, Ameen Mosa and Mohammad, Taj and Mohammad-Alizadeh-Charandabi, Sakineh and Mohammadi, Abdolreza and Mohammadi, Ida and Mohammadi, Saeed and Mohammadi, Sammy and Mohammadi, Seyed Omid and Mohammadian-Hafshejani, Abdollah and Mohammadpour, Saeed and Mohammadzadeh, Ibrahim and Mohammed, Hussen and Mohammed, Shafiu and Mohammed, Yahaya and Mohan, Syam and Mohsen, Yazan and Mohsenzadeh, Amin and Mohsin, Aleenah and Mokdad, Ali H. and Mokhirev, Alexandr and Vardanjani, Hossein Molavi and Molinaro, Sabrina and Momani, Shaher and Momeni, Hamidreza and Monasta, Lorenzo and Monazzami, Amirabbas and Moni, Mohammad Ali and Mons, Ute and Namin, Sara Montazeri and Moradi, Tayebeh and Moraga, Paula and Morales-Juárez, Linda and Morawska, Lidia and Moreira, Rafael Silveira and Morgan, Anthony Kwame and Morovatdar, Negar and Morsy, Mahmoud M. and Morze, Jakub and Mossialos, Prof Elias and Motaharinezhad, Fatemeh and Motappa, Rohith and Motavvef, Maha and Motiei, Mahsa and Mousavi, Parsa and Khaneghah, Amin Mousavi and Kiasary, Seyed Mohamad Sadegh Mousavi and Mowafy, Hagar and Mozafar, Mehrdad and MozafaryBazargany, Mohammadhossein and Yousefi, Kimia Mozahheb and Mubarik, Sumaira and Muccioli, Lorenzo and Mueller, Ulrich Otto and Mukherjee, Sumoni and Mukoro, George Duke and Mulatu, Sileshi and Mulita, Admir and Mulita, Francesk and Mulu, Getaneh Baye and Muneer, Muneeb Ahmad and Muniyandi, Malaisamy and Munjal, Kavita and Munkhsaikhan, Yanjinlkham and Munshi, Anjana and Murillo-Zamora, Efren and Musa, Abbas and Musa, Sani and Mushtaq, Ali and Mustafa, Ahmad and Mustafa, Ghulam and Muthu, Sathish and Muthupandian, Saravanan and Muvunyi, Claude Mambo and Muzaffar, Muhammad and Mwita, Julius C. and Myung, Woojae and Nafei, Ayoub and Nagarajan, Ahamarshan Jayaraman and Naghavi, Pirouz and Naghshbandi, Mobin and Naik, Ganesh R. and Naik, Gurudatta and Naik, Hiten and Nainu, Firzan and Nair, Sanjeev and Najafi, Mohammad Sadeq and Najmuldeen, Hastyar Hama Rashid and Ansari, Noureddin Nakhostin and Nambi, Gopal and Nanavaty, Dhairya P. and Nangia, Vinay and Naqvi, Atta Abbas and Swamy, Sreenivas Narasimha and Nargus, Shumaila and Nascimento, Bruno Ramos and Nascimento, Gustavo G. and Naser, Mohammad and Nashwan, Abdulqadir J. and Nasrollahizadeh, Ali and Nasrollahizadeh, Amir and Nassar, Mahmoud and Natto, Zuhair S. and Nauman, Javaid and Naureen, Zakira and Navaratna, Samidi Nirasha Kumari and Nayak, Biswa Prakash and Nayak, Shalini Ganesh Ganesh and Nayon, Md Fahad Shahariar and Nchanji, G Takop and Ndejjo, Rawlance and Ndungu, Anthony Wainaina and Neal, Bruce and Nega, Amanuel Tebabal and Negahdary, Masoud and Negash, Wubshet D. and Negru, Alina Gabriela and Nejjari, Chakib and Nekouei, Omid and Nematollahi, Mohammad Hadi and Nepal, Gaurav and Netsere, Henok Biresaw and Nezameslami, Ahmadreza and Ng, Marie and Ngunjiri, Josephine W. and Nguyen, Cuong Tat and Nguyen, Dang and Nguyen, Hau Thi Hien and Nguyen, Hien Quang and Nguyen, Kieu Viet Nhi and Nguyen, Long and Nguyen, The Phuong and Nguyen, Van Thanh and Niazi, Robina Khan and Nieddu, Luciano and Nikoobar, Ali and Nikravangolsefid, Nasrin and Niranjan, Vikram and Niroomand, Behnaz and Niyonsenga, Jean Marie Vianney and Nizam, Muhammad A. and Nkrumah-Boateng, Princess Afia Afia and Nnaji, Chukwudi A. and Nomura, Shuhei and Noor, Syed Toukir Ahmed and Noormohammadpour, Pardis and Noreen, Mamoona and Noroozi, Masoud and Noubiap, Jean Jacques and Nouri, Mehran and Nriagu, Valentine C. and Nri-Ezedi, Chisom Adaobi and Ntsekhe, Mpiko and Nugen, Fred and Nuh, Abdulkadir Mohamed and Nurchis, Mario Cesare and Nyadanu, Sylvester Dodzi Dodzi and Nyande, Felix Kwasi and Oancea, Bogdan and Odat, Ramez M. and Oddi, Fabio Massimo and Odukoya, Oluwakemi Ololade and Oduro, Michael Safo and Oghenetega, Onome Bright and Ogundeko-Olugbami, Oluwafunmilayo Tosin and Oguta, James Odhiambo and Oh, Sarah and O'Hagan, Edel T. and Ojedoyin, Olusegun Olatunji and Ojo-Akosile, Tolulope R. and Okati-Aliabad, Hassan and Okeke, Sylvester Reuben and Okekunle, Akinkunmi Paul and Okesanya, Olalekan John and Okonji, Osaretin Christabel and Okwute, Patrick Godwin and Olabisi, Oluwaseyi Isaiah and Olagunju, Andrew T. and Olalusi, Oladotun Victor and Olanrewaju, Timothy Olusegun and Olatubi, Matthew Idowu and Oliveira, Arão Belitardo and Oliveira, Gláucia Maria Moraes and Olorukooba, Abdulhakeem Abayomi and Oludoye, Oluseye Olalekan and Olum, Ronald and Oluwole, Oluwafemi G. and Omage, Folorunsho Bright and Omer, Goran Latif and Omonisi, Abidemi E. and Ong, Sok King and Onyeaghala, Chizaram A. and Oommen, Anu Mary and Opitz, Marcel and Ordak, Michal and Orscelik, Atakan and Ortiz, Alberto and Ortiz-Prado, Esteban and Osborne, Augustus and Osman, Alaa A.M. and Osman, Wael M.S. and Ostrominski, John W. and Osuagwu, Uchechukwu Levi and Othman, Elham H. and Otorkpa, Oche Joseph and Oumer, Abdu and Ouyahia, Amel and Owolabi, Mayowa O. and Owusu, Irene Amoakoh and Oyebanji, Oladayo Ayobami and Oyebola, Kolapo and Oyelade, Tope and A, Mahesh P. and Padda, Inderbir and Padron-Monedero, Alicia and Padubidri, Jagadish Rao and Palladino, Raffaele and Pan, Hai-Feng and Panda, Sujogya Kumar and Panda-Jonas, Songhomitra and Katare, Deepshikha Pande and Pandey, Ashok and Panelo, Carlo Irwin Able and Pang, Ke and Pani, Paola and Panigrahi, Sunil Kumar and Panos, Georgios D. and Panos, Leonidas D. and Pant, Suman and Pantazopoulos, Ioannis and Stoian, Anca Pantea and Papadimopoulos, Ilias and Papadopoulou, Paraskevi and Parekh, Utsav and Roudsari, Peyvand Parhizkar and Parikh, Romil R. and Park, Chulwoo and Park, Seoyeon and Parmar, Arpit Jashwantbhai and parvandi, Ava and Pashaei, Ava and Passera, Roberto and Patel, Hemal M. and Patel, Jay and Patel, Riya Jayesh and Patel, Sangram Kishor and Patil, Prof Shankargouda and Patoulias, Dimitrios and Pattnaik, Snigdha and Paudel, Deepak and Paudel, Susan and Pawar, Shrikant and Pawar, Shubhadarshini and Toroudi, Hamidreza Pazoki and Pedersini, Paolo and Pekarcikova, Jarmila and Pensato, Umberto and Pepito, Veincent Christian Filipino and Peprah, Emmanuel K. and Peprah, Prince and Pereira, Gavin and Pereira, Maria Odete and Perico, Norberto and Perna, Simone and Peter, Olumuyiwa James and Pham, Hoang Nhat and Pham, Hoang Tran and Pham, Tung Thanh and Phillips, Michael R. and Piradov, Michael A. and Pirera, Edoardo and Pisoni, Enrico and Plotnikov, Evgenii and Poddighe, Dimitri and Polibin, Roman V. and Pollner, Peter and Poluru, Ramesh and Avudaiappan, Arjun Pon and Porntaveetus, Thantrira and Pourbabaki, Reza and Pourghazi, Farzad and Pourkand, Donya and Poursadeqiyan, Mohsen and Pourshams, Akram and Prabhu, Ravindra Attur and Pradhan, Jalandhar and Pradhan, Pranil Man Singh and Prakash, Prem and Prakash, V. and Prasad, Ananya and Prashant, Akila and Pribadi, Dimas Ria Angga and Purohit, Jyotirekha and Puvvula, Jagadeesh and Qanash, Husam and Qasim, Nameer Hashim and Qattea, Ibrahim and Qi, Xiang and Qi, Zhipeng and Qian, Gangzhen and Qiu, Jia-Yong and Rabiee, Navid and Radhakrishnan, Venkatraman and Radojčić, Maja R. and Radpour, Negar and Rafiei, Deniz and Raghuveer, Pracheth and Rahim, Fakher and Rahim, Hawbash Mohammed-Amin and Rahimi, Mehran and Rahimian, Zahra and Rahimifard, Mahban and Rahman, Fryad Majeed and Rahman, Mohammad Hifz Ur and Rahman, Mohammad Meshbahur and Rahman, Mosiur and Rahman, Muhammad Aziz and Rahmani, Amir Masoud and Rahmani, Saeed and Rahmanian, Nazanin and Rahmati, Masoud and Rahmawaty, Setyaningrum and Rahmoune, Hakim and Rai, Pramila and Raina, Sunil Kumar and Raj, Jeffrey Pradeep and Raja, Sandesh and Rajaa, Sathish and Rajabi, Erta and Rajendran, Gunaseelan and Rajendran, Judah and Rajendran, Vinoth and Rajpurohit, Siddheesh and Rajput, Prashant and Ramadan, Mahmoud Mohammed and Ramadan, Majed and Ramadhan, Kadar and Ramasamy, Chitra and Ramasamy, Shakthi Kumaran and Ramírez-Vélez, Robinson and Ramphul, Kamleshun and Rana, Kritika and Rana, Rishabh Kumar and Ranabhat, Chhabi Lal and Rancic, Nemanja and Rao, Mithun and Rao, Sowmya J. and Rashedi, Sina and Rashedi, Vahid and Rashid, Mamunur and Rashidi, Mohammad-Mahdi and Rashidian, Pegah and Rasouli, Mohammad Aziz and Rasouli-Saravani, Ashkan and Rauniyar, Santosh Kumar and Rautalin, Ilari and Rawaf, David Laith and Rawaf, Salman and Rawassizadeh, Reza and Rawlley, Bharat and Rayati, Mohammad and Razo, Christian and Rebelo, Artur and Reddy, Murali Mohan Rama Krishna and Redwan, Elrashdy and Rege, Sanika and Rehman, Aqeeb Ur and Rehman, Wajiha and Reifels, Lennart and Reis-Mendes, Ana and Remuzzi, Giuseppe and Rengasamy, Kannan RR. and Rezaei, Nazila and Rezaeian, Mohsen and Eidgahi, Donya Rezazadeh and Rhee, Taeho Gregory and Rias, Yohanes Andy and Riaz, Mavra A. and Ribeiro, Antonio Luiz P and Rizvi, Moattar Raza and Rocha, Hermano Alexandre Lima and Rocha-Gomes, João Rocha and Silva, Thales Philipe Rodrigues da and Rodriguez, Jefferson Antonio Buendia and Roever, Leonardo and Rojas-Rueda, David and Romadlon, Debby Syahru and Ronfani, Luca and Rong, Jian and Roshandel, Gholamreza and Roshanshad, Amirhossein and Rotimi, Kunle and Rout, Prof Himanshu Sekhar and Rouzbahani, Shiva and Roy, Adrija and Roy, Bedanta and Roy, Nitai and Roy, Poulami and Roy, Sharmistha and Roy, Shubhanjali and Roy, Simanta and Russo, Michele and Rwegerera, Godfrey M. and N, Chandan S. and Eddin, Adnan Saad and Saadatian, Zahra and Saber, Korosh and Saber-Ayad, Maha Mohamed and Sabet, Cameron John and Sabour, Siamak and Sachdev, Perminder S. and Sachdeva, Rajesh and Sadarangani, Kabir P. and Saddik, Basema Ahmad and Sadee, Bashdar Abuzed and Sadegh, Tarannom and Sadeghi-Ghyassi, Fatemeh and Saeed, Umar and Safari, Mehdi and Sagar, Rajesh and Saghafi, Alireza and Saghazadeh, Amene and Sagoe, Dominic and Saha, Nondo and Sharif-Askari, Fatemeh Saheb and Sharif-Askari, Narjes Saheb and Sahebkar, Amirhossein and Sahiledengle, Biniyam and Sahoo, Pragyan Monalisa and Sahu, Kirti Sundar and Sahu, Monalisha and Sajadi, S Mohammad and Sajib, Md Refat Uz Zaman and Sajid, Mirza Rizwan and Salabat, Dorsa and Salami, Afeez Abolarinwa and Salarabedi, Mohammad-Mahdi and Salau, Ibrahim Layi and Saleh, Mohamed A. and Salehi, Mahdi and Salehi, Sana and Salehi, Sara and Omran, Hossein Salehi and Salem, Marwa Rashad and Salem, Mohammed Z. Y and Salimi, Sohrab and Samadzadeh, Sara and Samargandy, Saad and Samimisedeh, Parham and Samodra, Yoseph Leonardo and Samuel, Nahom Samuel and Samuel, Vijaya Paul and Samy, Abdallah M. and Sanabria, Juan and Sangle, Sandeep G. and Sanjari, Elaheh and Sanjeev, Rama Krishna and Santos, Itamar S. and Santos, Lucas H.C. C. and Santric-Milicevic, Milena M. and Jose, Bruno Piassi Sao and Sapkota, Krishna Prasad and Sarami, Marjan and Sarasmita, Made Ary and Saravanan, Aswini and Saravi, Babak and Sarikhani, Mahshad and Sarikhani, Yaser and Sarkar, Tanmay and Sarlak, Hamid and Sarma, Hemen and Sarmadi, Mohammad and Sarode, Gargi Sachin and Sarode, Sachin C. and Sarrafzadegan, Nizal and Sassano, Michele and Sathian, Brijesh and Narayanan, Mukesh Kumar Sathya and Satpathy, Maheswar and Sattarpour, Reza and Saulam, Jennifer and Far, Mehrdad Savabi and Saxena, Sangeeta Gopal and Saya, Ganesh Kumar and Sayeed, Abu and Schaarschmidt, Benedikt Michael and Schinckus, Christophe and Schmidt, Maria Inês and Schuermans, Art and Schumacher, Austin E. and Schutte, Aletta Elisabeth and Schwebel, David C. and Schwendicke, Falk and Sebastian, Sneha Annie and Seboka, Binyam Tariku and Semreen, Mohammad H. and Sendekie, Ashenafi Kibret and Sengupta, Pallav and Senol, Yigit Can and Senthilkumaran, Subramanian and Sepanlou, Sadaf G. and Serban, Andreea Claudia and Serban, Dragos and Sethi, Yashendra and Sewor, Christian and Alshohadaei, Seyed Mohammad Seyed and Seylani, Allen and Seyoum, Abebaw B. and Sha'aban, Abubakar and Shafie, Mahan and Shahab, Muhammad and Shaharudin, Shazlin and Shahid, Izza and Shahid, Samiah and Shahid, Syed Ahsan Ahsan and Shahid, Wajeehah and Shahkarami, Farshad and Shahrahmani, Fatemeh and Shahsavari, Hamid R. and Shahwan, Moyad Jamal and Shaikh, Masood Ali and Shaikh, Nafhat and Shamim, Muhammad Aaqib and Shams-Beyranvand, Mehran and Shamshad, Hina and Shamsi, Anas and Shamsutdinova, Alfiya and Shan, Dan and Shanawaz, Mohd and Shanmugasundaram, Devika and Sharath, Medha and Sharew, Nigussie Tadesse and Sharif, Muhammad Junaid Hassan and Sharifan, Amin and Sharma, Avimanu and Sharma, Bunty and Sharma, Prof Kamal and Sharma, Prof Manoj and Sharma, Ujjawal and Sharma, Vishal and Shastry, Shamee and Shawahna, Ramzi and Shawel, Samrawit and Shayan, Amir Mehdi and Bappah, Babangida Shehu and Sheida, Fateme and Sheidaei, Ali and Shekhar, Shashank and Shen, Jiabin and Shenoy, Rekha Raghuveer and Shetty, Pavanchand H. and Shi, Hui-Zhong and Shi, Wenming and Shibuya, Prof Kenji and Shiferaw, Desalegn and Shimaponda-Mataa, Nzooma Munkwangu and Shimels, Tariku and Shimul, Md Monir Hossain and Shin, Min-Jeong and Shiri, Rahman and Shittu, Aminu and Shivarov, Velizar and Shlobin, Nathan A. and Shoaib, Ambreen and Shojaie, Shima and Eshkiki, Zahra Shokati and Shool, Sina and Shorofi, Seyed Afshin and Shrestha, Sunil and Shuval, Kerem and Si, Lei and Si, Yafei and Sibuyi, Nicole R.S. and Siddig, Emmanuel Edwar and Siddiqi, Ahmed Kamal and Sidiq, Mohammad and Siegel, Martin and Sikdar, Mithun and Silva, Prof Luís Manuel Lopes Rodrigues and Simegn, Gizeaddis Lamesgin and Simkhada, Padam Prasad and Singh, Abhinav and Singh, Ambrish and Singh, Baljinder and Singh, Bhim Pratap and Singh, Harmanjit and Singh, Harpreet and Singh, Jasvinder A. and Singh, Lucky and Singh, Paramdeep and Singh, Poornima Suryanath and Singh, Puneetpal and Singh, Surendra and Singh, Surjit and Sinha, Mukesh Kumar and Sinha, Ratnesh and Sivaramakrishnan, Gowri and Siwal, Samarjeet Singh and Skhvitaridze, Natia and Sleet, David A. and Sliwa, Karen and Sohal, Aalam and Sohrabi, Somaye and Sokhal, Balamrit Singh and Solanki, Shipra and Solikhah and Soliman, Ahmed M. and Soliman, Sameh S.M. and Howyzeh, Mehdi Soltani and Song, Weiyi and Soni, Mansi and Soni, Suha and Sood, Aayushi and Sood, Prashant and Soraneh, Soroush and Soriano, Joan B. and Sorrentino, Michele and Sousa, Marco Aurelio and Souza, Tamires C.M. and Soyiri, Ireneous N. and Spartalis, Michael and Spearman, Sandra and Sreeramareddy, Prof Chandrashekhar T and Srichawla, Bahadar S. and Srinivasamurthy, Suresh Kumar and Stachteas, Panagiotis and Stafford, Lauryn K. and Stanaway, Jeffrey D. and Stanikzai, Muhammad Haroon and Starodubova, Antonina V. and Steckling-Muschack, Nadine and Steiropoulos, Paschalis and Stephan, Blossom Christa Maree and Stevanović, Aleksandar and Stockfelt, Leo and Stortecky, Stefan and Stubbs, Peter and Subedi, Narayan and Sukaew, Thitiporn and Sulaiman, Surajo Kamilu Kamilu and Suleiman, Auwal Garba and Odidi, Muritala Odidi Suleiman and Suleman, Muhammad and Sulistiyorini, Desy and Sullman, Mark J. M and Meo, Anusha Sultan and Sun, Jing and Sun, Xiaohui and Sun, Zhong and Sundaram, Shanthosh Priyan and Sundström, Johan and Sunny, Sumam and Sunuwar, Dev Ram and Susianti, Hani and Swain, Chandan Kumar and Vetha, Berwin Singh Swami and Szarpak, Prof Lukasz and Damavandi, Payam Tabaee and Tabarés-Seisdedos, Rafael and Tabatabaei, Seyyed Mohammad and Tabche, Celine and Tabibi, Ramin and Tabish, Mohammad and Tabuchi, Takahiro and Tadesse, Getu Ferenji and Tafida, Buhari Abdullahi and Arashlow, Farzin Tahmasbi and Taiba, Jabeen and Tajabadi, Shima and Takele, Wubet Worku and Talaat, Iman M. and Talic, Stella and Tampa, Mircea and Tamuzi, Jacques Lukenze and Tanashat, Mohammad and Tang, Haosu and Tantisattamo, Ekamol and Tarekegn, Gebrekidan Ewnetu and Tariq, Saba and Tavakoli, Kiarash and Tavangar, Seyed Mohammad and Tavasol, Arian and Tekola, Abainash and Temesgen, Worku Animaw and Temsah, Mohamad-Hani and Teramoto, Masayuki and Tewari, Jay and Teye-Kwadjo, Enoch and Teymourzadeh, Azin and Thankappan, Prof Kavumpurathu Raman and Thapa, Rajshree and Thapar, Rekha and Thavamani, Aravind and Sundaram, Mahalakshmi Thayumana and Thiruvengadam, Muthu and Thomas, Joe and Tian, Wei and Ticoalu, Jansje Henny Vera and Tilakaratne, Pramitha Gishan and Tiwari, Krishna and Tleshev, Madi and Tomo, Sojit and Tonelli, Prof Marcello and Topor-Madry, Roman and Touvier, Mathilde and Tovani-Palone, Marcos Roberto and Trabelsi, Khaled and Tran, Nghia Minh and Tran, Ngoc Ha and Tran, Quynh Thuy Huong and Tran, Tam Quoc Minh and Tran, Thang Huu and Duc, Nguyen Tran Minh and Trico, Domenico and Trihandini, Indang and Tripathi, Manjari and Tripathi, Tulika and Tripathy, Jaya Prasad and Tromans, Samuel Joseph and Truong, Quynh Xuan Nguyen and Truyen, Thien Tan Tri Tai and Tsai, Daniel Hsiang-Te and Tse, Gary and Tsermpini, Evangelia Eirini and Tuglo, Lawrence Sena and Narayanappa, Santhosh Kumar Tumkur and Tumurkhuu, Munkhtuya and Tusa, Biruk Shalmeno and Tye, Sok Cin and Tyrovolas, Stefanos and Udoakang, Aniefiok John and Ulhaq, Inam and Ullah, Atta and Ullah, Saeed and Ullah, Shahid and Umair, Muhammad and Umar, Hauwa Onozasi Onozasi and Umar, Lawan and Umar, Muhammad and Unim, Brigid and Unnikrishnan, Bhaskaran and Upadhya, Dinesh and Upadhyay, Era and Uppal, Dipan and Urmey, Jeba Mahiad and Urso, Daniele and Usman, Jibrin Sammani and Ussai, Silvia and Ustunsoz, Damla and Ozsahin, Dilber Uzun and Uzunçıbuk, Hande and Uzzaman, Nazim and Vadagam, Pratyusha and Vahdati, Sanaz and Vaithinathan, Asokan Govindaraj and Vakilian, Alireza and Vakilpour, Azin and Valizadeh, Gelareh and Daalen, Kim Robin van and Eynde, Jef Van den and Varghese, Joe and Varma, Ravi Prasad and Varthya, Shoban Babu and Varughese, Santosh and Vasankari, Tommi Juhani and Vasudevan, Srivatsa Surya and Vellingiri, Balachandar and Venketasubramanian, Narayanaswamy and Venkidasamy, Baskar and Verras, Georgios-Ioannis and Vervoort, Dominique and Vijayageetha, Mathavaswami and Villafañe, Jorge Hugo and Villani, Leonardo and Vipparthy, Sharath Chaitanya and Vishwakarma, Mukesh and Vlassov, Vasily and Volovat, Simona Ruxandra and Vosoughi, Mehdi and Vounzoulaki, Elpida and Vujcic, Isidora S. and Wada, Abubakar Sadiq and Wadhwa, Medha and Wafula, Solomon T. and Waheed, Yasir and Wahidin, Mugi and Wahiduzzaman, Mohammad and Wahood, Samer and Wan, Jin-Yi and Wang, Kongjia and Wang, Liang and Wang, Minmin and Wang, Nelson and Wang, Shu and Wang, Wei and Wang, Yanzhong and Wang, Yuan-Pang and Wanjau, Mary Njeri and Waqar, Ahmed Bilal and Waqas, Muhammad and Wassie, Gizachew Tadesse and Weerakoon, Kosala Gayan and Weerasekara, Ishanka and Weintraub, Robert G. and Westerman, Ronny and Wiangkham, Taweewat and Wibowo, Yohanes Cakrapradipta and Wicaksana, Anggi Lukman and Wickramasinghe, Dakshitha Praneeth and Wickramasinghe, Nuwan Darshana Darshana and Wijarnpreecha, Karn and Wijayanto, Matthew Aldo and Wilandika, Angga and Willeit, Prof Peter and Wireko, Andrew Awuah and Wirtu, Gemechu Kumera and Wojewodzic, Marcin W. and Wojtyniak, Bogdan and Wonde, Tewodros Eshete and Wondmeneh, Yohannes Chemere and Wongnaah, Florence Gyembuzie and Worku, Minichil Chanie Chanie and Wu, Prof Felicia and Wu, James Fan and Wu, Jiayuan and Wu, Junhui and Wu, Zenghong and Wubie, Yihun Miskir Miskir and Xiao, Lishun and Xie, Wanqing and Xu, Site and Xu, Wanqing and Xu, Xiaoyue and Xue, Mingyang and Yadav, Vikas and Yadollahi, Mahnaz and Yaghoubi, Sajad and (Syed), Saba Yahoo and Yahya, Galal and Yang, Xinxin and Yano, Yuichiro and Yao, Haiqiang and Yao, Laiang and Yarahmadi, Amir and Melesse, Debas Yaregal and Yasufuku, Yuichi and Yavari, Mohammadjavad and Yaya, Sanni and Yayeh, Melesse Belayneh and Ye, Pengpeng and Yeganeh, Meghdad and Yekdeş, Ali Cem and Yesodharan, Renjulal and Yesuf, Subah Abderehim and Yezengaw, Telksew Yelma and Yezli, Saber and Yi, Siyan and Yin, Dehui and Yon, Dong Keon and Yonemoto, Naohiro and Youm, Yoosik and Yousefi, Zabihollah and Yousefzadeh-Chabok, Shahrokh and Yu, Chuanhua and Yu, Hairui and Yu, Yong and Yuce, Deniz and Yunusa, Ismaeel and Yunusa, Umar and Zaghampour, Manijeh and Abidin, Emilia Zainal and Zairov, Dilmurat and Zakham, Fathiah and Zamagni, Giulia and Zanghì, Aurora and Zare, Iman and Zaresharifi, Shirin and Zarinfar, Yasaman and Zastrozhin, Michael and Zawiah, Mohammed and Zazouli, Mohammad Ali and Zeariya, Mohammed G.M. and Zemariam, Alemu Birara Birara and Zensen, Sebastian and Zhan, Tiansong and Zhang, Casper J.P. and Zhang, Haijun and Zhang, Jinpeng and Zhang, Lin and Zhang, Liqun and Zhang, Xiaoyi and Zhang, Yunquan and Zhang, Zhiqiang and Zhao, Hanqing and Zhao, Zhenping and Zheng, David X. and Zheng, Jinxin and Zheng, Ming-Hua and Zhong, Anthony and Zhou, Jiayan and Zhou, Juexiao and Zhou, Shuduo and Zhou, Xianghong and Zhou, Xiao-Dong and Zhu, Bin and Zhu, Wei and Zhumagaliuly, Abzal and Ziegelmayer, Sebastian and Zielińska, Magdalena and Zoghi, Ghazal and Zoromba, Mohamed Ali Ali and Zou, Prof Zhiyong and Zuber, Mohammed and Zyoud, Ahed H. and Zyoud, Sa'ed H. and Zyoud, Shaher H. and Murray, Christopher J. L and Mensah, George A. and Roth, Gregory A.},
journal = {JACC},
year = {2025},
month = {dec},
volume = {86},
number = {22},
pages = {2167-2243},
doi = {10.1016/j.jacc.2025.08.015},
url = {https://doi.org/10.1016/j.jacc.2025.08.015}
}
@article{husy2025global,
title = {Global, regional, and national burden of headache disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023},
author = {Hus⊘y, Andreas Kattem and Xu, Yvonne Yiru and Steinmetz, Jaimie D and Aalipour, Mohammad Amin and Aalruz, Hasan and Abdulah, Deldar Morad and Aboagye, Richard Gyan and Abtahi, Dariush and Rumeileh, Samir Abu and Aburuz, Salahdein and Adnani, Qorinah Estiningtyas Sakilah and Adonteng-Kissi, Obed and Affinito, Giuseppina and Ahmad, Danish and Ahmadi, Negar Sadat and Ahmed, Ali and Ahmed, Asma and Ahmed, Shahzaib and Zoubi, Mohammad Ahmmad Mahmoud Al and Alabbad, Sawsan and Al-Ajlouni, Yazan and Albashtawy, Mohammed and Alhalaiqa, Fadwa Naji and Alhumaidi, Ashraf and Ali, Mohammed Usman and Ali, Syed Shujait and Al-Iede, Montaha and Almazan, Joseph Uy and Alshahrani, Najim Z and Altaf, Awais and Al-Wardat, Mohammad and Al-Worafi, Yaser Mohammed and Alzoubi, Karem H and Amiri, Sohrab and Amusa, Ganiyu Adeniyi and Anderson, David B and Anil, Abhishek and Arabloo, Jalal and Aravkin, Aleksandr Y and Areda, Demelash and Anar, Mahsa Asadi and Asghari-Jafarabadi, Mohammad and Ashina, Sait and Aurangzeb, Khursheed and Azadnia, Arian and Azzam, Ahmed Y and Bae, Youngoh and Bahreini, Razieh and Bandyopadhyay, Soham and Barqawi, Hiba Jawdat and Bashiri, Azadeh and Basri, Rehana and Bastan, Mohammad-Mahdi and Behjati, Jina and Bemanalizadeh, Maryam and Bhandari, Jeetendra and Bhaskar, Sonu and Bhatti, Gurjit Kaur and Bhatti, Jasvinder Singh and Bhatti, Rajbir and Biswas, Bijit and Bizzozero-Peroni, Bruno and Boloor, Archith and Boukhiam, Meriem and Bustanji, Yasser and J, Sanjay C and Cámera, Luis Alberto and Caronna, Edoardo and Carvalho-e-Silva, Ana Paula and Chakraborty, Sandip and Chattu, Vijay Kumar and Chaudhary, Anis Ahmad and Ching, Patrick R and Chu, Hongyuan and Comachio, Josielli and Contreras, Daniela and Cruz-Martins, Natalia and Dadras, Omid and Dai, Xiaochen and D'Amico, Emanuele and Dang, Anh Kim and D'Anna, Lucio and Deekonda, Sindhura and Delbari, Pouria and Demetriades, Andreas K and Derviševic, Emina and Devanbu, Vinoth Gnana Chellaiyan and Dhane, Amol S and Dhungel, Bibha and Ding, Xueting and Do, Huyen Phuc and Doshi, Ojas Prakashbhai and Dutta, Siddhartha and Ebraheim, Lamiaa Labieb Mahmoud and Eini, Ebrahim and Ekholuenetale, Michael and Eskandarieh, Sharareh and Faro, Andre and Feigin, Valery L and Fekadu, Gelana and Fekadu, Ginenus and Fereshtehnejad, Seyed-Mohammad and Feroze, Abdullah H and Ferrara, Pietro and Ferreira, Nuno and Fiorilla, Claudio and Fischer, Florian and Fornari, Arianna and Rodrigues, Celia Fortuna and Foschi, Matteo and Gad, Abdelrahman Gamil and Gajdács, Márió and Garcia-Azorin, David and Gatzioufas, Zisis and Gautam, Rupesh K and Gebregergis, Miglas Welay and Gnedovskaya, Elena V and Gobbo, Massimiliano and Golechha, Mahaveer and Goleij, Pouya and Goulart, Alessandra C and Gupta, Ishita and Gupta, Sapna and Gutiérrez-Murillo, Roberth Steven and Hadi, Najah R and Haghdoost, Faraidoon and Hagins, Hailey and Hamed, Mohamed and Hanson, Victoria Funmilayo and Hassan, Amr and Hay, Simon I and Hayat, Khezar and Hebert, Jeffrey J and Heidari, Golnaz and Helfer, Bartosz and Hoseinzadeh, Mehdi and Hossain, Md Jubayer and Huang, Yongsong and Iannone, Luigi Francesco and Ibitoye, Segun Emmanuel and Ilesanmi, Olayinka Stephen and Ilic, Irena M and Ilyas, Muhana Fawwazy and Ilyasu, Salim and Islam, Md Rabiul and Islam, Md Sahidul and Ismail, Nahlah Elkudssiah and Jacob, Louis and Jahrami, Haitham and Jairoun, Ammar Abdulrahman and Jamali, Navid and Janodia, Manthan Dilipkumar and Jayasinghe, Ruwan Duminda and Jin, Shuai and Jonas, Jost B and Joseph, Nitin and Joshua, Charity Ehimwenma and Kamenova, Saltanat and Kamireddy, Arun and Kantar, Rami S and Kar, Sujita Kumar and Karobari, Mohmed Isaqali and Khajuria, Himanshu and Khasbage, Sameer Uttamaro and Khubchandani, Jagdish and Kim, Yun Jin and Gargari, Omid Kohandel and Kompani, Farzad and Kondybayeva, Aida and Krishan, Kewal and Defo, Barthelemy Kuate and Kulimbet, Mukhtar and Kumar, Chandan and Kumar, Rakesh and Kumar, Vijay and Kytö, Ville and Ledda, Caterina and Lee, Seung Won and Lenzi, Jacopo and Li, Jianan and Li, Linyan and Lian, Yanxue and Lucchetti, Giancarlo and Lusk, Jay B and Saute, Ricardo Lutzky and Mahalingam, Sasikumar and Maiti, Rituparna and Malik, Ahmad Azam and Malkamu, Birhanemaskal and Mansouri, Vahid and Margetis, Konstantinos and Marzo, Roy Rillera and Mathangasinghe, Yasith and Mavrovounis, Georgios and Meles, Hadush Negash and Meretoja, Atte and Mestrovic, Tomislav and Mettananda, Sachith and Miazgowski, Bartosz and Minervini, Giuseppe and Mishra, Archana and Misra, Arup Kumar and Ahmed, Khabab Abbasher Hussien Mohamed and Mohammed, Omer and Mohammed, Shafiu and Mokdad, Ali H and Momani, Shaher and Moradi-Lakeh, Maziar and Morovvati, Mahdis and Heris, Reza Mosaddeghi and Munjal, Kavita and Munkhsaikhan, Yanjinlkham and Murillo-Zamora, Efren and Murray, Christopher J L and Mustafa, Ghulam and Naddafi, Fatemehzahra and Natto, Zuhair S and Nepal, Gaurav and Newton, Charles Richard James and Nguyen, Cao Duy and Nguyen, Cuong Tat and Nguyen, Hien Thu and Nguyen, Long and Niazi, Robina Khan and Nieddu, Luciano and Nugen, Fred and Nwakama, Chijindu N and Nzoputam, Ogochukwu Janet and Oancea, Bogdan and Oduro, Michael Safo and Okati-Aliabad, Hassan and Olagunju, Andrew T and Oliveira, Arão Belitardo and Ouyang, Jia and Overton, Mark and Owolabi, Mayowa O and A, Mahesh P and Palena, Giuseppina and Panos, Leonidas D and Pantazopoulos, Ioannis and Pardhan, Shahina and Parikh, Romil R and Parmar, Arpit and Pasovic, Maja and Patil, Shankargouda and Patra, Apurba and Pedersini, Paolo and Peres, Mario F P and Perna, Simone and Perveen, Wajida and Pham, Hai Quang and Prakash, Sanjay and Prashant, Akila and Puvvula, Jagadeesh and Radojcic, Maja R and Raggi, Alberto and Rahman, Mohammad Meshbahur and Rahmani, Amir Masoud and Ramadan, Mahmoud Mohammed and Rathish, Devarajan and Rawaf, Salman and Rezaeian, Mohsen and Rhee, Taeho Gregory and Romadlon, Debby Syahru and Romoli, Michele and Romozzi, Marina and Saeed, Umar and Saghazadeh, Amene and Sahebkar, Amirhossein and Saleh, Mohamed A and Salimi, Sohrab and Samy, Abdallah M and Santos, Lucas H C C and Saravanan, Aswini and Sarma, Hemen and Senol, Yigit Can and Sethi, Yashendra and Shaalan, Yara Khaled Fouad Sayed and Shahid, Wajeehah and Shamsi, Anas and Shan, Dan and Sharifan, Amin and Shenoy, Rekha Raghuveer and Shetty, Premalatha K and Eshkiki, Zahra Shokati and Shrestha, Sunil and Singh, Harmanjit and Singh, Jasvinder A and Singh, Satwinder and Skryabin, Valentin Yurievich and Sobia, Farrukh and Sorensen, Reed J D and Straube, Sebastian and Swain, Chandan Kumar and Y, Sree Sudha T and Damavandi, Payam Tabaee and Tabche, Celine and Tanveer, Mohsan and Tareke, Minale and Tavares, Claudia Baptista and Temsah, Mohamad-Hani and Teramoto, Masayuki and Thirunavukarasu, Arun James and Tiwari, Ashutosh and Tran, Thang Huu and Duc, Nguyen Tran Minh and Tseriotis, Vasilis-Spyridon and Narayanappa, Santhosh Kumar Tumkur and Udoakang, Aniefiok John and Ullah, Himayat and Usman, Jibrin Sammani and Sambo, Abdulkadir Usman and Eynde, Jef Van den and Vasankari, Tommi Juhani and Venketasubramanian, Narayanaswamy and Villafañe, Jorge Hugo and Wander, Arvinder and Wang, Wei and Wang, Xingxin and Wang, Yuan-Pang and Wiangkham, Taweewat and Wieckiewicz, Mieszko and Xu, Wanqing and (Syed), Saba Yahoo and Yismaw, Yazachew Engida and Yon, Dong Keon and Yonemoto, Naohiro and Yousuf, Abdilahi and Zanghì, Aurora and Zastrozhin, Michael and Zhang, Anthony Lin and Zhao, Zhongyi and Zielinska, Magdalena and Ong, Kanyin Liane and Steiner, Timothy J and Vos, Theo},
journal = {The Lancet Neurology},
year = {2025},
month = {dec},
volume = {24},
number = {12},
pages = {1005-1015},
doi = {10.1016/s1474-4422(25)00402-8},
url = {https://doi.org/10.1016/s1474-4422(25)00402-8}
}
@article{wijeratne2025global,
title = {Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021},
author = {Wijeratne, Tissa and Oh, Jiyeon and Kim, Soeun and Yim, Yesol and Kim, Min Seo and Shin, Jae Il and Oh, Yun-Seo and Jung, Raon and Kim, Yun Seo and Smith, Lee and Aalruz, Hasan and Abd-Rabu, Rami and Abdulah, Deldar Morad and Aboagye, Richard Gyan and Abolmaali, Meysam and Abtahi, Dariush and Abualhasan, Ahmed and Adedoyin, Rufus Adesoji and Adnani, Qorinah Estiningtyas Sakilah and Afrashteh, Fatemeh and Aggarwal, Navidha and Ahmad, Danish and Ahmadi, Ali and Ahmadi, Negar Sadat and Ahmadzade, Amir Mahmoud and Ahmed, Syed Anees and Awaidy, Salah Al and Alabbad, Sawsan and Alajlani, Muaaz M. and Al-Ajlouni, Yazan and Ali, Mohammed Usman and Ali, Syed Shujait and Ali, Waad and Almazan, Joseph Uy and Alshahrani, Najim Z. and Altaf, Awais and Al-Wardat, Mohammad and Alzoubi, Karem H. and Amiri, Sohrab and Amu, Hubert and Amusa, Ganiyu Adeniyi and Anderson, David B. and Anwar, Saleha and Areda, Demelash and Asghari-Jafarabadi, Mohammad and Ashina, Sait and Ashraf, Javed and Ashraf, Tahira and Azargoonjahromi, Ali and Bahurupi, Yogesh and Baig, Atif Amin and Bandyopadhyay, Soham and Bardhan, Mainak and Barqawi, Hiba Jawdat and Bashiri, Azadeh and Bastan, Mohammad-Mahdi and Bemanalizadeh, Maryam and Bensenor, Isabela M. and Berhie, Alemshet Yirga Yirga and Bhagavathula, Akshaya Srikanth and Bhaskar, Sonu and Bhat, Vivek and Bhatti, Gurjit Kaur and Bhatti, Jasvinder Singh and Bilgin, Cem and Biswas, Atanu and Bizzozero-Peroni, Bruno and Bustanji, Yasser and Cámera, Luis Alberto and Caronna, Edoardo and Carvalho, Andre F. and Chakraborty, Sandip and Ching, Patrick R. and Christodoulou, Nikos and Chu, Dinh-Toi and Chu, Hongyuan and Cruz-Martins, Natalia and Dadras, Omid and Dai, Xiaochen and D'Amico, Emanuele and Darwish, Amira Hamed and Deekonda, Sindhura and Devanbu, Vinoth Gnana Chellaiyan and Dharmaratne, Samath Dhamminda and Dima, Adriana and Dinkayehu, Temesgien Ergetie and Do, Huyen and Doku, Paul Narh and Doshi, Ojas Prakashbhai and E’mar, Abdel Rahman and Eissazade, Negin and Eltaha, Chadi and Fahim, Ayesha and Fares, Jawad and Kouhanjani, Mohsen Farjoud and Faro, Andre and Fazeli, Patrick and Fereshtehnejad, Seyed-Mohammad and Ferrara, Pietro and Ferreira, Nuno and Fischer, Florian and Fornari, Arianna and Gajdács, Márió and Gebregergis, Miglas Welay and Ghadimi, Delaram J. and Jolfayi, Amir Ghaffari and Gnedovskaya, Elena V. and Golechha, Mahaveer and Figueroa, Enrique Gomez and Hashempur, Mohammad Hashem and Hasnain, Md Saquib and Hassan, Amr and Hassan, Nageeb and Tabatabaei, Mahgol Sadat Hassan Zadeh and Hegazy, Mohamed I. and Heidari, Golnaz and Helfer, Bartosz and Hossain, Md Mahbub and Househ, Mowafa and Hu, Chengxi and Iavicoli, Ivo and Ilesanmi, Olayinka Stephen and Ilic, Irena M. and Ilyas, Muhana Fawwazy and Ilyasu, Salim and Ismail, Nahlah Elkudssiah and Jafari-Khounigh, Ali and Jahrami, Haitham and Janodia, Manthan Dilipkumar and Jayasinghe, Ruwan Duminda and Jeswani, Bijay Mukesh and Jonas, Jost B. and Joseph, Nitin and Kalani, Rizwan and Khan, Moien A.B. and Khateri, Sorour and Khatib, Mahalaqua Nazli and Kashani, Hamid Reza Khayat and Khidri, Feriha Fatima and Khormali, Moein and Khosravi, Sepehr and Kim, Yun Jin and Kompani, Farzad and Kostev, Karel and Krishan, Kewal and Krishnan, Bindu and Defo, Barthelemy Kuate and Kuddus, Mohammed and Kulimbet, Mukhtar and Kumar, Rakesh and Kumar, Vijay and Kytö, Ville and Lasrado, Savita and Lee, Seung Won and Lenzi, Jacopo and Leonardi, Matilde and Lucchetti, Giancarlo and Lugo, Alessandra and Makhdoom, Irsa Fatima and Mallahzadeh, Arashk and Mansouri, Vahid and Marzo, Roy Rillera and Mathangasinghe, Yasith and Mayeli, Mahsa and Mehmood, Asim and Meretoja, Atte and Mestrovic, Tomislav and Mettananda, Sachith and Minervini, Giuseppe and Mishra, Archana and Mithra, Prasanna and Ahmed, Khabab Abbasher Hussien Mohamed and Mohammadzadeh, Ibrahim and Mohammed, Shafiu and Monasta, Lorenzo and Morrison, Shane Douglas and Nabavi, Amin and Natto, Zuhair S. and Nauman, Javaid and Nieddu, Luciano and Nugen, Fred and Olagunju, Andrew T. and Oliveira, Arão Belitardo and Oliveira, Welber Sousa and Omar, Hany A. and Omer, Goran Latif and Otstavnov, Nikita and A, Mahesh P and Panos, Leonidas D. and Parikh, Romil R. and Patil, Shankargouda and Patra, Apurba and Pedersini, Paolo and Pensato, Umberto and Peprah, Prince and Peres, Mario F.P. and Piradov, Michael A. and Pozo-Rosich, Patricia and Pradhan, Jalandhar and Prakash, Sanjay and Prashant, Akila and Puvvula, Jagadeesh and Rafiei, Alireza and Raggi, Alberto and Rahmani, Amir Masoud and Ramadan, Mahmoud Mohammed and Rathish, Devarajan and Rautalin, Ilari and Rawaf, Salman and Rezaeian, Mohsen and Eidgahi, Donya Rezazadeh and Rhee, Taeho Gregory and Roy, Priyanka and Eddin, Adnan Saad and Sabet, Cameron John and Saddik, Basema Ahmad and Sadeghi, Erfan and Saeed, Umar and Sharif-Askari, Fatemeh Saheb and Sharif-Askari, Narjes Saheb and Sahoo, Pragyan Monalisa and Salimi, Sohrab and Samy, Abdallah M. and Saulam, Jennifer and Sawhney, Monika and Senol, Yigit Can and Senthilkumaran, Subramanian and Sethi, Yashendra and Seyedmirzaei, Homa and Shafie, Mahan and Shamsi, Anas and Sharifan, Amin and Shehata, Hatem Samir and Shenoy, Rekha Raghuveer and Shokraneh, Farhad and Sidhu, Jaspreet Kaur and Singh, Baljinder and Singh, Harmanjit and Singh, Jasvinder A. and Singh, Surjit and Skryabina, Anna Aleksandrovna and Sobia, Farrukh and Srichawla, Bahadar S. and Suresh, Vinay and Swain, Chandan Kumar and Y, Sree Sudha T and Damavandi, Payam Tabaee and Tabche, Celine and Tabish, Mohammad and Tanwar, Manoj and Temsah, Mohamad-Hani and Teramoto, Masayuki and Tran, Nghia Minh and Tran, Thang Huu and Tsatsakis, Aristidis and Udoakang, Aniefiok John and Usman, Jibrin Sammani and Uzunçıbuk, Hande and Eynde, Jef Van den and Vasankari, Tommi Juhani and Venketasubramanian, Narayanaswamy and Villafañe, Jorge Hugo and Wang, Lintao and Wang, Xingxin and Wang, Yuan-Pang and Wiangkham, Taweewat and Winkler, Andrea Sylvia and Wollie, Alemayehu Molla and Xiao, Zheman and Yismaw, Yazachew Engida Engida and Yousuf, Abdilahi and Zhao, Zhongyi and Zielińska, Magdalena and Chu, Min Kyung and Song, Tae-Jin and Yon, Dong Keon and Feigin, Valery L.},
journal = {Cell Reports Medicine},
year = {2025},
month = {oct},
volume = {6},
number = {10},
pages = {102348},
doi = {10.1016/j.xcrm.2025.102348},
url = {https://doi.org/10.1016/j.xcrm.2025.102348}
}
@article{force2025global,
title = {The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023},
author = {Force, Lisa M and Kocarnik, Jonathan M and May, Miranda L and Bhangdia, Kayleigh and Crist, Andrew and Penberthy, Louise and Pritchett, Natalie and Acheson, Alistair and Deitesfeld, Lee and A, Bhoomadevi and Aalruz, Hasan and Abbas, Nasir and bashash, Maryam Abbasalipour and Magied, Abdallah H A Abd Al and ElHafeez, Samar Abd and Abdalla, Ashraf Nabiel and Abdalla, Mohammed Altigani and Abdel-Rahman, Wael M and Abdi, Parsa and Abdisa, Wakgari Mosisa and Abdissa, Daba and Abdollahi, Arash and Abdoun, Meriem and Abdous, Arman and Abdullahi, Auwal and Abebe, Mesfin and Abedi, Armita and Abidi, Syed Hani and Abie, Alemwork and Abiodun, Olumide and Aboagye, Richard Gyan and Abolhassani, Hassan and Abonie, Ulric Sena and Abreu, Lucas Guimarães and Abubakar, Aminu Kende and Abubakar, Bilyaminu and Abu-Gharbieh, Eman and Abukhadijah, Hana J and Aburuz, Salahdein and Abu-Zaid, Ahmed and Achar, Raghu Ram and Acuna, Juan Manuel and Adams, Lisa C and Adamu, Lawan Hassan and Addo, Isaac Yeboah and Adedokun, Kamoru Ademola and Adegoke, Nurudeen A and Adekanmbi, Victor and Adesiyan, Ibukun Modupe and Adewuyi, Habeeb Omoponle and Adiga, Usha and Adnani, Qorinah Estiningtyas Sakilah and Adoma, Prince Owusu and Adzigbli, Leticia Akua and Afifi, Ahmed M and Afolabi, Aanuoluwapo Adeyimika and Afrashteh, Fatemeh and Afrooghe, Arya and Afzal, Muhammad Sohail and Agampodi, Suneth Buddhika and Aggarwal, Navidha and Agide, Feleke Doyore and Sobrinho, César Agostinis and Agyemang-Duah, Williams and Ahinkorah, Bright Opoku and Ahmad, Aqeel and Ahmad, Danish and Ahmad, Faisal and Ahmad, Khurshid and Ahmad, Muayyad M and Ahmad, Sajjad and Ahmad, Tauseef and Ahmadi, Elham and Ahmadzade, Amir Mahmoud and Ahmadzade, Mohadese and Ahmed, Anisuddin and Ahmed, Ayman and Ahmed, Gasha Salih and Ahmed, Ibrar and Ahmed, Luai A and Ahmed, Mehrunnisha Sharif and Ahmed, Meqdad Saleh and Ahmed, Muktar Beshir and Ahmed, Nesredin and Ahmed, Syed Anees and Ajala, Dolapo Emmanuel and Ajami, Marjan and Akhigbe, Roland Eghoghosoa and Akinosoglou, Karolina and Awaidy, Salah Al and Hamad, Hanadi Al and Hasan, Syed Mahfuz Al and Omari, Omar Al and Qadire, Mohammad Al and Thaher, Yazan Al and Zaabi, Omar Ali Mohammed Al and Alam, Khurshid and Alam, Zufishan and Alansari, Amani and Al-Ashwal, Fahmi Y and Al-Daken, Laila Ismael and Aldhaleei, Wafa A and Aleidi, Shereen M and Alemayehu, Bezawit Abeje and Al-Eyadhy, Ayman and Algammal, Abdelazeem M and Al-Gheethi, Adel Ali Saeed and Al-Hanawi, Mohammed Khaled and Alhuwail, Dari and Ali, Abid and Ali, Endale Alemayehu and Ali, Mohammad Daud and Ali, Mohammed Usman and Ali, Rafat and Ali, Syed Shujait and Ali, Waad and Alif, Sheikh Mohammad and Al-Jabi, Samah W and Aljunid, Syed Mohamed and Alkhatib, Ahmad and Almasri, Nihad A and Al-Mekhlafi, Hesham M and Alnaeem, Mohmmad Minwer and Alniss, Hasan Yaser and Sukumar, Margret Beaula Alocious and Alomari, Mahmoud A and Alosta, Mohammad R and Alqahtani, Saleh A and Al-Qudimat, Ahmad Rajeh and Al-Raddadi, Rajaa M Mohammad and Alrawashdeh, Ahmad and Alrimawi, Intima and Alrousan, Sahel Majed and Al-Sabah, Salman Khalifah and Alshahrani, Najim Z and Altaf, Awais and Al-Tammemi, Alaa B and Alvarez, Elysia M and Alvis-Guzman, Nelson and Al-Worafi, Yaser Mohammed and Aly, Hany and Alyahya, Mohammad Sharif Ibrahim and Alzoubi, Abdallah and Alzoubi, Karem H and Al-Zubayer, Md Akib and Mohammadi, Masoud Aman and Amin, Tarek Tawfik and Amindarolzarbi, Alireza and Aminnia, Shiva and Aminu, Nafiu and Amirzade-Iranaq, Mohammad Hosein and Amu, Hubert and Amusa, Ganiyu Adeniyi and Ancuceanu, Robert and Anderlini, Deanna and Anil, Abhishek and Anoushiravani, Amir and Ansariniya, Hossein and Anuoluwa, Iyadunni Adesola and Anvari, Saeid and Anwar, Saleha and Anwar, Sumadi Lukman and Anwer, Razique and Anyabolo, Ekenedilichukwu Emmanuel and Anyasodor, Anayochukwu Edward and Apeagyei, Angela Esi and Arab, Juan Pablo and Arabloo, Jalal and Bahri, Razman Arabzadeh and Arafa, Elshaimaa A and Arafat, Mosab and Aravkin, Aleksandr Y and Arcieri, Martina and Areda, Demelash and Ariffin, Hany and Arkew, Mesay and Artamonov, Anton A and Arul, Santhosh and Arumuganainar, Deepavalli and Asghari-Jafarabadi, Mohammad and Ashames, Akram and Ashraf, Muhammad Abdul Basit and Ashraf, Tahira and Asiamah-Asare, Bernard Kwadwo Yeboah and Asmerom, Haftu Asmerom and Assembekov, Batyrbek and Asthana, Smita and Atorkey, Prince and Atout, Maha Moh'd Wahbi and Atta, Julie Alaere and Ausloos, Marcel and Awedew, Atalel Fentahun and Awotidebe, Adedapo Wasiu and Quintanilla, Beatriz Paulina Ayala and Ayatollahi, Haleh and Ayyoubzadeh, Seyed Mohammad and Azargoonjahromi, Ali and Azimi, Amirali and Aziz, Mohd Yusmaidie and Aziz, Sadat Abdulla and Aziz, Shahkaar and Azizi, Hosein and Azzam, Ahmed Y and Badar, Muhammad and Badiye, Ashish D and Badran, Alaa Aboelnour and Bagheri, Nasser and Baghizadeh, Fereshteh and Bahreini, Razieh and Bai, Ruhai and Baig, Atif Amin and Bains, Lovenish and Bajpai, Ram Chandra and Bakkannavar, Shankar M and Bala, Auwal Adam and Balcha, Wondu Feyisa and Hasankhani, Mohammadreza Balooch and Bandyopadhyay, Soham and Banik, Rajon and Barac, Aleksandra and Barati, Shirin and Bardhan, Mainak and Barker-Collo, Suzanne Lyn and Barqawi, Hiba Jawdat and Barrow, Amadou and Basharat, Zarrin and Bashir, Shahid and Basiru, Afisu and Baskaran, Pritish and Bastan, Mohammad-Mahdi and Batra, Kavita and Bauckneht, Matteo and Bayati, Mohsen and Bayisa, Feyisa Shasho and Beeraka, Narasimha M and Behnam, Babak and Behnoush, Amir Hossein and Behzadi, Payam and Ramirez, Diana Fernanda Bejarano and Belachew, Sewunet admasu and Bilgin, Gokce Belge and Belo, Luis and Benzian, Habib and Berhie, Alemshet Yirga Yirga and Bermudez, Amiel Nazer C and Bhadoria, Ajeet Singh and Bhagavathula, Akshaya Srikanth and Bhakta, Nickhill and Bhala, Neeraj and Bharadwaj, Ravi and Bhardwaj, Nikha and Bhardwaj, Pankaj and Bhardwaj, Prarthna V and Bhaskar, Sonu and Bhat, Ajay Nagesh and Bhat, Vivek and Bhattacharjee, Shuvarthi and Bhatti, Gurjit Kaur and Bhatti, Jasvinder Singh and Bhuiyan, Mohiuddin Ahmed and Bhuyan, Soumitra S and Bievel-Radulescu, Raluca and Bilgin, Cem and Bisignano, Catherine and Biswas, Mohammad Shahangir and Biswas, Monirujjaman and Bizzozero-Peroni, Bruno and Bjørge, Tone and Bodhare, Trupti and Bolarinwa, Obasanjo Afolabi and Boloor, Archith and Borhany, Hamed and Bosoka, Samuel Adolf and Carvajal, Alejandro Botero and Bouaoud, Souad and Bozic, Marija M and Braithwaite, Dejana and Brauer, Michael and Brenner, Hermann and Bui, Linh Phuong and Burkart, Katrin and Busch, Felix and Bustamante-Teixeira, Maria Teresa and Bustanji, Yasser and Butt, Nadeem Shafique and Butt, Zahid A and Cai, Guangyao and Cámera, Luis Alberto and Campos-Nonato, Ismael and Cao, Si and Cao, Yubin and Capodici, Angelo and Carreras, Giulia and Carvalho, Márcia and Castañeda-Orjuela, Carlos A and Catalá-López, Ferrán and Cattaruzza, Maria Sofia and Cegolon, Luca and Cembranel, Francieli and Cerin, Ester and Cernigliaro, Achille and Cerrai, Sonia and Chakraborty, Aditya and Chakraborty, Chiranjib and Chakraborty, Sandip and Chandika, Rama Mohan and Chattu, Vijay Kumar and Chaudhary, Anis Ahmad and Chaudhuri, Sirshendu and Chaurasia, Akhilanand and Chemeda, Galmesa Bekana and Chen, Hana and Chen, Kai and Chen, Meng Xuan and Chichagi, Fatemeh and Chimed-Ochir, Odgerel and Ching, Patrick R and Chirinos-Caceres, Jesus Lorenzo and Cho, William C S and Choi, Dong-Woo and Choi, Sungchul and Chong, Bryan and Chong, Yuen Yu and Chopra, Hitesh and Chopra, Shivani and Chou, Hou In and Choudhari, Sonali Gajanan and Chu, Dinh-Toi and Chukwu, Isaac Sunday and Chung, Eric and Chung, Sunghyun and Cioffi, Iolanda and Columbus, Alyssa and Conde, Joao and Costa, Vera Marisa and Cruz-Martins, Natalia and Dabo, Bashir and Dadras, Omid and Dai, Xiaochen and Dandona, Lalit and Dandona, Rakhi and D'Anna, Lucio and Danpanichkul, Pojsakorn and Soltani, Reza Darvishi Cheshmeh and Darwesh, Aso Mohammad and Das, Saswati and Dash, Nihar Ranjan and Dashti, Mohsen and Dassah, Cornelius and Davletov, Dimash and Hoz, Fernando Pio De la and Dean, Frances E and Dee, Edward Christopher and Deekonda, Sindhura and Delsoz, Mohammad and Demeke, Abel Desalegn and Denova-Gutiérrez, Edgar and Desai, Rupak and Desale, Aragaw Tesfaw and Dessie, Gashaw and Devegowda, Devananda and Dewan, Syed Masudur Rahman and Dhali, Arkadeep and Dhane, Amol S and Dhimal, Meghnath and Dhingra, Sameer and Dhungel, Bibha and Pumpo, Marcello Di and Diaz, Luis Antonio and Diaz, Michael J and Do, Thao Huynh Phuong and Doaei, Saeid and Dondi, Francesco and Dorostkar, Fariba and Santos, Wendel Mombaque dos and Doshi, Ojas Prakashbhai and Doshmangir, Leila and Dosumu, Taiwo Omotayo and Dowou, Robert Kokou and Dresse, Menayit Tamrat and Dube, John and Duraisamy, Senbagam and Durojaiye, Oyewole Christopher and Dutta, Sulagna and Dziedzic, Arkadiusz Marian and E'mar, Abdel Rahman and Edinur, Hisham Atan and Eftekhari, Behrad and Sedeh, Ashkan Eighaei and Ekholuenetale, Michael and Ekundayo, Temitope Cyrus and Arab, Rabie Adel El and Omri, Abdelfatteh EL and Sayed, Iman El and Zaki, Maysaa El Sayed and Elahi, Reza and Elemam, Noha Mousaad and Elhadi, Muhammed and El-Huneidi, Waseem and Elkannishy, Sherif and Elmehrath, Ahmed O and Elmoselhi, Adel B and Elsheikh, Randa and El-Sherbiny, Yasser Mohamed and Elsohaby, Ibrahim and Eltahawy, Abdelgawad Salah Abdelgawad and Eltahir, Mohd Elmagzoub and Haque, Syed Emdadul and Emeto, Theophilus I and Emran, Talha Bin and Endeshaw, Destaw and Eshrati, Babak and Eslami, Majid and Ezzikouri, Sayeh and Fadavian, Heidar and Fagbamigbe, Adeniyi Francis and Fahim, Ayesha and Fahimi, Saman and Fahira, Aamir and Fakhradiyev, Ildar Ravisovich and Fakhri-Demeshghieh, Aliasghar and Falzone, Luca and Farahani, Alireza and Farahmand, Mohammad and Faraji, Seyed Nooreddin and Faramarzpour, Mahsa and Farashi, Ebrahim and Farhana, Zaki and Faris, MoezAlIslam Ezzat Mahmoud and Faris, Pawan Sirwan and Faro, Andre and Farooque, Umar and Farrokhpour, Hossein and Fasanmi, Abidemi Omolara and Fasihi, Kiana and Fasusi, Emmanuel Toluwani and Fattahi, Hamed and Feizkhah, Alireza and Fekadu, Ginenus and Ferrante, Daniela and Ferrara, Pietro and Ferreira, Nuno and Fetensa, Getahun and Fischer, Florian and Fisher, James L and Florin, Bobirca Teodor and Folayan, Olumuyiwa Shola and Fornari, Arianna and Forouhari, Ali and Foroutan, Behzad and Fotouhi, Maryam and Fukumoto, Takeshi and Fukunaga, Ami and Gadanya, Muktar A and Gajdács, Márió and Gallus, Silvano and Gamawa, Adamu Usman and Gandhi, Aravind P and Gangachannaiah, Shivaprakash and Gangireddy, Mounika and Garlasco, Jacopo and Gautam, Rupesh K and Gebre, Feven Sahle and Gebregergis, Miglas Welay and Gebrehiwot, Mesfin and Gebremeskel, Teferi Gebru and Gebreslassie, Haftay Gebremedhin and Geremew, Gebremariam Wulie and Getahun, Genanew K and Ghafarian, Sadegh and Jolfayi, Amir Ghaffari and Gharaibeh, Lobna Faiz and Ghasrsaz, Haniyeh and Ghassemi, Fariba and Ghazy, Ramy Mohamed and Gholamalizadeh, Maryam and Gholizadeh, Nasim and Ghotbi, Elena and Giannakis, Konstantinos and Gil, Artyom Urievich and Gilani, Syed Abdullah and Girmay, Alem Abera and Girombelli, Alessandro and Goel, Amit and Goel, Anil Kumar and Golechha, Mahaveer and Golinelli, Davide and Goodarzian, MReza and Gorini, Giuseppe and Gu, Changhao and Guan, Shi-Yang and Guarducci, Giovanni and Gubari, Mohammed Ibrahim Mohialdeen and Guo, Zheng and Guo, Zhifeng and Gupta, Bhawna and Gupta, Sapna and Gutiérrez, Reyna Alma and Guzman-Esquivel, Jose and Habibzadeh, Adrina and Habibzadeh, Farrokh and Habibzadeh, Parham and Hadaro, Tesfahun Simon Simon and Hadi, Najah R and Haghmorad, Dariush and Nam, Nguyen Hai and Hailu, Haimanot Ewnetu and Halil, Hassen Mosa Mosa and Hamad, Islam M and Hamadeh, Randah R and Hamdy, Nadia M and Hameed, Sajid and Hanifi, Nasrin and Haque, Ashanul and Haro, Josep Maria and Hasaballah, Ahmed I and Hasan, Md Kamrul and Hasan, S M Mahmudul and Hasani, Fatemeh and Hasani, Hamidreza and Hasanzadeh, Alireza and Hashi, Abdiwahab and Hasnain, Md Saquib and Hassan, Ikrama Ibrahim and Hassan, Treska S and Tabatabaei, Mahgol Sadat Hassan Zadeh and Haubold, Johannes and Hay, Simon I and Hayat, Khezar and He, Guohua and He, Qiang and He, Wen-Qiang and Heibati, Behzad and Heidari, Mohammad and Herteliu, Claudiu and Hesami, Hamed and Heydari, Majid and Heydari, Mojtaba and Heydarifard, Zahra and Heyi, Demisu Zenbaba and Hezam, Kamal and Hiraike, Yuta and Hoang, Mai and Holla, Ramesh and Horita, Nobuyuki and Hoseinzadeh, Mehdi and Hosgood, H Dean and Hossain, Alamgir and Hossain, Md Mahbub and Hossain, Md Sabbir and Hossain, Mohammad Bellal and Hosseini, Mohammad-Salar and Adli, Ahmad Hosseinzadeh and Hostiuc, Mihaela and Hsieh, Vivian Chia-rong and Hu, Chengxi and Hu, Junjie and Huang, Junjie and Hushmandi, Kiavash and Hussain, Javid and Hussain, Salman and Hussein, Dursa and Hussein, Nawfal R and Husseiny, Mohamed Ibrahim and Huynh, Hong-Han and Iavicoli, Ivo and Ibitoye, Segun Emmanuel and Ibrahim, Reem and Ibrayeva, Anel and Idalsoaga, Francisco Javier and Iftikhar, Pulwasha Maria and Ikiroma, Adalia and Ilesanmi, Olayinka Stephen and Ilic, Irena M and Ilic, Milena D and Ilyas, Muhana Fawwazy and Ilyasu, Salim and Imam, Mohammad Tarique and Immurana, Mustapha and Imoh, Lucius Chidiebere and Iqbal, Javed and Isa, Mustafa Alhaji and Islam, Md Rabiul and Ismail, Faisal and Issa, Ramzy and Iwagami, Masao and Iwu, Chidozie Declan and Iyer, Mahalaxmi and Jacob, Louis and Jadidi-Niaragh, Farhad and Jafarzadeh, Abdollah and Jahrami, Haitham and Jain, Ayushi and Jairoun, Ammar Abdulrahman and Jaiswal, Abhishek and Jakovljevic, Mihajlo and Jaliliyan, Ali and Yengejeh, Reza Jalilzadeh and Jalloh, Mohamed L and Jamal, Qazi Mohammad Sajid and Jamil, Safayet and Javaid, Syed Sarmad and Jawaid, Talha and Jayarajah, Umesh and Jayaram, Shubha and Jayasinghe, Ruwan Duminda and Jee, Sun Ha and Jena, Diptismita and Jin, Shuai and Jin, Wenyi and Jokar, Mohammad and Jonas, Jost B and Joo, Tamas and Jose, Jobin and Joseph, Abel and Joseph, Nitin and Joshua, Charity Ehimwenma and Joukar, Farahnaz and Jürisson, Mikk and Juweid, Malik E and Jyoti, Anupam and Kaambwa, Billingsley and Kabir, Ali and Kabir, Zubair and Kabiri, Maryam and Kadir, Dler Hussein and Kalan, Ebbie and Kalankesh, Leila R and Kamal, Mehnaz and Kamal, Vineet Kumar and Kamarajah, Sivesh Kathir and Kamireddy, Arun and Kamorudeen, Ramat T. and Nejad, Fatemeh Kanaani and Kankam, Samuel Berchi and Kanmodi, Kehinde Kazeem and Kapoor, Neeti and Karajizadeh, Mehrdad and Karami, Jafar and Karasneh, Reema A and Karch, André and Karimi, Aliasghar and Karimi, Mohammad Amin and Karimzadhagh, Sahand and Karpiński, Tomasz M and Kashoo, Faizan Zaffar and Kauppila, Joonas H and Kaur, Navjot and Kausar, Mohd Adnan and Kazemi, Foad and Kebede, Fekadu Abera and Keshwani, Ariz and Kesse-Guyot, Emmanuelle and Khader, Yousef Saleh and Khajuria, Himanshu and Khalid, Asaad and Khalifa, Hazim O and Khalili, Anita and Khalili, Pantea and Khalilian, Alireza and Khalili-Tanha, Ghazaleh and khalis, Mohamed and Khamesipour, Faham and Khan, Ajmal and Khan, Faiz Ullah and Khan, Gulfaraz and Khan, Mohammad Jobair and Khan, Moien AB and Khan, Salman Ali and Khanmohammadi, Shaghayegh and Khatatbeh, Moawiah Mohammad and Khatib, Mahalaqua Nazli and Khayamzadeh, Maryam and Kashani, Hamid Reza Khayat and Kheradmand, Daniel and Khidri, Feriha Fatima and Khosla, Atulya Aman and Khosravi, Mohammad Ali and Khubchandani, Jagdish and Kim, Kwanghyun and Kim, Yun Jin and Kim, Yun Seo and Kimokoti, Ruth W and Kisa, Adnan and Kisa, Sezer and KM, Shivakumar and Kokkorakis, Michail and Kolahi, Ali-Asghar and Kompani, Farzad and Kong, Jianqiu and Konstas, Anastasios Georgios and Kostev, Karel and Kotnis, Ashwin Laxmikant and Laxminarayana, Sindhura Lakshmi Koulmane and Kretchy, Irene Akwo and Krishan, Kewal and Kuchay, Raja Amir Hassan and Kuddus, Mohammed and Kulimbet, Mukhtar and Kumar, Dewesh and Kumar, G Anil and Kumar, Nithin and Kumar, Vijay and Kundu, Satyajit and Kunutsor, Setor K and Kushawaha, Pramod Kumar and Kustanti, Christina Yeni Yeni and Kutluk, Tezer and Kuttikkattu, Ambily and Kuttybayev, Assylkhan and Kyei, Grace Kwakyewaa and Kyei-Arthur, Frank and Kytö, Ville and Vecchia, Carlo La and Ladan, Muhammad Awwal and Lahariya, Chandrakant and Lai, Daphne Teck Ching and Lai, Hanpeng and Lakanova, Balzhan and Lal, Dharmesh Kumar and Lám, Judit and Lanfranchi, Francesco and Lasrado, Savita and Latif, Mahrukh and Lauriola, Paolo and Lawal, Basira Kankia and Le, Huu-Hoai and Le, Minh Huu Nhat and Le, Nhi Huu Hanh and Le, Thao Thi Thu and Ledda, Caterina and Lee, Ivan and Lee, Sang-woong and Lee, Seung Won and Lee, Shaun Wen Huey and Lee, Wei-Chen and Legesse, Awol Yemane and Leigh, James and Leong, Elvynna and Li, Ming-Chieh and Li, Wang-Zhong and Li, Wei and Li, Xiaopan and Li, Yongze and Li, Zhengrui and Li, Zhihui and Lim, Stephen S and Lin, Queran and Liu, Chaojie and Liu, Gang and Liu, Jue and Liu and Liu, Xiaofeng and Liu, Xuefeng and Llanaj, Erand and Lubinda, Jailos and Lutambi, Angelina M and Lytras, Miltiadis D and Lytvyak, Ellina and Amin, Hawraz Ibrahim M and Ma, Zheng Feei and Maalman, Raymond Saa-Eru and Madadizadeh, Farzan and Madani, Seyedeh Panid and Mafi, Alireza and Maghazachi, Azzam A and Mahamed, Abdulahi Abdiwali and Mahmood, Nozad Hussein and Mahmoud, Mansour Adam and Mahumud, Rashidul Alam and Majeed, Azeem and Makram, Abdelrahman M and Makram, Omar M and Makris, Konstantinos Christos C and Malasala, Satyaveni and Maleki-Kakelar, Hadi and Malhotra, Kashish and Malik, Ahmad Azam and Malik, Iram and Malinga, Lesibana Anthony and Malta, Deborah Carvalho and Mansouri, Vahid and Mansourian, Marjan and Mansournia, Mohammad Ali and Mantovani, Lorenzo Giovanni and Mao, Changkun and Marateb, Hamid Reza and Marghani, Basma Hamed and Marino, Mirko and Martini, Santi and Martorell, Miquel and Marzo, Roy Rillera and Marzouk, Sammer and Mathangasinghe, Yasith and Mathur, Medha and Matozinhos, Fernanda Penido and Matthew, Indu Liz and McKee, Martin and McPhail, Steven M and Mechili, Enkeleint A and Meena, Jitendra Kumar and Meftah, Elahe and Mehboob, Riffat and Mehmood, Asim and Meto, Tesfahun Mekene and Meles, Hadush Negash and Melese, Addisu and Mendez-Lopez, Max Alberto and Mendoza, Walter and Menezes, Ritesh G and Menges, Dominik and Mengesha, Endalkachew Worku and Menon, Tara P and Mentis, Alexios-Fotios A and Meo, Sultan Ayoub Ayoub and Meretoja, Atte and Meretoja, Tuomo J and Mestrovic, Tomislav and Metwally, Mohamed M M and Miazgowski, Tomasz and Michalek, Irmina Maria and Miller, Ted R and Minervini, Giuseppe and Mirghafourvand, Mojgan and Misganaw, Awoke and Misra, Sanjeev and Mithra, Prasanna and Mogessie, Yidnek and Mohamadkhani, Ashraf and Mohamed, Jama and Mohamed, Mona Gamal and Mohamed, Nouh Saad and Mohammad, Karzan Abdulmuhsin and Mohammad, Taj and Mohammad-Alizadeh-Charandabi, Sakineh and Mohammadi, Abdolreza and Mohammadi, Mohammad Kazem and Mohammadi, Seyed Omid and Mohammadian-Hafshejani, Abdollah and Mohammadzadeh, Ibrahim and Mohammadzadeh, Zeinab and Mohammed, Al-Kassim Hassan and Mohammed, Mustapha and Mohammed, Shafiu and Mohsenzadeh, Amin and Mokdad, Ali H and Vardanjani, Hossein Molavi and Molinaro, Sabrina and Momani, Shaher and Monasta, Lorenzo and Moni, Mohammad Ali and Moradi, Yousef and Moraga, Paula and Morrison, Shane Douglas and Morsy, Mahmoud M and Mossialos, Elias and Motaharinezhad, Fatemeh and Motappa, Rohith and Yousefi, Kimia Mozahheb and Msherghi, Ahmed and Mubarak, Rabia and Mubarik, Sumaira and Mukoro, George Duke and Mulita, Admir and Munjal, Kavita and Murillo-Zamora, Efren and Mushtaq, Ali and Mushtaq, Saima and Mustafa, Sherzad Ibrahim and Muthupandian, Saravanan and Myung, Woojae and Nabavi, Amin and Nagarajan, Ahamarshan Jayaraman and Nagel, Gabriele and Naghavi, Pirouz and Naik, Gurudatta and Naimzada, Mukhammad David and Nainu, Firzan and Nair, Tapas Sadasivan and Najmuldeen, Hastyar Hama Rashid and Nam, Hae Sung and Nargus, Shumaila and Nartey, Yvonne and Nashwan, Abdulqadir J and Nassar, Mahmoud and Natto, Zuhair S and Nauman, Javaid and Nawsherwan and Nayak, Biswa Prakash and Nayon, Md Fahad Shahariar and Nazri-Panjaki, Athare and Ndishimye, Pacifique and Nega, Amanuel Tebabal and Negahdary, Masoud and Negoi, Ionut and Nejjari, Chakib and Nekouei, Omid and Nepal, Gaurav and Netsere, Henok Biresaw and Ngabonziza, Jean Claude Semuto Semuto and Nguyen, Cuong Tat and Nguyen, Dang and Nguyen, Kieu Viet Nhi and Nguyen, Nhan and Nguyen, The Phuong and Nguyen, Tuan Thanh and Nguyen, Van Thanh and Niazi, Robina Khan and Nieddu, Luciano and Nikravangolsefid, Nasrin and Niranjan, Vikram and Niyonsenga, Jean Marie Vianney and Nnaji, Chukwudi A and Nnyanzi, Lawrence Achilles and Nomura, Shuhei and Noor, Nurulamin M and Noor, Syed Toukir Ahmed and Noorafrooz, Mohammadamin and Noroozi, Masoud and Nri-Ezedi, Chisom Adaobi and Nugen, Fred and Nurrika, Dieta and Nzoputam, Chimezie Igwegbe and Nzoputam, Ogochukwu Janet and Oancea, Bogdan and Obakachi, Vincent Adeiza and Odetokun, Ismail A and Oduro, Michael Safo and Oguta, James Odhiambo and Oh, In-Hwan and Okati-Aliabad, Hassan and Okeke, Sylvester Reuben and Okekunle, Akinkunmi Paul and Okonji, Osaretin Christabel and Olagunju, Andrew T and Olanrewaju, Timothy Olusegun Olusegun and Olatubi, Matthew Idowu and Omage, Folorunsho Bright and Omar, Hany A and Omer, Goran Latif and Omonisi, Abidemi E and Ong, Sok King and Onwujekwe, Obinna E and Opitz, Marcel and Ordak, Michal and Orish, Verner N and Orscelik, Atakan and Ortiz-Prado, Esteban and Osborne, Augustus and Osman, Alaa AM and Ostroff, Samuel M and Osuagwu, Uchechukwu Levi and Othman, Elham H and Otorkpa, Oche Joseph and Otstavnov, Stanislav S and Ouyahia, Amel and Owolabi, Mayowa O and Oyebanji, Oladayo Ayobami and Oyebola, Kolapo and Ozsahin, Ilker and A, Mahesh P and Padron-Monedero, Alicia and Padubidri, Jagadish Rao and Palicz, Tamás and Panda, Sujogya Kumar and Panda-Jonas, Songhomitra and Katare, Deepshikha Pande and Pandi-Perumal, Seithikurippu R and Pang, Ke and Panos, Georgios D and Panos, Leonidas D and Pantazopoulos, Ioannis and Papa, Mario Virgilio and Paranjkhoo, Parinaz and Roudsari, Peyvand Parhizkar and Parikh, Romil R and Park, Eun-Cheol and Pasovic, Maja and Passera, Roberto and Patel, Jay and Patel, Riya Jayesh and Patil, Shankargouda and Patra, Apurba and Toroudi, Hamidreza Pazoki and Pekarcikova, Jarmila and Pensato, Umberto and Peprah, Prince and Pereira, Jeevan and Peres, Mario F P and Perna, Simone and Pestell, Richard G and Peter, Olumuyiwa James and Petermann-Rocha, Fanny Emily and Pham, Hoang Tran and Pham, Tung Thanh and Pierannunzio, Daniela and Pillay, Julian David and Piracha, Zahra Zahid and Pirouzpanah, Saeed and Poluru, Ramesh and Avudaiappan, Arjun Pon and Postma, Maarten J and Pourbabaki, Reza and Pourghazi, Farzad and Prabhu, Disha and Pradhan, Jalandhar and Prakash, Peralam Yegneswaran and Prasad, Chandra P and Prashant, Akila and Prates, Elton Junio Sady and Pribadi, Dimas Ria Angga and Puvvula, Jagadeesh and Qazi, Asma Saleem and Qiu, Suli and Qurbani, Karzan and Shahraki, Hadi Raeisi and Rafiee, Ata and Rafiei, Alireza and Raghuveer, Pracheth and Rahim, Hawbash Mohammed-Amin and Rahman, Fryad Majeed and Rahman, Md Mijanur and Rahman, Mohammad Meshbahur and Rahman, Mosiur and Rahman, Muhammad Aziz and Rahmani, Amir Masoud and Rahmani, Saeed and Rahmati, Masoud and Rai, Pramila and Raimondo, Diego and Raimondo, Ivano and Rajaa, Sathish and Rajabi, Rayan and Rajizadeh, Mohammad Amin and Ramadan, Majed and Ramasamy, Chitra and Ramasamy, Shakthi Kumaran and Ramesh, Pushkal Sinduvadi and Ramezani, Zahra and Rana, Juwel and Rana, Rishabh Kumar and Rancic, Nemanja and Noei, Fatemeh Ranjbar and Rao, Christopher and Rao, Kumuda and Rao, Mithun and Rao, Sowmya J and Rashedi, Vahid and Rashidi, Mohammad-Mahdi and Rathish, Devarajan and Rauniyar, Santosh Kumar and Rautalin, Ilari and Rawaf, Salman and Rawal, Lal and Redwan, Elrashdy and Rege, Sanika and Reis-Mendes, Ana and Restaino, Stefano and Rezaei, Nazila and Rezaei, Negar and Rezaei, Nima and Rezaeian, Mohsen and Silva, Tércia Moreira Ribeiro da and Guerra, Maximiliano Ribeiro Ribeiro and Rizvi, Moattar Raza and Roberts, Thomas J and Rocha, Hermano Alexandre Lima and Rocha-Gomes, João Rocha and Silva, Thales Philipe Rodrigues da and Rohilla, Ravi and Rohloff, Peter and Root, Kevin T and Roshandel, Gholamreza and Roshanshad, Amirhossein and Rout, Himanshu Sekhar and Rovera, Guido and Roy, Nitai and Roy, Sharmistha and Saber, Korosh and Saber-Ayad, Maha Mohamed and Sabet, Cameron John and Sabour, Siamak and Saddik, Basema Ahmad and Sadegh, Tarannom and Saeb, Mohammad Reza and Saeed, Kanza and Saeed, Mohd and Saeed, Umar and Saghazadeh, Amene and Sharif-Askari, Fatemeh Saheb and Sharif-Askari, Narjes Saheb and Sahebkar, Amirhossein and Sahoo, Pragyan Monalisa and Sahoo, Soumya Swaroop and Sajid, Mirza Rizwan and Saleh, Mohamed A and Salehi, Leili and Farrokhi, Amir Salek and Salem, Marwa Rashad and Salimi, Sohrab and Samadi, Pouria and Samaranayake, Jayami Eshana and Samodra, Yoseph Leonardo and Samy, Abdallah M and Sanabria, Juan and Santric-Milicevic, Milena M and Sarasmita, Made Ary and Saravanan, Aswini and Sargazi, Saman and Sarkar, Tanmay and Sarode, Gargi Sachin and Sarode, Sachin C and Sarveazad, Arash and Sassano, Michele and Sathian, Brijesh and Satpathy, Maheswar and Sattarpour, Reza and Saulam, Jennifer and Sawhney, Monika and Saxena, Juhi and Schaarschmidt, Benedikt Michael and Schinckus, Christophe and Schneider, Ione Jayce Ceola and Schuermans, Art and Schumacher, Austin E and Sekar, Durairaj and Sekaran, Saravanan and Šekerija, Mario and Semreen, Mohammad H and Sendekie, Ashenafi Kibret and Sengupta, Pallav and Senol, Yigit Can and Senthilkumaran, Subramanian and Serban, Dragos and Sethi, Yashendra and Alshohadaei, Seyed Mohammad Seyed and Seyedmirzaei, Homa and Seylani, Allen and Shabany, Maryam and Shafie, Mahan and Shahab, Muhammad and Shahbandi, Ataollah and Shahid, Samiah and Shahid, Syed Ahsan Ahsan and Shahsavari, Hamid R and Shahwan, Moyad Jamal and Shaikh, Masood Ali and Shamim, Muhammad Aaqib and Shams, Elahe and Shams-Beyranvand, Mehran and Shamsi, Anas and Shamsutdinova, Alfiya and Shan, Dan and Shanawaz, Mohd and Shankar, Abhishek and Shannawaz, Mohammed and Sharew, Nigussie Tadesse and Sharifan, Amin and Sharma, Manoj and Sharma, Rajesh and Sharma, Ujjawal and Sharma, Vishal and Shastry, Shamee and Shawahna, Ramzi and Shayan, Maryam and Sheida, Fateme and Sherchan, Samendra P and Shetty, Pavanchand H and Shetty, Premalatha K and Shetty, Ranjitha S and Shetty, Suraj S and Shibani, Mosa and Shittu, Aminu and Shivarov, Velizar and Eshkiki, Zahra Shokati and Shongwe, Sinegugu Nosipho and Shool, Sina and Shorofi, Seyed Afshin and Shrestha, Sunil and Shuval, Kerem and Si, Yafei and Sibuyi, Nicole R S and Siddig, Emmanuel Edwar and Siddiqi, Ahmed Kamal and Silva, Luís Manuel Lopes Rodrigues and Singh, Amit and Singh, Baljinder and Singh, Harmanjit and Singh, Jasvinder A and Singh, Kalpana and Singh, Mayank and Singh, Paramdeep and Singh, Prashant Kumar and Singh, Puneetpal and Singh, Satwinder and Singh, Surjit and Sinha, Mukesh Kumar and Sitas, Freddy and Siyoum, Dagne Feleke and Skryabina, Anna Aleksandrovna and Smith, Amanda E and Sobia, Farrukh and Solikhah and Soliman, Sameh S M and Sood, Aayushi and Spearman, Sandra and Srichawla, Bahadar S and Srinivasamurthy, Suresh Kumar and Srivastava, Devin Bailey and Straif, Kurt and Subramaniyan, Vetriselvan and Suleiman, Auwal Garba and Odidi, Muritala Odidi Suleiman and Suleman, Muhammad and Sulistiyorini, Desy and Meo, Anusha Sultan and Sun, Zhong and Suresh, Vinay and Susianti, Hani and Swain, Chandan Kumar and Szarpak, Lukasz and Y, Sree Sudha T and Damavandi, Payam Tabaee and Tabarés-Seisdedos, Rafael and Tabatabaei, Fatemeh Sadat and Tabatabaei, Seyyed Mohammad and Tabibi, Ramin and Tabish, Mohammad and Taha, Seyed Reza and Abkenar, Yasaman Taheri and Soodejani, Moslem Taheri and Taiba, Jabeen and Talaat, Iman M and Tampa, Mircea and Tamuzi, Jacques Lukenze and Tan, Ker-Kan and Tanwar, Manoj and Tariq, Saba and Tavangar, Seyed Mohammad and Taye, Birhan Tsegaw and Tbakhi, Abdelghani and Tekola, Abainash and Temsah, Mohamad-Hani and Terefa, Dufera Rikitu and Tesfamariam, Wegen Beyene and Teye-Kwadjo, Enoch and Thangavelu, Lakshmi and Thapar, Rekha and Thayakaran, Rasiah and Sundaram, Mahalakshmi Thayumana and Theyra-Enias, Hadiza and Thomas, Nihal and Thomas, Nikhil Kenny and Ticoalu, Jansje Henny Vera and Tiruye, Tenaw Yimer and Tiwari, Krishna and Topor-Madry, Roman and Toriola, Adetunji T and Touvier, Mathilde and Tovani-Palone, Marcos Roberto and Traini, Eugenio and Tran, Bach Xuan and Tran, Ngoc Ha and Tran, Quynh Thuy Huong and Tran, Thang Huu and Trico, Domenico and Tsatsakis, Aristidis and Tualeka, Abdul Rohim and Amirikah, Mike Tuffour and Tuglo, Lawrence Sena and Ullah, Atta and Ullah, Saeed and Umakanthan, Srikanth and Umar, Lawan and Umar, Shehu Salihu and Umar, Umar Muhammad and Unim, Brigid and Unnikrishnan, Bhaskaran and Upadhya, Dinesh and Vaithinathan, Asokan Govindaraj and Vakili, Omid and Eynde, Jef Van den and Varasteh, Javad and Varthya, Shoban Babu and Vaziri, Siavash and Vellingiri, Balachandar and Verma, Madhur and Veroux, Massimiliano and Verras, Georgios-Ioannis and Villa, Simone and Villanueva, Gabriela Ines and Violante, Francesco S and Vizzielli, Giuseppe and Vladimirov, Sergey Konstantinovitch and Vlassov, Vasily and Vollset, Stein Emil and Vounzoulaki, Elpida and Waheed, Yasir and Wang, Cong and Wang, Ruixuan and Wang, Xing and Wang, Yanzhong and Waqas, Muhammad and Ward, Paul and Wassie, Toyiba Hiyaru and Weerakoon, Kosala Gayan and Westerman, Ronny and Wicaksana, Anggi Lukman and Wickramasinghe, Dakshitha Praneeth and Wickramasinghe, Nuwan Darshana Darshana and Wijarnpreecha, Karn and Willeit, Peter and Wojewodzic, Marcin W and Wolf, Axel Walter and Wu, Felicia and Wu, James Fan and Wu, Zenghong and Xia, Qing and Xia, Zhijia and Xiao, Lishun and Xie, Wanqing and Xu, Libo and Xu, Suowen and Xue, Mingyang and Yadav, Mukesh Kumar and Yahya, Galal and Yarahmadi, Amir and Yassin, Mohamed A and Yaya, Sanni and Ye, Pengpeng and Yesuf, Subah Abderehim and Yezli, Saber and Yin, Dehui and Yirdaw, Biksegn Asrat and Yon, Dong Keon and Yonemoto, Naohiro and Younis, Mustafa Z and Yousefi, Zabihollah and Yu, Chuanhua and Yuan, Chun-Wei and Zadnik, Vesna and Zafar, Syed Nabeel and Zaghampour, Manijeh and Zakham, Fathiah and Zaki, Nazar and Zamagni, Giulia and Zaman, Burhan Abdullah and Zaman, Sojib Bin and Sakhvidi, Mohammad Javad Zare and Zastrozhin, Michael and Zawiah, Mohammed and Zeariya, Mohammed G M and Zemariam, Alemu Birara and Zensen, Sebastian and Zhang, Jianrong and Zhang, Jingya and Zhang, Liqun and Zhang, Xiaoyi and Zhang, Zhi-Jiang and Zhao, Yang and Zheng, David X and Zheng, Jinxin and Zheng, Ming-Hua and Zhong, Anthony and Zhong, Claire Chenwen and Zhou, Jiayan and Zhou, Juexiao and Zhu, Bin and Zhumagaliuly, Abzal and Zielińska, Magdalena and Zitoun, Osama A and Zrieq, Rafat Mohammad and Zuber, Mohammed and Zyoud, Sa'ed H and Zyoud, Shaher H and Vos, Theo and Murray, Christopher J L},
journal = {The Lancet},
year = {2025},
month = {oct},
volume = {406},
number = {10512},
pages = {1565-1586},
doi = {10.1016/s0140-6736(25)01635-6},
url = {https://doi.org/10.1016/s0140-6736(25)01635-6}
}
Context: Clitoria ternatea, commonly known for its potential health benefits, is believed to possess anti-inflammatory properties and has been traditionally utilized for a variety of health applications. However, its effects on vaginal health and reproductive hormones remain underexplored. Aims: To assess the effects of C. ternatea on vaginal health by evaluating bacterial vaginosis occurrence, vaginal pH, Nugent scores, and inflammatory markers (TGF-β, IL-6) and to investigate its impact on reproductive hormones by measuring progesterone and estradiol levels. Methods: Thirty female participants were enrolled in a single-group pre- and post-test design study. Subject participants were given administration of C. ternatea 460 mg twice daily for 28 days. Demographic data and clinical evaluations were documented. Before and after the intervention, samples were collected for microscopic examination and ELISA-based assessment of TGF-β, IL-6, progesterone, and estradiol levels. Results: This study indicated that C. ternatea supplementation significantly reduced bacterial vaginosis occurrence from 93.1% to 51.7% (p<0.001), decreased vaginal pH from 5.04 ± 0.518 to 4.67 ± 0.679 (p=0.004), and improved Nugent scores from 6.96 ± 1.480 to 5.00 ± 1.840 (p<0.001). Additionally, there were significant reductions in TGF-β (116.86 ± 52.518 ng/mL to 46.16 ± 49.246 ng/mL, p<0.001) and IL-6 (320.96 ± 139.189 ng/L to 128.31 ± 181.669 ng/L, p<0.001). However, there were no significant changes in progesterone or estradiol levels. Conclusions: C. ternatea may significantly improve vaginal health by reducing the occurrence of bacterial vaginosis, lowering vaginal pH, and decreasing inflammatory markers. However, it does not appear to affect reproductive hormone levels. This study provides preliminary evidence supporting the use of C. ternatea for vaginal health, warranting further investigation in larger, controlled trials.
@article{novika2025effect,
title = {Effect of Clitoria ternatea L. on vaginal health, inflammation, and reproductive hormones: A pilot study},
author = {Novika, Revi Gama Hatta and Yunus, Ahmad and Wahidah, Nurul J. and Sumarno, Lanjar and Ilyas, Muhana F.},
journal = {Journal of Pharmacy \& Pharmacognosy Research},
year = {2025},
month = {sep},
volume = {13},
number = {5},
pages = {1338-1344},
doi = {10.56499/jppres24.2192_13.5.1338},
url = {https://doi.org/10.56499/jppres24.2192_13.5.1338}
}
@article{husna2025effect,
title = {Effect of transcranial direct current stimulation combined with speech and language therapy in post ischemic stroke aphasia: A systematic review},
author = {Husna, Isna Imroah and Mardiyah, Putri Ma'rifatul and Adyanata, Yanuareza Totti and Hasna, Zahra Roidah Amalia and Syah, Faris Khairuddin and Ilyas, Muhana Fawwazy},
journal = {Brain Disorders},
year = {2025},
month = {sep},
volume = {19},
pages = {100269},
doi = {10.1016/j.dscb.2025.100269},
url = {https://doi.org/10.1016/j.dscb.2025.100269}
}
Introduction: Lissencephaly is a rare brain malformation that causes severe developmental delays and intractable seizures. Traditional anti-epileptic drugs (AEDs) often fail to control seizures in these patients. Vagal nerve stimulation (VNS) has shown promise as an adjunctive treatment for refractory epilepsy. Case Presentation: A 19-year-old male with lissencephaly and epileptic encephalopathy was referred for VNS implantation after experiencing poorly controlled seizures despite maximum doses of Levetiracetam and Valproic Acid. The patient had daily seizures and frequent episodes of convulsive status epilepticus. EEG revealed multifocal spikes, primarily in the frontal regions. VNS implantation was performed, initially set at 0.2 mA and gradually increased to 1.5 mA over two months. Follow-up results showed a progressive reduction in seizure frequency. By two months, the patient experienced 5-7 seizure-free days each month, with further improvements noted at six months. At ten months, the seizures were brief and infrequent, and the patient no longer required rescue medication. Conclusion: VNS therapy significantly improved seizure control and the patient’s quality of life. Regular follow-up and tailored adjustments to the VNS settings were essential for optimizing seizure management. This case highlights VNS as a valuable option for managing refractory epilepsy in patients with severe neurological conditions.
@article{khairani2025vagal,
title = {Vagal Nerve Stimulation for Refractory Epileptic Encephalopathy in Patient with Lissencephaly: Case Report from Indonesia},
author = {Khairani, Arie and Sulistyanto, Adi and Ilyas, Muhana Fawwazy},
journal = {Archives of Pediatric Neurosurgery},
year = {2025},
month = {sep},
volume = {7},
number = {3},
pages = {e3102025},
doi = {10.46900/apn.v7i3.310},
url = {https://doi.org/10.46900/apn.v7i3.310}
}
Introduction: Acupuncture has emerged as an effective adjunctive therapy for polycystic ovary syndrome (PCOS) with concern on the higher rate of adverse events (AE). In addition, timing of intervention, specific acupoints, and stimulation strength are concerning, as high-stimulation electroacupuncture (EA) may increase miscarriage risk. This review aims to systematically evaluate the safety profile of acupuncture in PCOS. Materials and Methods: PubMed, ScienceDirect, and Scopus were searched prior to September 8, 2024. This study included randomized controlled trials (RCTs) comparing acupuncture with “control” (sham/no acupuncture) or active drugs. Study quality was assessed using RoB 2.0. Meta-analyses were conducted with R Studio. Results: From 1,041 articles, 13 RCTs were included. There was no significant serious or life-threatening AE occurred in all trials. In acupuncture versus control groups, mild to moderate AEs were similar overall, except bruising, which was significantly more frequent at needle insertion sites with acupuncture (OR = 3.34; 95% CI: 1.76–6,37; p < 0.01). In acupuncture versus active drugs, there were no significantly higher mild to moderate AEs in the acupuncture group. Miscarriage rates were comparable with acupuncture versus controls or ovulation-induction drugs, particularly with low-frequency (2 Hz) EA applied prepregnancy. Collectively, the findings support acupuncture’s safety profile, including no significant increase in miscarriage risk when administered prior to pregnancy. Conclusions: Acupuncture has emerged as a safe option for complementary therapy in PCOS. Further research is needed to refine acupuncture protocols, which further position it as a preferred adjunctive treatment in PCOS.
@article{nurwati2025safety,
title = {Safety of Acupuncture in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
author = {Nurwati, Ida and Tristan, Christopher Daniel and Modesty, Kyra and Kynaya, Erlangga Masykur and Hanif, Ihsan and Sudiono, Nathania Ella and Ilyas, Muhana Fawwazy},
journal = {Medical Acupuncture},
year = {2025},
month = {aug},
volume = {37},
number = {4},
pages = {281-291},
doi = {10.1177/19336586251360119},
url = {https://doi.org/10.1177/19336586251360119}
}
Introduction Recent studies have highlighted the presence of right ventricular dysfunction (RVD) in a substantial proportion of peripartum cardiomyopathy (PPCM), with evidence suggesting that RVD is associated with worse outcomes and a lower likelihood of left ventricular (LV) recovery. This study aims to comprehensively assess the pooled prevalence, associated outcomes and LV recovery of RVD in PPCM. Methods PubMed, Scopus and ScienceDirect were used to identify relevant literature prior to 19 January 2025. Statistical analysis was conducted using RStudio. All meta-analyses were performed using random effects, with subsequent subgroup analysis and univariate meta-regression conducted for prevalence meta-analysis. Results The pooled prevalence of RVD in PPCM was 0.48 (95% CI: 0.36 to 0.59; I² 95.3%) across 14 studies (1385 patients). RVD was diagnosed using multimodality imaging (e.g., echocardiography and cardiac magnetic resonance imaging), with diagnostic criteria defined in the original studies. Meta-regression showed a decreasing trend in RVD prevalence in more recent publications (p=0.03), with variability based on study design, location and diagnostic modality on subgroup analysis. Patients with RVD had a significantly higher risk of composite adverse outcomes (including death, LV assist device implantation, heart transplantation or the use of extracorporeal membrane oxygenation; hazard ratio 2.71; 95% CI 1.08 to 6.84; p=0.04; three studies) and heart transplantation (risk ratio (RR) 4.71; 95% CI 1.82 to 12.20; p<0.01; two studies). Additionally, RVD was associated with a lower baseline LV ejection fraction (mean difference −10.94; 95% CI −14.80 to −7.08; p<0.01; six studies) and an increased risk of unrecovered LV function (RR 1.62; 95% CI 1.25 to 2.11; p<0.01; four studies). Conclusion RVD occurs in nearly half of patients with PPCM and is associated with a poor prognosis. It may represent a crucial marker for prognostic stratification, particularly for the risk of unrecovered LV function. PROSPERO registration number CRD42025626739.
@article{wijayanto2025prevalence,
title = {Prevalence and associated outcomes of right ventricular dysfunction in peripartum cardiomyopathy: a systematic review, meta-analysis and meta-regression},
author = {Wijayanto, Matthew Aldo and Tristan, Christopher Daniel and Lukas, Graciella Angelica and Rahma, Annisa Aghnia and Ilyas, Muhana Fawwazy and Myrtha, Risalina and Muliawan, Hary Sakti and Siswanto, Bambang Budi},
journal = {Open Heart},
year = {2025},
month = {jul},
volume = {12},
number = {2},
pages = {e003253},
doi = {10.1136/openhrt-2025-003253},
url = {https://doi.org/10.1136/openhrt-2025-003253}
}
Purpose: Previous studies have suggested that milk consumption can promote growth in children. However, limited studies have been performed on the effects of cow milk varieties, especially β-casein A2 milk. This study aims to investigate the effect of β-casein A2 cow milk supplementation on physical growth, inflammation, and growth-related hormone and nutritional biomarker profiles in growth-stunted children.Methods: This is a quasi-experimental study with only one group and a pre-and posttest design. This research is divided into 3 stages: allele testing in the β-casein gene, processing into ready-to-drink milk, and a clinical trial. The participants were children aged 12–36 months who were given 200-mL β-casein A2 cow milk supplementation once a day for 3 months. The outcome assessments were physical growth (body weight and height), inflammation (tumor necrosis factor-alpha [TNF-α] and cortisol levels), and biological markers related to growth and nutrition (insulin-like growth factor-1 [IGF-1], growth hormone [GH], and transferrin) that were measured during pre-, mid (week 6)-, and post (week 12)-intervention periods.Results: This study included 30 study participants. Significant body weight and height improvements were observed at week 6 and postintervention (week 12) compared to preintervention. There were significant reductions in the inflammation markers TNF-α and cortisol levels postintervention. Additionally, IGF-1 and GH levels increased significantly, and transferrin levels also rose, potentially reflecting improved nutritional status.Conclusion: This study suggests that β-casein A2 milk supplementation was associated with improvements in physical growth and related biomarkers in stunted children. Additionally, β-casein A2 milk may produce fewer BCM-7 metabolites compared to β-casein A1 milk, which has been hypothesized to be associated with certain adverse health outcomes. However, further controlled studies are needed to confirm its efficacy as a dietary intervention.
@article{novika2025effect,
title = {Effect of β-casein A2 cow milk supplementation on physical growth, inflammation, growth-related hormones, and nutritional biomarkers in stunted children},
author = {Novika, Revi Gama Hatta and Sari, Atriany Nilam and Nurhidayati, Siti and Maulina, Rufidah and Maulida, Luluk Fajria and Wahidah, Nurul Jannatul and Ilyas, Muhana Fawwazy and Sumarno, Lanjar and Prastowo, Sigit and Jevitt, Cecilia M.},
journal = {Annals of Pediatric Endocrinology \& Metabolism},
year = {2025},
month = {jun},
volume = {30},
number = {3},
pages = {119-126},
doi = {10.6065/apem.2448158.079},
url = {https://doi.org/10.6065/apem.2448158.079}
}
Christopher D. Tristan, Risalina Myrtha, Matthew A. Wijayanto, Erlangga M. Kynaya, Muhammad F. Hamka, Nathania E. Sudiono, Muhammad A. Rusyidi, Muhana F. Ilyas
Olezarsen emerged as a novel promising Apo-C3 inhibitor for dyslipidemia. However, its dose-response relationship remains uncertain. This review aims to evaluate the lipid-lowering effect of olezarsen, safety measures, and dose-response effects to determine the optimal dose. A systematic search was conducted across Scopus, PubMed, ScienceDirect, and CENTRAL on January 2, 2025. Randomized controlled trial (RCT) comparing olezarsen with placebo in dyslipidemia was included. The Rob 2.0 tool was implemented to assess quality. R-studio and STATA were used to conduct statistical analysis. From a total of 194 documents at initial search, four RCTs involving 361 patients were included in the present analysis. Olezarsen significantly reduces plasma Apo-C3 across all dosage cohorts, including a 50 mg dose (MD: -70.31%; 95% CI: -83.89 to -56.74; p < 0.01) and an 80 mg dose administered every four weeks. It also significantly lowered triglycerides at any dose level, with reductions observed at 50 mg (MD: -49.84%; 95% CI = -70.42 to -22.37; p = 0) and 80 mg (MD: -52.32%; 95% CI: -58.25 to -46.40; p < 0.01). Olezarsen has minimal effect on low-density lipoprotein (LDL) but significantly increases high-density lipoprotein (HDL). Dose-response meta-analysis modeling suggests that 50 mg administered every four weeks may represent the optimal dose, beyond which added benefits diminish. Safety analysis revealed tolerability in liver, renal, and hematological parameters. In conclusion, olezarsen is an effective Apo-C3 inhibitor that improves lipid profiles with a favorable safety profile. This modeling-based insight refines previous findings by delineating a clearer therapeutic window
@article{tristan2025efficacy,
title = {Efficacy and Safety of Olezarsen in Dyslipidemia: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials},
author = {Tristan, Christopher D. and Myrtha, Risalina and Wijayanto, Matthew A. and Kynaya, Erlangga M. and Hamka, Muhammad F. and Sudiono, Nathania E. and Rusyidi, Muhammad A. and Ilyas, Muhana F.},
journal = {Journal of the Saudi Heart Association},
year = {2025},
month = {jun},
volume = {37},
number = {3},
doi = {10.37616/2212-5043.1439},
url = {https://doi.org/10.37616/2212-5043.1439}
}
@article{szcs2025epidemiology,
title = {The epidemiology and burden of ten mental disorders in countries of the Association of Southeast Asian Nations (ASEAN), 1990–2021: findings from the Global Burden of Disease Study 2021},
author = {Szücs, Anna and Lubbe, Stephanie C C van der and Torre, Jorge Arias de la and Valderas, Jose M and Hay, Simon I and Bisignano, Catherine and Morgan, Brooks W and Acharya, Swetha and Adnani, Qorinah Estiningtyas Sakilah and Apostol, Geminn Louis Carace and Aslam, Muhammad Shahzad and Asri, Yuni and Aung, Zaw Zaw and Aurizki, Gading Ekapuja and Baig, Atif Amin and Bermudez, Amiel Nazer C and Cenderadewi, Muthia and Danpanichkul, Pojsakorn and Efendi, Ferry and Estrada, Crystal Amiel M and Fauk, Nelsensius Klau and Fridayani, Ni Kadek Yuni and Garcia, Fernando Barroga and Hasan, Faizul and Ibrahim, Umar Idris and Ilyas, Muhana Fawwazy and Ismail, Nahlah Elkudssiah and Jamaluddin, Jazlan and Jamora, Roland Dominic G and Jonas, Jost B and Kanmodi, Kehinde Kazeem and Khan, Kashif Ullah and Khotimah, Fireza Husnul and Kim, Yun Jin and Kurniasari, Maria Dyah and Kustanti, Christina Yeni and Kusuma, Dian and Laksono, Tri and Lau, Jerrald and Loreche, Arianna Maever and Ma, Zheng Feei and Maravilla, Joemer C and Marzo, Roy Rillera and Maude, Richard James and Porntaveetus, Thantrira and Rahmawaty, Setyaningrum and Rodriguez, Alina and Roy, Bedanta and Salami, Afeez Abolarinwa and Samodra, Yoseph Leonardo and Sreeramareddy, Chandrashekhar T and Subramaniyan, Vetriselvan and Sukaew, Thitiporn and Sulistiyorini, Desy and Sumpaico-Tanchanco, Lourdes Bernadette C and Wicaksana, Anggi Lukman and Wong, Yen Jun and Younis, Mustafa Z and Zuniga, Yves Miel H and Murray, Christopher J L and Santomauro, Damian F and Ng, Marie},
journal = {The Lancet Public Health},
year = {2025},
month = {jun},
volume = {10},
number = {6},
pages = {e480-e491},
doi = {10.1016/s2468-2667(25)00098-2},
url = {https://doi.org/10.1016/s2468-2667(25)00098-2}
}
Backgrounds Aluminum phosphide (AIP)-related death, whether suicidal or homicidal, is a major global health problem, especially within agricultural countries in which it is commonly used as a pesticide. While toxicological analysis is the primary identification method, autopsy findings and histopathological changes might serve as valuable early identification clues. Herein, this review aimed to systematically review the possible and the most common autopsy findings as well as histopathological changes in AIP-related death as identified through post-mortem examination. Main body A literature search was conducted in three databases (Scopus, PubMed, and ScienceDirect). Possible findings were evaluated qualitatively and quantitatively using single-arm meta-analysis to identify the most common findings. In this study, ten observational studies with 2,450 autopsies were included. The autopsy results consistently showed multi-organ congestion, with respiratory system congestion being the most common [prevalence: 99% (95% CI: 0.97–1.00)]. Additional findings were a distinct garlicky odor, froth in the mouth or nostrils, and discoloration. In the histopathological examination, widespread congestion was observed in the liver, lungs, kidneys, spleen, and brain, along with focal myocardial necrosis and gastric mucosal necrosis. Conclusions Multiorgan congestion was the most prevalent finding in AIP-related death. Histopathological analysis revealed widespread congestion and necrosis. These findings highlight the systemic nature of AIP-induced fatalities and provide crucial forensic insights for early post-mortem identification in clinical practice.
@article{tristan2025autopsy,
title = {Autopsy findings and histopathological changes in aluminum phosphide-related death: a systematic literature review and meta-analysis},
author = {Tristan, Christopher Daniel and Nugroho, Novianto Adi and Wijayanto, Matthew Aldo and Kynaya, Erlangga Masykur and Ilyas, Muhana Fawwazy},
journal = {Egyptian Journal of Forensic Sciences},
year = {2025},
month = {may},
volume = {15},
number = {1},
pages = {28},
doi = {10.1186/s41935-025-00446-0},
url = {https://doi.org/10.1186/s41935-025-00446-0}
}
Background: The impact of COVID-19 on vulnerable populations, including pregnant female, is critical due to higher risks and potential complications. This study aims to compare the clinical and laboratory features of COVID-19 between pregnant and non-pregnant female. Materials and Methods: This retrospective cohort study included 245 COVID-19 patients admitted to Universitas Sabellas Maret (UNS) Hospital, Indonesia, from March 2020 to May 2022. Among them, 72 were pregnant, and 173 were non-pregnant. Data on demographics, clinical presentations, and laboratory findings were collected from medical records. Statistical analysis utilized Chi-square or Fisher exact tests, Mann-Whitney or independent t-tests, and multiple linear regression. Results: No significant demographic differences were found, except in hospitalization status. Clinically, pregnant female had a higher prevalence of symptoms such as cough ( p = 0.002), fatigue ( p = 0.025), and shortness of breath ( p = 0.035), with no differences in other symptoms or length of stay. Laboratory findings indicated significant differences in White Cell Count (WCC), Absolute Lymphocyte Count (ALC), High Fluorescence Lymphocyte Count (HFLC), lymphocyte percentage, neutrophil percentage, Neutrophil Lymphocyte Ratio (NLR), Red Cell Count (RCC), Hemoglobin (Hb), Hematocrit (Hct), Platelet Count (PC), Prothrombin Time (PT), International Normalized Ratio (INR), D-Dimer, and Sodium ( p values < 0.05). Multivariate analysis identified WCC, lymphocyte percentage, HFLC, neutrophil percentage, PT, INR, D-Dimer, Creatinine, and Potassium as significant predictors of length of stay (R²adj = 0.874, F = 17.979, p < 0.001). Conclusions: Pregnant female with COVID-19 exhibited distinct laboratory profiles compared to non-pregnant female. These findings highlight the need for tailored management strategies for COVID-19 in pregnant patients and provide a foundation for further research.
@article{ilyas2025differences,
title = {Differences in Clinical and Laboratory Features of Pregnant and Non-Pregnant Female with Hospitalized COVID-19},
author = {Ilyas, Muhana F. and Novika, Revi G. H. and Triniputri, Winastari Y. and Pradipta, I M. E. W. and Ksamawati, Ni W. P. S. and Wahidah, Nurul J. and Hartono and Sumarno, Lanjar},
journal = {Iranian Journal of Nursing and Midwifery Research},
year = {2025},
month = {may},
volume = {30},
number = {3},
pages = {322-331},
doi = {10.4103/ijnmr.ijnmr_86_23},
url = {https://doi.org/10.4103/ijnmr.ijnmr_86_23}
}
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disorder associated with significant morbidity. The role of high-intensity exercise in HCM remains controversial due to concerns about potential adverse effects. This study aims to conduct a systematic review of experimental and observational studies to evaluate the effects of high-intensity training (HIT) on patients diagnosed with HCM. This systematic review was conducted according to the Preferred Reporting Items in the Systematic Review and Meta-analysis Guidelines 2020. A comprehensive search was performed using Proquest, Pubmed, Scopus, and JSTOR databases to identify relevant studies published up to March 2024. Both experimental and observational studies written in English were included in the study. No restrictions were placed on the year, country of publication, or duration of follow-up. Study quality was evaluated using the Effective Public Health Practice Project (EPHPP) tool. A narrative synthesis was also conducted to summarize the findings. A total of 1418 references were identified through the search strategy. After removing 151 duplicates, 1267 records were screened based on title and abstract, resulting in the exclusion of 1253 studies. The full text of 14 articles was assessed for eligibility, of which ten were excluded. Four papers with a total of 2008 sample sizes were included. Significant differences were observed in several echocardiographic parameters. HCM athletes exhibited higher left ventricular end-diastolic volume (96 ± 33 vs. 76 ± 27 mL; p = 0.001, effect size = 0.682) and stroke volume (58 ± 21 vs. 47 ± 17 mL; p = 0.004, effect size = 0.593) compared to non-athletes. Additionally, significant differences were found in left ventricular outflow tract (LVOT) gradients: both resting ( p < 0.001, effect size = − 0.192) and provoked ( p < 0.001, effect size = − 0.258) LVOT gradients were significantly lower in the vigorous exercise group compared to the non-vigorous exercise group. In contrast, no significant differences were found between HIT and the comparator group in vital signs and functional aerobic capacity. Moreover, no significant differences were observed in arrhythmias, cardiac arrest, or mortality, suggesting that HIT did not increase the risk of arrhythmias or other adverse events compared to the comparator group. HIT improves cardiac function and exercise capacity in patients with HCM without increasing the risk of severe adverse events. These findings support reconsidering the guidelines on physical activity restrictions for individuals with HCM.
@article{cantika2025highintensity,
title = {High-Intensity Training on Patients with Hypertrophic Cardiomyopathy: A Systematic Review},
author = {Cantika, Catalya Christina and Wiradiharja, Muhammad Nur Hidayah Rayhan and Fahreza, Lufthi and Putri, Cici Irawanti and Ahmad, Verousson and Ilyas, Muhana Fawwazy and Wijayanto, Matthew Aldo and Febrianto, Adigama Priamas},
journal = {The Egyptian Heart Journal},
year = {2025},
month = {may},
volume = {77},
number = {1},
pages = {45},
doi = {10.1186/s43044-025-00642-2},
url = {https://doi.org/10.1186/s43044-025-00642-2}
}
Background: Infertility affects approximately one in six individuals globally and remains a growing reproductive health concern, often linked to modifiable risk factors present before conception. Preconception care (PCC) has gained recognition as a preventive strategy, however the implementation of PCC at scale remains challenged and yet its research landscape in relation to infertility remains under-mapped.This study aimed to analyze global research trends on preconception care in the context of infertility prevention using bibliometric methods.Subjects and Method: A bibliometric analysis was conducted using the Scopus database, with data retrieved on May 12, 2024. The search strategy included terms related to PCC and infertility, yielding 486 eligible publications after screening. Included documents were English-language publications in final form, relevant to preconception care and infertility, and classified as articles, reviews, conference papers, or book materials. Analysis was performed using Scopus tools, Biblioshiny (R), and VOSviewer to examine publication trends, key contributors, and thematic evolution.Results: A total of 486 publications from 1991 to 2025 were identified, with an annual growth rate of 6.43%. Most documents were original articles (67.7%) and reviews (28.4%), authored by 2,529 contributors across 307 publication sources. Several national strategies have formalized PCC into broader public health policy to reduce disparities in pregnancy outcomes and unmet fertility needs, but there remains a critical gap in the global PCC research agenda, such as the heterogeneity in intervention protocols.Conclusion: Research on preconception care in the context of infertility prevention has expanded steadily. However, Future research should prioritize longitudinal and interventional studies, foster global collaboration, and align with broader reproductive justice goals to strengthen the evidence base. Ultimately, enhancing the visibility and implementation of PCC in both clinical and public health domains will be pivotal in addressing modifiable infertility risks and promoting equitable reproductive outcomes worldwide.
@article{novika2025global,
title = {Global Research Trends on Preconception Care on the Infertility Prevention: A Bibliometric Study},
author = {Novika, Revi Gama Hatta and Sari, Atriany Nilam and Nurhidayati, Siti and Maulina, Rufidah and Maulida, Luluk Fajria and Wahidah, Nurul Jannatul and Ilyas, Muhana Fawwazy},
journal = {Journal of Epidemiology and Public Health},
year = {2025},
month = {apr},
volume = {10},
number = {2},
pages = {267-282},
doi = {10.26911/jepublichealth.2025.10.02.12},
url = {https://doi.org/10.26911/jepublichealth.2025.10.02.12}
}
Background/objectives Handgrip strength is a critical indicator of overall health, particularly in older adults, and is associated with frailty, sarcopenia and risk of adverse health outcomes. Precise and reliable measurement instruments are necessary to ensure accuracy in personalised diagnostic evaluations. This study aimed to assess the inter-instrument reliability and agreement between the Jamar Plus+ digital and Jamar hydraulic dynamometers in measuring handgrip strength. Methods A cross-sectional study was conducted to assess the handgrip strength of older individuals in the community aged more than 60, using the Jamar Plus+ digital and Jamar hydraulic dynamometers. The inter-instrument reliability and agreement between the devices were evaluated using Intraclass Correlation Coefficients (ICCs) and Bland-Altman analysis. Results A total of 109 participants with a mean age of 66±5.3 years were included in this study. The Jamar Plus+ digital dynamometer recorded significantly higher handgrip strength measurements (27.0±7.1 kg) compared with the Jamar hydraulic dynamometer (21.0±6.7 kg). The ICCs between the two devices ranged from 0.67 to 0.70, indicating moderate reliability. Bland-Altman analysis revealed a consistent overestimation of handgrip strength by the Jamar Plus+ digital dynamometer, with systematic biases of 4.8 kg in men and 6.26 kg in women compared with the Jamar hydraulic dynamometer. Conclusion The Jamar Plus+ digital dynamometer consistently overestimated handgrip strength compared with the Jamar hydraulic dynamometer, but both devices demonstrated moderate reliability. The Jamar Plus+ showed greater responsiveness to variations in strength. Selecting appropriate diagnostic tools is crucial for optimising individualised health assessments in older adults.
@article{sari2025handgrip,
title = {Handgrip strength assessment in geriatric populations: digital dynamometers comparative study},
author = {Sari, Nina Kemala and Stepvia and Ilyas, Muhana Fawwazy and Setiati, Siti and Harimurti, Kuntjoro and Fitriana, Ika},
journal = {BMJ Supportive \& Palliative Care},
year = {2025},
month = {apr},
volume = {15},
number = {4},
pages = {473-479},
doi = {10.1136/spcare-2024-005245},
url = {https://doi.org/10.1136/spcare-2024-005245}
}
Irnizarifka, Christopher D. Tristan, Matthew A. Wijayanto, Risalina Myrtha, Kyra Modesty, Annisa A. Rahma, Enrico A. Budiono, Awalil R. K. Rahman, Muhammad Farid Hamka, Muhana F. Ilyas
Catheter ablation has been the go-to treatment for ventricular arrhythmia, with traditional fluoroscopy-guided and non-zero fluoroscopy (NZF) catheter ablation posing high radiation risk for operators and patients. Zero-fluoroscopy technique offers elimination of radiation risk; however, its efficacy and safety in ventricular arrhythmia patients are not well explored. The aim of this study was to systematically evaluate the effectiveness, safety, and feasibility of zero-fluoroscopy ablation on ventricular arrhythmia patients. This study only included relevant studies comparing zero-fluoroscopy and NZF in ventricular arrhythmia ablation that were identified from Scopus, PubMed, and ScienceDirect (up to June 20, 2024). The quality of the study was assessed using the ROBINS-I tool, and the meta-analysis was conducted using a random-effect model. Out of 383 studies found, nine cohort studies were included with 1.408 patients. There was no significant difference in the acute procedural success rate of the zero-fluoroscopy and NZF (relative risk: 1.01; 95%CI: 0.95–1.07; p=0.69), with a similar recurrence rate (p=0.88; for four studies; n=374), and comparable procedural time (mean difference: -19.22 minutes; 95%CI: -41.16–2.72; p=0.09). Adverse events such as pericardial effusion, pseudoaneurysm, and hematoma were similar between zero-fluoroscopy and NZF. Overall, zero-fluoroscopy catheter ablation has demonstrated non-inferiority as a treatment option for ventricular arrhythmia ablation. As zero-fluoroscopy eliminates radiation risk without compromising procedural efficacy, zero-fluoroscopy has the potential to become a widely adopted approach for catheter ablation in ventricular arrhythmia.
@article{irnizarifka2025zerofluoroscopy,
title = {Zero-fluoroscopy versus fluoroscopy-guided catheter ablation in ventricular arrhythmia: A systematic review and meta-analysis},
author = {Irnizarifka and Tristan, Christopher D. and Wijayanto, Matthew A. and Myrtha, Risalina and Modesty, Kyra and Rahma, Annisa A. and Budiono, Enrico A. and Rahman, Awalil R. K. and Hamka, Muhammad Farid and Ilyas, Muhana F.},
journal = {Narra J},
year = {2025},
month = {apr},
volume = {5},
number = {2},
doi = {10.52225/narraj.v5i2.2094},
url = {https://doi.org/10.52225/narraj.v5i2.2094}
}
Objectives Genetic‐associated epilepsy in the Indonesian population is rarely discussed, and no study was specifically studied about photosensitive epilepsy. The fundamental goal of this research endeavor was to evaluate whether the single nucleotide polymorphism (SNP) of the Bromodomain‐Containing Protein 2 (BRD2) gene gives vulnerability to photosensitive epilepsy among Indonesian descent. Methods This observational case–control study includes patients of Indonesian descent with Javanese ancestry. Clinical and neurophysiological data, along with electroencephalographic (EEG) recordings, were used to diagnose epilepsy and photosensitive epilepsy. Blood samples were collected and analyzed for BRD2 gene SNPs (rs206781, rs188245, and rs15912) using polymerase chain reaction (PCR), electrophoresis, and the Sanger sequencing method. Results This study included 27 participants, consisting of 17 patients in the epilepsy group (nine patients with photosensitive epilepsy and eight patients without photosensitive epilepsy) and 10 patients in the non‐epilepsy group. Significant statistical differences were found in genotype (rs206781, p = 0.008 and rs188245, p = 0.004) and allele frequencies (rs206781, p < 0.001 and rs188245, p < 0.001) of the BRD2 gene in Indonesian descent with Javanese race patients diagnosed with photosensitive epilepsy and in those without this condition. Significance Our study corroborates the observation that genetic diversity within the BRD2 locus (rs206781 and rs188245) is associated with PE in Indonesian descendants of the Javanese race. To acquire a complete knowledge of the development of photosensitive epilepsy, further polymorphism studies at other SNP locations or genes are necessary. Plain Language Summary This study investigated whether genetic differences in the BRD2 gene were linked to photosensitive epilepsy (a type of epilepsy triggered by visual stimuli like flashing lights) in individuals of Indonesian Javanese descent. We analyzed deoxyribonucleic acid (DNA) samples from patients with epilepsy, including those with photosensitive epilepsy, and found that certain variations in the BRD2 gene were significantly more common in people with photosensitive epilepsy. These findings imply that genetic factors, specifically variations in the BRD2 gene, could elevate the risk of individuals in this population experiencing photosensitive epilepsy.
@article{mirawati2025bromodomaincontaining,
title = {Bromodomain‐containing protein 2 gene polymorphism among patients with photosensitive epilepsy in Indonesia},
author = {Mirawati, Diah Kurnia and Ilyas, Muhana Fawwazy and Hafizhan, Muhammad and Putra, Stefanus Erdana and Suroto and Subandi and Danuaji, Rivan and Budianto, Pepi and Hambarsari, Yetty and Hamidi, Baarid Luqman and Prabaningtyas, Hanindia Riani and Hutabarat, Ervina Arta Jayanti and Ristinawati, Ira and Tejomukti, Teddy and Tedjo, Raden Andi Ario and Syah, Faris Khairuddin},
journal = {Epilepsia Open},
year = {2025},
month = {mar},
volume = {10},
number = {2},
pages = {571-580},
doi = {10.1002/epi4.70019},
url = {https://doi.org/10.1002/epi4.70019}
}
@article{santoso2025psychotherapeutic,
title = {Psychotherapeutic modalities for phantom limb pain: a scoping review},
author = {Santoso, Suciwati and Tan, Kenneth and Sidharta, Steffanie Irena and Rafif, Naufal and Koeshermanto, Tyasno and Renanita, Theda and Benedictus and Ilyas, Muhana Fawwazy},
journal = {East Asian Archives of Psychiatry},
year = {2025},
month = {mar},
volume = {35},
number = {1},
pages = {37-49},
doi = {10.12809/eaap2449},
url = {https://doi.org/10.12809/eaap2449}
}
Background: Astrocytoma is a common pediatric brain tumor that poses a significant health burden. Recent advancements in artificial intelligence (AI), particularly neural network algorithms, have been studied for their precision and efficiency in medical diagnostics via effectively analyzing imaging data to identify patterns and anomalies. Objective: To systematically review AI-based diagnostic tools with neural network algorithms’ methodologies, sensitivities, specificities, and potential clinical integration for pediatric astrocytoma, providing a consolidated perspective on their overall performance and impact on clinical decision-making. Methods: As per PRISMA 2020 guidelines, we conducted a comprehensive search in PubMed, Scopus, and ScienceDirect on February 5, 2024. The search strategy was guided by a PECO question focusing on pediatric astrocytoma diagnosis using AI algorithms vs computed tomography or magnetic resonance imaging (MRI). Keywords were terms related to AI and neural network algorithms. We included studies analyzing the diagnostic accuracy of AI-based methods in cases of pediatric astrocytoma (World Health Organization grades 1-3), with no restrictions on a publication year or country. We excluded papers written in languages other than English or Bahasa Indonesia and nonhuman studies. Data was assessed using the Effective Public Health Practice Project tool. Results: Of 454 articles screened, 6 met inclusion criteria. These studies varied in design, location, and sample size, ranging from 10 to 135 subjects. The AI methods showed high sensitivity and specificity, often surpassing traditional radiological techniques. Notably, neural network algorithms using 3-dimensional MRI demonstrated improved accuracy compared with 2-dimensional MRI (96% vs 77%). The AI models exhibited performance levels comparable to or exceeding that of expert radiologists, with metrics such as tumor classification accuracy of 92% and high values of the area under the receiver operating characteristic curve. Conclusions: AI with neural network algorithms shows significant promise in enhancing accuracy of pediatric astrocytoma diagnosis. The studies reviewed indicate that these advanced methods can achieve superior sensitivity and specificity compared with conventional diagnostic techniques. Integrating AI into clinical practice could substantially improve diagnostic precision and patient outcomes.
@article{farmawati2025artificial,
title = {Artificial Intelligence With Neural Network Algorithms in Pediatric Astrocytoma Diagnosis: A Systematic Review},
author = {Farmawati, Floresya K. and Nurwakhid, Della W.A. and Pradhea, Tifani A. and Fitriasa, Rayyan and Arrahmi, Hutami H. and Ilyas, Muhana F. and Nur, Fadhilah T.},
journal = {Innovative Medicine of Kuban},
year = {2025},
month = {feb},
volume = {10},
number = {1},
pages = {93-100},
doi = {10.35401/2541-9897-2025-10-1-93-100},
url = {https://doi.org/10.35401/2541-9897-2025-10-1-93-100}
}
Background: Gastroesophageal reflux disease (GERD) and bipolar disorder impose substantial global burdens on individuals and healthcare systems. Previous studies suggest a bidirectional association between GERD and bipolar disorder. By searching and reviewing the results of existing studies, this systematic review and meta-analysis aims to review the two-way relationship between GERD and bipolar disorder. Methods: This study adhered to PRISMA Guidelines, including a comprehensive search of PubMed and Scopus for observational longitudinal studies. Quality (risk of bias) assessment employed the Newcastle-Ottawa Scale, and RevMan version 5.3 facilitated meta-analysis. Results: Five longitudinal studies (161888 patients) revealed a significant bidirectional link between GERD and bipolar disorder. Patients with GERD had a 2.29-fold higher risk of bipolar disorder (OR=2.29 [1.64, 3.21]; P<0.001), while individuals with bipolar disorder had a 2.80-fold higher risk of GERD (OR=2.80 [1.36, 5.76]; P=0.005). This study also identified independent risk factors, including sex, age under 60 years, and alcohol consumption disorders, influencing the occurrence of bipolar disorder in patients with GERD, as well as there is an influence of the number of psychoactive drugs in the occurrence of GERD in patients with bipolar disorder. Conclusion: These findings highlight a bidirectional relationship between GERD and bipolar disorder, emphasizing the necessity for integrated care models and personalized treatment plans. The results underscore the importance of considering both gastrointestinal and mental health aspects in managing these interconnected conditions.
@article{nurita2025bidirectional,
title = {Bidirectional Association between Gastroesophageal Reflux Disease and Bipolar Disorder: A Systematic Review and Meta-analysis of Longitudinal Studies},
author = {Nurita, Rahma and Faturohman, Adit and Santoso, Febrina Mustika and Magdalena, Bianca and Ilyas, Muhana Fawwazy},
journal = {Middle East Journal of Digestive Diseases},
year = {2025},
month = {jan},
volume = {17},
number = {1},
pages = {68-75},
doi = {10.34172/mejdd.2025.411},
url = {https://doi.org/10.34172/mejdd.2025.411}
}
Introduction Spinal tuberculosis (TB), or Pott's disease, remains a significant global health issue, particularly in regions with high TB prevalence. Despite antitubercular drug therapy being the primary treatment, surgical intervention is often required in cases of spinal instability or neurological complications. This study aims to conduct a comprehensive bibliometric analysis of worldwide publications related to the surgical management of spinal TB and to compare contributions from orthopaedic surgery and neurosurgery in this field. Methods A bibliometric analysis was performed using data from the Scopus database, covering publications from 1896 to 2024. The search strategy focused on terms related to spinal TB and surgical interventions. The analysis included 1,857 publications, which were examined for trends, key contributors, and the evolution of surgical techniques. Metrics such as the number of publications, leading authors, affiliations, countries, and funding sponsors were compared between orthopaedic surgery and neurosurgery. Results This study identified a steady increase in the number of publications over time. Key topics evolved from basic surgical methods, including early spinal procedures, to integrating pharmacological approaches alongside surgical techniques, such as antitubercular drugs, advancing into imaging research and procedure research involving refined surgical methods like spinal fusion. The recent phase reflects a shift towards technology-driven approaches, including minimally invasive techniques, artificial intelligence, and machine learning. China emerged as the leading country with the most contributions based on author, affiliations, funding sponsors, and countries. Last, orthopaedic surgery had more publications (274) than neurosurgery (96). Discussion In conclusion, spinal TB surgery has evolved significantly, with a notable shift towards advanced, technology-driven approaches. Orthopaedic surgery leads in research output compared to neurosurgery. This bibliometric analysis provides valuable insights into the global research landscape, guiding future studies in the management of spinal TB.
@article{romaniyanto2025current,
title = {Current update on surgical management for spinal tuberculosis: a scientific mapping of worldwide publications},
author = {Romaniyanto and Ilyas, Muhana Fawwazy and Lado, Aldebaran and Sadewa, Daffa and Dzikri, Dykall Naf'an and Budiono, Enrico Ananda},
journal = {Frontiers in Surgery},
year = {2025},
month = {jan},
volume = {11},
pages = {1505155},
doi = {10.3389/fsurg.2024.1505155},
url = {https://doi.org/10.3389/fsurg.2024.1505155}
}
Introduction The aging process is frequently associated with a decline in functional capacity, endurance, muscle quality, and overall quality of life. Examining aging-related biomarkers often requires significant time and financial resources, underscoring the need for a straightforward and practical indicator. This study aims to investigate the association between handgrip strength and aging-related laboratory parameters in the elderly population of Indonesia. Methods A cross-sectional study was conducted involving 109 participants aged 60–82 years. Handgrip strength was measured using a Jamar hydraulic hand dynamometer and Jamar PLUS+ digital dynamometer. Aging-related laboratory biomarkers were defined as those indicating physiological aging processes. Results The study revealed a significant association between handgrip strength and several aging-related laboratory parameters, including leukocyte count, absolute neutrophil count, absolute lymphocyte count, neutrophil/lymphocyte ratio, and erythrocyte sedimentation rate. Discussion These findings suggest that handgrip strength could serve as a cost-effective, non-invasive predictor of aging-related health status in older adults. Its practical utility highlights its potential for guiding health interventions targeting the elderly population.
@article{sari2025handgrip,
title = {Handgrip strength as a potential indicator of aging: insights from its association with aging-related laboratory parameters},
author = {Sari, Nina Kemala and Stepvia and Ilyas, Muhana Fawwazy and Setiati, Siti and Harimurti, Kuntjoro and Fitriana, Ika},
journal = {Frontiers in Medicine},
year = {2025},
month = {jan},
volume = {12},
pages = {1491584},
doi = {10.3389/fmed.2025.1491584},
url = {https://doi.org/10.3389/fmed.2025.1491584}
}
R. F. Yefri, A. F. Kurniawan, Muhana Fawwazy Ilyas, Y. A. S. Hidayat, M. Prasetya
Indonesian Journal of Neurosurgery 8(1):9-12
@article{yefri2025managing,
title = {Managing secondary trigeminal neuralgia during pregnancy: case series and insights from an Indonesian neurosurgical center},
author = {Yefri, R. F. and Kurniawan, A. F. and Ilyas, Muhana Fawwazy and Hidayat, Y. A. S. and Prasetya, M.},
journal = {Indonesian Journal of Neurosurgery},
year = {2025},
volume = {8},
number = {1},
pages = {9-12}
}
S. Ermawati, W. Y. Triniputri, Muhana Fawwazy Ilyas, S. Adilla, S. N. Hanifa, A. Auliarahman
International Journal of Ophthalmology 18(9):1747
@article{ermawati2025research,
title = {Research on neurotrophic factor for glaucoma: a worldwide bibliometric analysis},
author = {Ermawati, S. and Triniputri, W. Y. and Ilyas, Muhana Fawwazy and Adilla, S. and Hanifa, S. N. and Auliarahman, A.},
journal = {International Journal of Ophthalmology},
year = {2025},
volume = {18},
number = {9},
pages = {1747}
}
Context: L-citrulline is a non-essential amino acid primarily sourced from watermelon (Citrullus vulgaris). Many studies on L-citrulline have been conducted in the past 10 years. However, no bibliometric analyses have been performed. Aims: To establish bibliometric analysis as a comprehensive review of L-citrulline literature. Methods: Articles on L-citrulline published between 2013 and 2022 were retrieved from the Scopus database. The data was then analyzed for trends and quantity descriptions of authors, countries, and journals. The Vosviewer software was used to visualize the networks of keywords. Results: The analysis was conducted on September 9, 2022. From 2013 to 2022, 563 papers were retrieved in total. The number of L-citrulline publications had increased dramatically. The United States appeared to be the leading nation, providing the greatest number of publications and involving the world's leading writers and organizations. L-citrulline research has primarily concentrated on nitric oxide synthase, ergogenic aid, and exercise performance. Based on the analysis of keywords with the less frequent occurrence, this study also identified possible themes for future investigation, especially in topics such as ‘body composition’, ‘diabetic nephropathy’, ‘exercise capacity’, ‘human recombinant arginase I’, ‘lactate’, ‘lactation’, ‘microcirculation’, ‘reactive oxygen species’, ‘skeletal muscle’, ‘watermelon rind’ and ‘watermelon juice’. Conclusion: Publications on L-citrulline are essential, but the amount is still insufficient. Further research is required.
@article{ghozali2024bibliometric,
title = {A bibliometric analysis of 10 years of publications on L-citrulline},
author = {Ghozali, Dhoni A. and Doewes, Muchsin and Soetrisno and Indarto, Dono and Ilyas, Muhana F.},
journal = {Journal of Pharmacy \& Pharmacognosy Research},
year = {2024},
month = {dec},
volume = {12},
number = {s1},
pages = {S27-S31},
doi = {10.56499/jppres23.1758_12.s1.27},
url = {https://doi.org/10.56499/jppres23.1758_12.s1.27}
}
Context: The anxiety experienced by mothers during postpartum may have a negative impact on the emotional, psychological, and social development of newborns. Moreover, a psychological intervention known as psychocurative aims to maintain a Person’s mental state, encompassing their cognitive, spiritual, social, and physical well-being. However, the impact of the intervention on hormonal changes during postpartum remains unknown. Therefore, this study aimed to analyze the impact of psychocurative intervention on levels of cortisol, serotonin, and prolactin, as well as the anxiety scale. Aims: To analyze the impact of psychocurative intervention on levels of cortisol, serotonin, and prolactin, as well as the anxiety scale. Methods: This study was quasi-experimental research and employed one-group pre-test and post-test designs. Moreover, the research subjects were twenty postpartum women at Sibela Public Health Center in Surakarta. Additionally, the Wilcoxon test was employed to analyze all variables. Furthermore, the intervention was given to the research subjects once a week in the mother’s class provided by the Sibela Public Health Center and twice at their homes. In addition, the DASS-21 was employed to measure the anxiety scale, while the ELISA test was employed to measure levels of cortisol, serotonin, and prolactin. All variables were evaluated before and after the intervention to see the significant impact. Results: The difference in the mean result of levels of cortisol, serotonin, and prolactin, as well as the anxiety before and after psychocurative intervention, was significant (p<0.05). Conclusion: Psychocurative has been demonstrated to increase serotonin and prolactin expression while decreasing cortisol levels and the anxiety scale.
@article{soetrisno2024effectiveness,
title = {The effectiveness of psychocurative on the anxiety scale and the levels of cortisol, serotonin, and prolactin in postpartum women},
author = {Soetrisno and Novika, Revi Gama Hatta and Cahyanto, Erindra Budi and Nurinasari, Hafi and Arifa, Haris Nur Ashfi and Sari, Atriany Nilam and Maulida, Luluk Fajria and Ilyas, Muhana Fawwazy},
journal = {Journal of Pharmacy \& Pharmacognosy Research},
year = {2024},
month = {dec},
volume = {12},
number = {s1},
pages = {S121-S125},
doi = {10.56499/jppres23.1778_12.s1.121},
url = {https://doi.org/10.56499/jppres23.1778_12.s1.121}
}
Background Dental pulp inflammation, often initiated by Gram-negative microorganisms and lipopolysaccharides (LPS), can lead to pulpitis and, subsequently, dental pulp necrosis, compromising tooth structure and increasing susceptibility to fracture. Asiatic acid, derived from Centella asiatica , has demonstrated pharmacological properties, including anti-inflammatory and antioxidant effects, making it a potential candidate for mitigating LPS-induced pulp inflammation. This in vivo study aims to investigate the impact of Asiatic acid on the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in Rattus norvegicus with LPS-induced pulp inflammation. Methods This quasi-laboratory experimental in vivo study employed a post-test-only control group design to investigate the effects of Asiatic acid on LPS-induced pulp inflammation in Wistar rats. Thirty rats were randomly divided into six groups subjected to various interventions. LPS was administered to all groups for 6 h except the standard control group (CG, n = 5). The negative control group (NCG, n = 5) received only glass ionomer cement. The positive control group (PCG, n = 5) received Eugenol with glass ionomer cement. Intervention groups 1, 2, and 3 (IG1, IG2, IG3; n = 5 each) received Asiatic acid at concentrations of 0.5%, 1%, and 2%, respectively, with glass ionomer cement. Dental pulp inflammation was confirmed through immunological (tumor necrosis factor alpha (TNF-α) levels), histopathological (inflammatory parameters), and physiological (pain assessment using the rat grimace scale) analyses. Additionally, Nrf2 levels were examined using enzyme-linked immunosorbent assay (ELISA). Results Asiatic acid administration significantly influenced Nrf2 levels in rats with LPS-induced pulp inflammation. Nrf2 levels were significantly higher in groups treated with 0.5% (IG1) (8.810 ± 1.092 ng/mL; p = 0.047), 1.0% (IG2) (9.132 ± 1.285 ng/mL; p = 0.020), and 2.0% (IG3) (11.972 ± 1.888 ng/mL; p = 0.000) Asiatic acid compared to NCG (7.146 ± 0.706). Notably, Nrf2 levels were also significantly higher in the 2.0% Asiatic acid group (IG3) compared to the PCG treated with Eugenol (8.846 ± 0.888 ng/mL; p = 0.001), as well as IG1 ( p = 0.001) and IG2 ( p = 0.002). However, no significant difference was observed between administering 0.5% Asiatic acid (IG1), 1.0% Asiatic acid (IG2), and Eugenol (PCG). Conclusion This research showed that Asiatic acid significantly impacted the Nrf2 levels in rats with LPS-induced pulp inflammation. This suggests that it has the potential to be used as a therapeutic agent for reducing dental pulp inflammation. These findings support the need to further explore Asiatic acid as a promising intervention for maintaining dental pulp health.
@article{cilmiaty2024asiatic,
title = {Asiatic acid reduces lipopolysaccharides-induced pulp inflammation through activation of nuclear factor erythroid 2-related factor 2 in rats},
author = {Cilmiaty, Risya and Nurhapsari, Arlina and Prayitno, Adi and Rahma, Annisa Aghnia and Ilyas, Muhana Fawwazy},
journal = {PeerJ},
year = {2024},
month = {sep},
volume = {12},
pages = {e18004},
doi = {10.7717/peerj.18004},
url = {https://doi.org/10.7717/peerj.18004}
}
Highlights:1. This study elucidates the effect of L-citrulline supplementation on creatine kinase MM (CK-MM) expression post-eccentric exercise, offering novel insights into its potential role in mitigating muscle damage.2. The findings demonstrate that L-citrulline administration significantly reduces CK-MM expression levels in skeletal muscle tissue, suggesting its therapeutic potential in enhancing muscle recovery and performance following exercise-induced damage.3. This study contributes valuable insights into the multifaceted benefits of L-citrulline supplementation for supporting overall muscle health and performance by identifying its protective effects under different mechanisms, including improved blood flow, antioxidant activity, enhanced mitochondrial function, and promotion of muscle protein synthesis. Abstract Eccentric exercise often induces muscle injuries in athletes, resulting in impaired performance and prolonged recovery time. Creatine kinase MM (CK-MM) is a biomarker for assessing muscle damage, with elevated levels indicating injury. L-citrulline, an amino acid, has shown promise in enhancing performance and reducing recovery time. However, its specific effect on CK-MM remains unclear. This study utilized immunohistochemistry analysis to investigate the effect of L-citrulline supplementation on CK-MM expression post-eccentric exercise in male BALB/c mice. This in vivo study was conducted with a post-test-only design. A total of 25 mice were divided into two control groups (normal/C1 and negative/C2) and three treatment groups (T1, T2, and T3), each containing five mice. The T1, T2, and T3 groups were daily administered 250, 500, and 1,000 mg/kg bw of L-citrulline for seven days, respectively. All mice, except the C1 group, performed a downhill running procedure. The CK-MM expression in skeletal muscle tissue post-eccentric exercise was assessed using immunohistochemistry analysis. The statistical analysis included the Shapiro-Wilk test for data distribution and the Kruskal-Wallis and Mann-Whitney post-hoc tests for significant differences (p<0.05). The results showed that CK-MM expression in the C2 group (91.00±2.24%) was significantly higher (p=0.008) than that of the C1 group (70.00±10.0%). Subsequently, the T1 (68.00±9.08%, p=0.008), T2 (72.00±7.58%, p=0.008), and T3 (67.00±9.75%, p=0.008) groups exhibited significantly lower expressions than the C2 group. These results were consistent with the role of CK-MM as a marker for muscle damage, and they indicated that L-citrulline might have a protective effect against muscle damage post-eccentric exercise. However, no significant differences were observed among the C1, T1, T2, and T3 groups. In conclusion, L-citrulline supplementation demonstrates promise in attenuating muscle damage following eccentric exercise, as evidenced by reduced CK-MM expression levels. These findings highlight the potential therapeutic role of L-citrulline in enhancing muscle recovery and performance.
@article{ghozali2024effect,
title = {Effect of L-Citrulline on Creatine Kinase MM (CK-MM) Isoenzymes in Mice: An In Vivo Study Focusing on Immunohistochemistry Analysis},
author = {Ghozali, Dhoni Akbar and Rahma, Annisa Aghnia and Hanifa, Shafira Nur and Ilyas, Muhana Fawwazy},
journal = {Folia Medica Indonesiana},
year = {2024},
month = {sep},
volume = {60},
number = {3},
pages = {192-199},
doi = {10.20473/fmi.v60i3.56143},
url = {https://doi.org/10.20473/fmi.v60i3.56143}
}
Paramasari Dirgahayu, Muhana F. Ilyas, Annisa A. Rahma, Shafira N. Hanifa, Matthew A. Wijayanto, Winastari Y. Triniputri, Graciella A. Lukas, Nanang Wiyono, Yulia Sari, Yusuf A. Mashuri
Human sparganosis, a parasitic infection prevalent in Asia, can progress to cerebral sparganosis, a severe condition with significant neurological symptoms. Diagnosis and treatment are challenging due to its clinical similarity to other infections, highlighting the need for improved detection and management strategies. The aim of this study was to observe research trends, key contributors, gaps in the existing knowledge, diagnosis challenges, effective treatment options, and prevention strategies, providing recommendations for future research directions and clinical practice improvements on cerebral sparganosis. A bibliometric analysis was conducted by extracting 139 documents from the Scopus database in June 2024. The retrieved data were analyzed using the R package's Bibliometrix (Biblioshiny) and VOSviewer. Spanning 97 different sources, the research exhibited an annual growth rate of 2.5%. Annual scientific production revealed fluctuating research activity with peaks in 2010 and 2011 and notable citation peaks in 1996 and 2005, indicating pivotal studies that significantly influenced subsequent research. Early studies focused on diagnosis and specific parasites, while recent studies (2010–2024) have increasingly addressed clinical outcomes, treatment strategies, and advanced diagnostic techniques. Trends revealed a shift towards clinical and diagnostic advancements, with recent emphasis on diagnostic imaging, immunoassays, and the relationship between cerebral sparganosis and brain tumors. In conclusion, the studies on cerebral sparganosis underscore the potential for enhancing clinical practice by improving diagnostic accuracy, informing treatment decisions, and implementing targeted screening efforts based on epidemiology and risk factors. Recommendation to further study needs to notify the cerebral sparganosis in high-risk countries with similar socioeconomic and cultural characteristics to endemic regions, including Indonesia.
@article{dirgahayu2024recent,
title = {Recent update on cerebral sparganosis: A bibliometric analysis and scientific mapping},
author = {Dirgahayu, Paramasari and Ilyas, Muhana F. and Rahma, Annisa A. and Hanifa, Shafira N. and Wijayanto, Matthew A. and Triniputri, Winastari Y. and Lukas, Graciella A. and Wiyono, Nanang and Sari, Yulia and Mashuri, Yusuf A.},
journal = {Narra J},
year = {2024},
month = {aug},
volume = {4},
number = {2},
pages = {e982},
doi = {10.52225/narra.v4i2.982},
url = {https://doi.org/10.52225/narra.v4i2.982}
}
Background/Objectives: Hand grip strength (HGS) is a crucial measure for evaluating muscle function and general physical ability, and it may be associated with several diseases. Previous studies have demonstrated inconsistent associations between anthropometric measurement and body composition with HGS. This study aims to investigate the association between anthropometric measurement and body composition with HGS in the elderly population residing in Indonesia. Methods: This is a cross-sectional study on older adults aged between 60 and 82 years who live in the community. Anthropometric parameters assessed in this study comprised the body mass index (BMI), mid-upper arm circumference (MUAC), calf circumference (CC), and waist circumference (WC). Subsequently, body composition measurements, including fat mass (FM), fat-free mass (FFM), muscle mass (MM), skeletal muscle mass (SMM), and the appendicular skeletal mass index (ASMI), were assessed using a body composition analyzer. Last, the measurement of HGS was conducted using a hand dynamometer. Results: A total of 109 participants were involved in this study. Our study demonstrates a significant association between anthropometric parameters, namely CC and HGS. Subsequently, several body composition parameters, including FFM, SMM, ASMI, and MM in the four extremities, are also significantly associated with HGS. However, in a multivariate analysis, only CC and FFM were able to significantly predict HGS. Conclusions: Improving CC and maintaining FFM may enhance muscle strength in older adults. This suggests that targeted exercise and nutrition programs could increase muscle mass and strength, thereby mitigating age-related decline and improving quality of life.
@article{sari2024association,
title = {The Association between Anthropometric Measurements and Body Composition with Hand Grip Strength among the Elderly Population in Indonesia},
author = {Sari, Nina Kemala and Stepvia and Ilyas, Muhana Fawwazy},
journal = {Journal of Clinical Medicine},
year = {2024},
month = {aug},
volume = {13},
number = {16},
pages = {4697},
doi = {10.3390/jcm13164697},
url = {https://doi.org/10.3390/jcm13164697}
}
Highlights:1. This study emphasizes the significance of understanding professional football players' various somatotype structures and body fat compositions as an important contribution to the area of sports science.This study lays the groundwork for future research to better understand the intricate interactions between somatotype structures, body composition, and athletic performance.2. Since a one-size-fits-all approach may not be successful, this study advocates for tailored evaluations of training regimens to cater to athletes' unique requirements and skills, which may lead to higher overall performance. Abstract This study investigated the effects of somatotype structures and body fat composition on professional football athletes' aerobic capacities and running speed. This study used an analytical observational design with a cross-sectional approach. The subjects comprised 27 professional football athletes from Bhayangkara Football Club, located in Bekasi, Indonesia. This study measured several variables, i.e., players' age, playing position, somatotype structures assessed using the Somatotype Rating Form and Heath-Carter Somatochart, body fat composition measured using Brozek and Siri formulas, aerobic capacities determined by the maximum rate of oxygen (VO2 max) through the Yo-Yo Intermittent Recovery Test Level 2, and running speed over a 30 m distance. The data were presented as mean ± standard deviation (SD), frequency (n), and percentage. The Shapiro-Wilk was used to determine the normality of the data distribution. The statistical analyses were conducted using one-way analysis of variance (ANOVA) followed by the post-hoc least significant difference (LSD) test, the Kruskal-Wallis test followed by the post-hoc Mann-Whitney test, as well as the independent t-test, the Mann-Whitney test, and Pearson's or Spearman's correlation tests. A value of p<0.05 was considered statistically significant. The athletes exhibited a predominant somatotype structure of mesomorph-endomorph (88.9%). Notable associations were found between mesomorphy rating and running speed (r=-0.548; p=0.003), body fat composition and aerobic capacity (r=-0.448; p=0.019), as well as age and aerobic capacity (r=-0.515; p=0.006). Notably, differences in aerobic capacity were observed among various age groups (p=0.031). There were also differences in body fat composition (p=0.003) and running speed (p=0.036) between two distinct somatotype structures. These findings underscore the importance of considering individualized training and conditioning programs that account for athletes' unique body compositions and ages.
@article{ghozali2024differences,
title = {Differences in Aerobic Capacity and Running Speed Across Various Somatotype Structures and Body Fat Compositions among Professional Football Athletes in Indonesia},
author = {Ghozali, Dhoni Akbar and Ridhallah, Muhammad Syauqi and Shabrina, Syania and Nurhani, Ahmad Isnaini Shidqi and Hastami, Yunia and Rahayu, Dwi and Aryoseto, Lukman and Handayani, Selfi and Munawaroh, Siti and Wiyono, Nanang and Riyanto, Agus Sugeng and Budiono, Enrico Ananda and Rahma, Annisa Aghnia and Ilyas, Muhana Fawwazy},
journal = {Folia Medica Indonesiana},
year = {2024},
month = {jun},
volume = {60},
number = {2},
pages = {103-110},
doi = {10.20473/fmi.v60i2.55757},
url = {https://doi.org/10.20473/fmi.v60i2.55757}
}
Background: The platelet-to-lymphocyte ratio (PLR) has emerged as a prognostic predictive marker in various diseases, but its role in traumatic brain injury (TBI) has not been fully elucidated. This study aims to evaluate the role of PLR as a prognostic predictive marker in adults with TBI. Methods: This systematic review was conducted according to the Preferred Reporting Items in the Systematic Review and Meta-analysis Guidelines 2020. A comprehensive search was performed using PubMed, Google Scholar, Scopus, Crossref, OpenAlex, Semantic Scholar, Library of Congress, and Jisc Library Hub Discover database to identify relevant studies published up to February 2023. Both prospective and retrospective observational studies written in English or Indonesian were included in the study. No restrictions were placed on the year and country of publication and duration of follow-up. Study quality was evaluated using the Newcastle-Ottawa Scale (NOS), and the risk of bias was estimated using the Cochrane Risk of Bias Assessment Tool for Nonrandomized Research (Ro-BANS) tool. A narrative synthesis was also conducted to summarize the findings. Results: We retrieved 1644 references using the search strategy, and 1623 references were excluded based on screening the title and abstract. The full text was retrieved for 20 articles and subjected to the eligibility criteria, of which 16 were excluded from the study. Four papers with a total of 1.467 sample sizes were included in the review. The median of NOS for study quality was 8–9, with the risk of selection bias using the Ro-BANS tool being low in all studies except for the blinding outcome assessments, which are all unclear. The study finding suggests that the PLR has the potential as an independent prognostic predictive marker in adult patients with TBI. In three studies, a high level of admission PLR may independently predict an increasing mortality risk in 30 days and adverse outcomes measured by the Glasgow outcome scale in 6 months following TBI. However, one study shows that PLR may have limited value as a predictor of mortality or favorable neurological outcomes compared to other hematological parameters. Further studies were needed to establish the clinical utility of PLR and fill the present gaps. Conclusion: This systematic review provides evidence supporting the utilization of PLR as a prognostic predictive marker in adult patients with TBI. The PLR can mainly be utilized, especially in rural practice, as PLR is a simple, low-cost, and routinely performed hematological examination.
@article{ilyas2024platelettolymphocyte,
title = {Platelet-to-lymphocyte ratio as a prognostic predictive marker on adults with traumatic brain injury: Systematic review},
author = {Ilyas, Muhana Fawwazy and Lado, Aldebaran and Budiono, Enrico Ananda and Suryaputra, Gregorius Prama and Ramadhana, Geizar Arsika and Novika, Revi Gama Hatta},
journal = {Surgical Neurology International},
year = {2024},
month = {jun},
volume = {15},
pages = {205},
doi = {10.25259/sni_878_2023},
url = {https://doi.org/10.25259/sni_878_2023}
}
Leprosy, a significant global health concern affecting primarily the peripheral nerves and integumentary system, is influenced by the host immune system’s response, affecting its pathology, disease progression, and reaction occurrence. MCP-1, integral to leprosy’s immunological processes, holds promise as a diagnostic tool and predictor of reaction occurrence. This systematic review aimed to investigate MCP-1’s involvement in leprosy. Literature search, employing specified MeSH keywords, covered databases such as PubMed, Scopus, ScienceDirect, and Wiley Online Library until September 30th, 2023, yielding seventeen relevant studies. Assessing each study’s quality with the Newcastle-Ottawa Scale (NOS) and investigating bias using the Risk of Bias Assessment tool for Non-randomized Studies (RoBANS), a narrative synthesis compiled findings. Seventeen distinct studies were included, each characterized by diverse designs, sample sizes, demographics, and outcome measures, highlighting MCP-1’s potential in diagnosing leprosy, differentiating it from control groups, and discerning leprosy types. Furthermore, MCP-1 shows promise in predicting leprosy reversal reactions. Although MCP-1 offers clinical benefits, including early diagnosis and type differentiation, further research with larger sample sizes and standardized methodologies is imperative to confirm its diagnostic utility fully.
@article{prakoeswa2024role,
title = {The role of monocyte chemoattractant protein-1 (MCP-1) as an immunological marker for patients with leprosy: a systematic literature review},
author = {Prakoeswa, Flora Ramona Sigit and Handoko, Ellen Josephine and Risanti, Erika Diana and Haningtyas, Nabila and Pambudi, Nasrurrofiq Risvana Bayu and Ilyas, Muhana Fawwazy},
journal = {PeerJ},
year = {2024},
month = {jun},
volume = {12},
pages = {e17400},
doi = {10.7717/peerj.17400},
url = {https://doi.org/10.7717/peerj.17400}
}
@article{mirawati2024research,
title = {Research productivity in catamenial epilepsy: A bibliometric analysis of worldwide scientific literature (1956–2022)},
author = {Mirawati, Diah Kurnia and Wiyono, Nanang and Ilyas, Muhana Fawwazy and Putra, Stefanus Erdana and Hafizhan, Muhammad},
journal = {Heliyon},
year = {2024},
month = {may},
volume = {10},
number = {10},
pages = {e31474},
doi = {10.1016/j.heliyon.2024.e31474},
url = {https://doi.org/10.1016/j.heliyon.2024.e31474}
}
Introduction The primary concern for women who have experienced peripartum cardiomyopathy (PPCM) is the safety of a subsequent pregnancy (SSP). To maximie decision-making, facilitate effective patient counselling, and ultimately improve maternal and fetal outcomes as a whole, it is critical to comprehend the outcomes of SSP in women who have previously experienced PPCM. This study aimed to evaluate the outcomes of SSP in women with PPCM. Methods Three databases (PubMed, Scopus, and ScienceDirect) were used to identify relevant studies prior to 17 October 2023. A total of 662 studies were reviewed. Following the abstract and full-text screenings, 18 observational studies were included, out of which 2 were deemed suitable for inclusion in this meta-analysis. The quality assessment was conducted using the Newcastle-Ottawa Scale. Results This study has a total of 487 SSPs. Although recovered left ventricular (LV) function before entering SSP has the potential to be a beneficial prognostic factor, recovered LV function still has a substantial risk of relapse. The mortality rate of PPCM in an SSP ranged from 0% to 55.5%. Persistent LV dysfunction was significantly associated with an increased mortality rate (OR 13.17; 95% CI 1.54 to 112.28; p=0.02) and lower LV ejection fraction (MD −12.88; 95% CI −21.67 to −4.09; p=0.004). Diastolic and right ventricular functions remained unchanged before SSP and at follow-up. The majority of the SSP was observed alongside hypertension, while pre-eclampsia emerged as the predominant hypertensive complication in most studies. Conclusion SSP increases the risk of relapse and mortality in women with a previous history of PPCM. Persistent LV dysfunction prior to the SSP has a higher mortality risk compared with recovered LV function. SSP was also associated with the worsening of LV echocardiography parameters.
@article{wijayanto2024outcomes,
title = {Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis},
author = {Wijayanto, Matthew Aldo and Myrtha, Risalina and Lukas, Graciella Angelica and Rahma, Annisa Aghnia and Hanifa, Shafira Nur and Zahira, Hadiqa Almas and Ilyas, Muhana Fawwazy},
journal = {Open Heart},
year = {2024},
month = {apr},
volume = {11},
number = {1},
pages = {e002626},
doi = {10.1136/openhrt-2024-002626},
url = {https://doi.org/10.1136/openhrt-2024-002626}
}
Introduction Involvement of a chemokine known as C-X-C motif chemokine ligand 10 or CXCL10 in the immunopathology of leprosy has emerged as a possible immunological marker for leprosy diagnosis and needed to be investigate further. The purpose of this systematic review is to assess CXCL10’s potential utility as a leprosy diagnostic tool and evaluation of therapy. Methods This systematic review is based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020. A thorough search was carried out to find relevant studies only in English and limited in humans published up until September 2023 using PubMed, Scopus, Science Direct, and Wiley Online Library database with keywords based on medical subject headings (MeSH) and no exclusion criteria. The Newcastle-Ottawa Scale (NOS) was utilized for quality assessment, while the Risk of Bias Assessment tool for Non-randomized Studies (RoBANS) was utilized for assessing the risk of bias. Additionally, a narrative synthesis was conducted to provide a comprehensive review of the results. Results We collected a total of 115 studies using defined keywords and 82 studies were eliminated after titles and abstracts were screened. We assessed the eligibility of the remaining 26 reports in full text and excluded four studies due to inappropriate study design and two studies with incomplete outcome data. There were twenty included studies in total with total of 2.525 samples. The included studies received NOS quality evaluation scores ranging from 6 to 8. The majority of items in the risk bias assessment, using RoBANS, across all included studies yielded low scores. However, certain items related to the selection of participants and confounding variables showed variations. Most of studies indicate that CXCL10 may be a helpful immunological marker for leprosy diagnosis, particularly in leprosy reactions as stated in seven studies. The results are better when paired with other immunological markers. Its effectiveness in field-friendly diagnostic tools makes it one of the potential biomarkers used in diagnosing leprosy patients. Additionally, CXCL10 may be utilized to assess the efficacy of multidrug therapy (MDT) in leprosy patients as stated in three studies. Conclusion The results presented in this systematic review supports the importance of CXCL10 in leprosy diagnosis, particularly in leprosy responses and in tracking the efficacy of MDT therapy. Using CXCL10 in clinical settings might help with leprosy early diagnosis. Yet the findings are heterogenous, thus more investigation is required to determine the roles of CXCL10 in leprosy while taking into account for additional confounding variables.
@article{prakoeswa2024role,
title = {The role of CXCL10 as a biomarker for immunological response among patients with leprosy: a systematic literature review},
author = {Prakoeswa, Flora Ramona Sigit and Haningtyas, Nabila and Dewi, Listiana Masyita and Handoko, Ellen Josephine and Azenta, Moch. Tabriz and Ilyas, Muhana Fawwazy},
journal = {PeerJ},
year = {2024},
month = {apr},
volume = {12},
pages = {e17170},
doi = {10.7717/peerj.17170},
url = {https://doi.org/10.7717/peerj.17170}
}
Context: Echinacea purpurea, a well-known herbal remedy, is believed to possess immunomodulatory properties and has been traditionally utilized for a wide range of health benefits. However, its antiviral activities, particularly against SARS-CoV-2, and its modulation of reproductive hormones remain unknown. Aims: To investigate the utilization of E. purpurea herbal preparations as an antiviral by evaluating the Transmembrane Serine Protease 2 (TMPRSS2) expression and investigating its effect on reproductive hormones by measuring androgen in males and estrogen in females. Methods: Forty male and female participants were randomly assigned to different groups. Daily administration of 400 mg of E. purpurea herbal preparations for 28 days constituted the intervention. The gathering of demographic data was documented. Before and after the intervention, samples were collected for investigation, which included the ELISA-based assessment of androgen, estrogen, and TMPRSS2 expression. Results: This study indicated that administration of E. purpurea can significantly down-regulate TMPRSS2 expression in both males (8.39 ± 1.13 to 4.16 ± 1.53; p=0.000) and females (14.18 ± 1.93 to 5.25 ± 1.13; p=0.000). The androgen was also significantly down-regulated in the male intervention group (22.73 ± 1.75 to 12.72 ± 2.26; p=0.000). In addition, estrogen levels were also significantly up-regulated in the female intervention group (72.33 ± 11.12 to 161.14 ± 35.13; p=0.000). Conclusions: E. purpurea may be capable of down-regulating androgen in males, up-regulating estrogen in females, and down-regulating TMPRSS2 expression. This study contributes to the growing body of literature exploring the effects of E. purpurea as an antiviral property, especially for SARS-CoV-2, and its effect on reproductive hormones.
@article{novika2024clinical,
title = {Clinical effect of Echinacea purpurea as an antiviral and its effect on reproductive hormones},
author = {Novika, Revi G.H. and Wahidah, Nurul J. and Yunus, Ahmad and Sumarno, Lanjar and Ilyas, Muhana F.},
journal = {Journal of Pharmacy \& Pharmacognosy Research},
year = {2024},
month = {mar},
volume = {12},
number = {2},
pages = {255-263},
doi = {10.56499/jppres23.1784_12.2.255},
url = {https://doi.org/10.56499/jppres23.1784_12.2.255}
}
Objective: This study aimed to find out the association between the perception of online learning and anxiety as well as stress levels among medical students. Methods: This is an observational analytic study with a cross-sectional approach. The sample was comprised of 213 undergraduate medical studentsept at Medical Faculty Universitas Sebelas Maret (UNS) and data were collected using total sampling. The study was conducted using the Taylor Manifest Anxiety Scale (TMAS), Perceived Stress Scale (PSS), and perception of online learning questionnaires. Data were analyzed using Chi-square, Cramer’s V, and Kendall tau b test. Results: This study shows a significant correlation between the perception of online learning and anxiety (p=0.049) as well as stress level (p=0.007). Sex also has an association with anxiety (p=0.010) and stress level (p=0.004). Furthermore, female has higher anxiety and stress levels compared to male. Conclusions: Perception of online learning is related to the anxiety and stress level among medical students.
@article{dewanti2024perception,
title = {Perception of online learning with anxiety and stress level among medical students},
author = {Dewanti, Nanda Derista Ayu and Nugroho, I Gusti Bagus Indro and Lestari, Anik and Yuliadi, Istar and Ilyas, Muhana Fawwazy and Triniputri, Winastari Yarhanim},
journal = {Majalah Kedokteran Andalas},
year = {2024},
month = {mar},
volume = {46},
number = {3},
pages = {600-608},
doi = {10.25077/mka.v46.i4.p600-608.2023},
url = {https://doi.org/10.25077/mka.v46.i4.p600-608.2023}
}
Neuroanatomy comprehension, an essential aspect of medical education, is important for understanding and diagnosing neurological cases. However, neuroanatomy is perceived as one of the most difficult subjects, thus contributing to the prevalence of neurophobia among medical students worldwide. This cross-sectional observational analytic study aimed to investigate the association of visual-spatial intelligence (VSI) levels and learning modality preferences with neuroanatomical comprehension levels among 229 freshman medical students of Universitas Sebelas Maret (UNS), Indonesia. VSI level was measured using the Revised Purdue Spatial Visualization Test: Visualization of Rotations (PSVT:R); learning modality preference using the VAK or visual (V), auditory (A), and kinaesthetic (K) learning styles survey; and neuroanatomical comprehension level using neuroanatomy final examination. The results show a significant correlation between VSI and comprehension of neuroanatomy (r = 0.229; p < 0.0001), with notable differences in learning modality preferences. Students with visual preferences (V, VA, VK, and VAK) exhibited higher neuroanatomical comprehension compared to those without visual preferences (A, K, and AK). Visual learning modality preference was a significant predictor of VSI (β = 0.206; p = 0.006) and neuroanatomy comprehension (β = 0.161; p = 0.033), and VSI was a significant predictor of neuroanatomy comprehension (β = 0.305; p < 0.0001). This study highlights the importance of considering VSI and learning modality preference in the context of neuroanatomy comprehension among medical students.
@article{ilyas2024visualspatial,
title = {Visual-spatial Intelligence and Learning Modality Preference for Neuroanatomy Comprehension Among Medical Students},
author = {Ilyas, Muhana Fawwazy and Wiyono, Nanang and Ghozali, Dhoni Akbar and Hastami, Yunia and Handayani, Selfi and Munawaroh, Siti and Muthmainah and Triniputri, Winastari Yarhanim and Widodo, Dhito Putranto Dwi and Khoirumuna, Khonsa},
journal = {Education in Medicine Journal},
year = {2024},
month = {mar},
volume = {16},
number = {1},
pages = {149-164},
doi = {10.21315/eimj2024.16.1.10},
url = {https://doi.org/10.21315/eimj2024.16.1.10}
}
@article{ilyas2024bibliometric,
title = {A bibliometric study of worldwide scientific literature on somatopsychics (1913‒2022)},
author = {ILYAS, Muhana Fawwazy and LUKAS, Graciella Angelica and LADO, Aldebaran and RAHMAYANI, Sarah Alya and TAN, Kenneth and BENEDICTUS, Benedictus and WIJAYANTO, Matthew Aldo and HITIPEUW, Hedva Rayna and SULASYONO, Putri Titania and SUMARNO, Lanjar and NOVIKA, Revi Gama Hatta},
journal = {Bratislava Medical Journal},
year = {2024},
volume = {125},
number = {07},
pages = {441-449},
doi = {10.4149/bll_2024_68},
url = {https://doi.org/10.4149/bll_2024_68}
}
@article{cilmiaty2024bibliometrics,
title = {A Bibliometrics and Scientometrics Study of Mineral Trioxide Aggregate Material for Irreversible Pulpitis},
author = {Cilmiaty, R. and Ilyas, Muhana Fawwazy},
journal = {Journal of Medicinal and Chemical Sciences},
year = {2024},
volume = {7},
number = {5},
doi = {10.26655/JMCHEMSCI.2024.5.9},
url = {https://doi.org/10.26655/JMCHEMSCI.2024.5.9}
}
@article{dirgahayu2024cerebral,
title = {Cerebral toxoplasmosis in population with immunosuppressive therapy: A research trends analysis using bibliometrics and scientific mapping},
author = {Dirgahayu, P. and Wijayanto, M. A. and Triniputri, W. Y. and Lukas, G. A. and Ilyas, Muhana Fawwazy and Rahma, A. A.},
journal = {Journal of Medicinal and Pharmaceutical Chemistry Research},
year = {2024},
volume = {7},
number = {3},
pages = {431-446},
doi = {10.48309/jmpcr.2025.463783.1298},
url = {https://doi.org/10.48309/jmpcr.2025.463783.1298}
}
@article{rantam2024enhancement,
title = {Enhancement of Schwann-like cells differentiation from adipose-derived mesenchymal stem cells by administration of platelet-rich plasma: An in vitro study},
author = {Rantam, F. A. and Notobroto, H. B. and Tinduh, D. and Prakoeswa, C. R. S. and Sumarwoto, T. and Ilyas, Muhana Fawwazy},
journal = {Journal of Medicinal and Pharmaceutical Chemistry Research},
year = {2024},
volume = {6},
number = {9},
pages = {1383-1394},
doi = {10.48309/jmpcr.2024.445568.1132},
url = {https://doi.org/10.48309/jmpcr.2024.445568.1132}
}
Background: In the ever-evolving healthcare landscape, the imperative to ensure patient safety has driven the adoption of robust safety approaches. One of the most popular methods is Healthcare Failure Mode and Effect Analysis (HFMEA). Objective: This study aims to conduct a bibliometric analysis of HFMEA research in a surgery setting to identify relevant authors, topics, and journals, highlighting the scholarly collaboration trends in this area. This analysis can provide valuable insights into the current state of research, emerging trends, and future research directions. Methods: The data was acquired online from the PubMed database on December 16th, 2023. The downloaded data were analyzed using Google Sheets to predict trends. The publication output was then analyzed using VOSviewer. Subsequently, Biblioshiny was used to analyze the characteristics of the study, productive author, institution, and country; thematic map analysis; and topic timeline analysis. Results: This study analyzes 25 documents spanning 2005 to 2022, reflecting a collaborative effort involving 155 contributors. The upward trend in annual scientific publications, notably the surge from 2014 onwards and significant peaks in 2019 and 2022, underscores the growing recognition of HFMEA in enhancing patient safety within surgical environments. The prominent influence from prolific authors like Ahmed K, leading institutions such as King’s College London, and the substantial contributions from Norway and the USA in shaping the HFMEA research landscape. Conclusion: This study contributes valuable insights that can shape the trajectory of HFMEA in the evolving landscape of surgical healthcare, ensuring enhanced patient safety and quality improvement.
@article{sumarwoto2024healthcare,
title = {Healthcare Failure Mode and Effect Analysis in Surgery Setting: A Bibliometrics Analysis and Literature Review},
author = {Sumarwoto, Tito and Ilyas, Muhana and Dewi, Arlina},
journal = {Acta Informatica Medica},
year = {2024},
volume = {32},
number = {1},
pages = {19},
doi = {10.5455/aim.2024.32.19-23},
url = {https://doi.org/10.5455/aim.2024.32.19-23}
}
Muhana Fawwazy Ilyas, A. Lado, A. F. Indarta, B. A. Madani, K. Y. Yarso, I. B. Budhi
Gastroenterology and Hepatology from Bed to Bench 17(4):379
@article{ilyas2024worldwide,
title = {Worldwide research on abdominal compartment syndrome: bibliometric analysis of scientific literature (1993-2022)},
author = {Ilyas, Muhana Fawwazy and Lado, A. and Indarta, A. F. and Madani, B. A. and Yarso, K. Y. and Budhi, I. B.},
journal = {Gastroenterology and Hepatology from Bed to Bench},
year = {2024},
volume = {17},
number = {4},
pages = {379}
}
Background Eccentric exercise may trigger mechanical stress, resulting in muscle damage that may decrease athletic performance. L-citrulline potentially prevents skeletal muscle damage after acute eccentric exercise. This study aimed to assess the dose-response effect of L-citrulline as a preventive therapy for skeletal muscle damage in mice after acute eccentric exercise. Methods This is a controlled laboratory in vivo study with a post-test-only design. Male mice (BALB/c, n = 25) were randomized into the following groups: a normal control (C1) ( n = 5); a negative control (C2) with downhill running and placebo intervention ( n = 5); treatment groups: T1 ( n = 5), T2 ( n = 5), and T3 ( n = 5), were subjected to downhill running and 250, 500, and 1,000 mg/kg of L-citrulline, respectively, for seven days. Blood plasma was used to determine the levels of TNNI2 and gastrocnemius muscle tissue NOX2, IL-6, and caspase 3 using ELISA. NF-κB and HSP-70 expressions were determined by immunohistochemistry. Results Skeletal muscle damage (plasma TNNI2 levels) in mice after eccentric exercise was lower after 250 and 500 mg/kg of L-citrulline. Further, changes in oxidative stress markers, NOX2, were reduced after a 1,000 mg/kg dose. However, a lower level of change has been observed in levels of cellular response markers (NF-κB, HSP-70, IL-6, and caspase 3) after administration of L-citrulline doses of 250, 500, and 1,000 mg/kg. Conclusion L-citrulline may prevent skeletal muscle damage in mice after acute eccentric exercise through antioxidant effects as well as inflammatory and apoptotic pathways. In relation to dose-related effects, it was found that L-citrulline doses of 250, 500, and 1,000 mg/kg significantly influenced the expression of NF-κB and HSP-70, as well as the levels of IL-6 and caspase 3. Meanwhile, only doses of 250 and 500 mg/kg had an impact on TNNI2 levels, and the 1,000 mg/kg dose affected NOX2 levels.
@article{ghozali2023doseresponse,
title = {Dose-response effect of L-citrulline on skeletal muscle damage after acute eccentric exercise: an in vivo study in mice},
author = {Ghozali, Dhoni Akbar and Doewes, Muchsin and Soetrisno and Indarto, Dono and Ilyas, Muhana Fawwazy},
journal = {PeerJ},
year = {2023},
month = {dec},
volume = {11},
pages = {e16684},
doi = {10.7717/peerj.16684},
url = {https://doi.org/10.7717/peerj.16684}
}
Leprosy is resulted from chronic infection by Mycobacterium leprae. Leprosy affects the skin, peripheral nerves, and upper respiratory tract. Leprosy is a global health concern and Indonesia has the highest prevalence of leprosy in the world. The disease is characterized by a cytokine response, which is associated with increased inflammatory activity in both limited and multibacillary forms. Therefore, in vitro and in vivo studies are necessary to understand the disease and develop more effective treatments. This systematic search was conducted in several international databases including Scopus, PubMed, ScienceDirect, and Epistemonikos. A search strategy that combined keywords based on Medical Subject Headings (MeSH) and free text, including mice, leprosis, bacterial examination and histopathology. The search was performed using a systematic search strategy. We performed data extraction independently using predefined sheets that included the following information: first author name, year of publication, sample size and characteristics, duration of follow up, exposure method, intervention grouping, and outcomes (bacterial examination, histopathological evaluation, and other inflammatory markers). The results of the risk of bias assessment were displayed in the form of traffic-light plot and summary plot graphs, illustrating the results of a low, high, or unclear risk of biased assessment. The data was analyzed qualitatively.
@misc{prakoeswa2023utilization,
title = {Utilization of Mice as Hansen Disease Models for Comprehensive Analysis of Pathogenesis, Immunological Responses, and Therapeutic Interventions: A Systematic Review Protocol},
author = {Prakoeswa, Flora Ramona Sigit and Asaduddin, Aiman Hilmi and Pramuningtyas, Ratih and Pondang, Josafat and Ilyas, Muhana Fawwazy and Yanuarsyah, Farhan Dhio},
howpublished = {Research Square},
year = {2023},
month = {nov},
doi = {10.21203/rs.3.rs-3643112/v1},
url = {https://doi.org/10.21203/rs.3.rs-3643112/v1}
}
M. Y. A. Hapsari, F. T. Baihaqy, Muhana Fawwazy Ilyas, P. Budianto, R. G. H. Novika
Jurnal Kedokteran Syiah Kuala 23(1):158-162
@article{hapsari2023effects,
title = {Effects of acetylcholinesterase inhibitor donepezil on cognitive function and vital sign in patients with dementia},
author = {Hapsari, M. Y. A. and Baihaqy, F. T. and Ilyas, Muhana Fawwazy and Budianto, P. and Novika, R. G. H.},
journal = {Jurnal Kedokteran Syiah Kuala},
year = {2023},
volume = {23},
number = {1},
pages = {158-162}
}
Background: Peripartum cardiomyopathy (PPCM) is a pregnancy-related myocardial disease. PPCM has a high morbidity and mortality rate, but neither partial nor complete recovery is highly probable. Objective: To analyze global scientific production and identify research hotspots related to PPCM. Methods: The keyword “peripartum cardiomyopathy” was used to retrieved articles from Scopus database. A total of 509 articles were extracted. We used Scopus database analysis report and VOSviewer (version 1.6.18) to analyze annual publication number, country, citation and H-index, authors, institution, source journal, reference, and research hotspot. Results: The trend of annual publication numbers has increased significantly, with the United States leading the amounts of publication and H-index in PPCM study. Hilfiker-Kleiner, D. contributed the most publications and the most active institution was Medizinische Hochschule Hannover MHH. By employing an overlay visualization, we shed light on the evolving research emphases, wherein prominent topics such as “diagnostic imaging” and “practical guidelines” have emerged as major areas of focus in recent years. Conclusion: From 1971 to 2022, numbers of publications in PPCM research have increased gradually, and this trend is predicted to keep arising. Recent studies are becoming more focused on diagnostic imaging and practical guidelines. In the future, expanding global collaboration and conducting more in-depth studies are needed.
@article{wijayanto2023global,
title = {Global Research Trends and Future Direction in Peripartum Cardiomyopathy: A Bibliometric Analysis},
author = {Wijayanto, Matthew and Lukas, Graciella and Greatalya, Lawly and Ilyas, Muhana and Myrtha, Risalina},
journal = {Acta Informatica Medica},
year = {2023},
volume = {31},
number = {4},
pages = {270},
doi = {10.5455/aim.2023.31.270-274},
url = {https://doi.org/10.5455/aim.2023.31.270-274}
}
Nanang Wiyono, H. Corrigan, Muhana Fawwazy Ilyas, M. Faqieh, D. S. Salma, F. I. Kartika
Yuma Pustaka · Textbook, in Indonesian
@book{wiyono2023jaras,
title = {Jaras Neuroanatomi: Dasar dan Aplikasi Klinis (Neuroanatomical Pathway: Basic and Clinical Application)},
author = {Wiyono, Nanang and Corrigan, H. and Ilyas, Muhana Fawwazy and Faqieh, M. and Salma, D. S. and Kartika, F. I.},
publisher = {Yuma Pustaka},
year = {2023}
}
Background: Brain tumor is a disease that is difficult to treat and causes high morbidity and morta¬lity. One of the clinical manifestations of brain tumors is cognitive impairment which is the most common neurological problem. The aim of this study is to determine the profile of cognitive impairment in patients with brain tumors.Subjects and Method: The design of this study was a retrospective cross-sectional using secondary data from the Neurology Polyclinic of RSUD Dr. Moewardi in January 2021-March 2022. The subject was diagnosed with a brain tumor based on anamnesis, physical examination, and neuroimaging. Cognitive impairment was inferred through the MoCA-Ina test. The analysis used was univariate descriptive analysis, independent T test, Mann-Whitney test, and Pearson correlation test.Results: There were 29 subjects with a mean MoCA-Ina score (17.97). Primary brain tumors (79.3%), more than metastatic tumors. The majority of patients were diagnosed with meningioma (55.2%). This study showed that there were differences in abstraction scores (p=0.015) and total MoCA-Ina scores (p=0.042) between patients with tumors located in the temporal lobe and non- temporal lobe; differences in abstraction scores (p=0.034) and orientation scores (p=0.042) between patients with supratentorial and infratentorial tumors; and differences in memory scores (p=0.028) between patients with and without radiation history. In addition, this study also found an association between the number of lobes affected by brain tumors with attention score (p=0.027; r=-0.409), abstraction score (p=0.004; r=-0.524), orientation score (p=0.021; r=-0.426), and the total score of MoCA-Ina (p=0.018, r=-0.435).Conclusion: There is an association between brain tumors and cognitive impairment which is concluded through the MoCA-Ina test. The clinical manifestations of cognitive impairment in the patient are in accordance with the neuroanatomical function of the brain affected by the lesion.Keywords: Cognitive, Tumor, MoCA-InaCorrespondence: Maria Yosita Ayu Hapsari. Department of Neurology, Faculty of Medicine, Universitas Sebelas Maret/ Moewardi Hospital, Indonesia. Email: ayositahapsari@gmail.com. Phone: 0813 3155 5412.Indonesian Journal of Medicine (2022), 07(02): 242-250https://doi.org/10.26911/theijmed.2022.07.02.12
@article{hapsari2022profile,
title = {Profile of Cognitive Impairement in Patients with Brain Tumors in Dr. Moewardi Hospital, Surakarta},
author = {Hapsari, Maria Yosita Ayu and Ilyas, Muhana Fawwazy and Ristinawati, Ira and Stepvia and Novika, Revi Gama Hatta},
journal = {Indonesian Journal of Medicine},
year = {2022},
month = {apr},
volume = {7},
number = {2},
pages = {242-250},
doi = {10.26911/theijmed.v7i2.532},
url = {https://doi.org/10.26911/theijmed.v7i2.532}
}
Anatomy has become one of the most fundamental knowledge in a medical education program and it's comprehensions are significantly important to understand another branch of clinical knowledge. General anatomy textbook or it's fancy as RAUL (Rangkuman Anatomi Umum Lengkap), arguably, got to be the main source of anatomy learning in the Faculty of Medicine, still need some evaluations. This research aim is to evaluate the eligibility of the fourth edition of the general anatomy textbook in chapter three. This study encompasses qualitative analysis which depends on its book. One technique that is being used in this research is qualitative analysis approaches with a mutually-related interactive model. The content eligibility was analyzed in depth with theory and particular data based instrument which come from various sources. The feasibility of content was assessed in terms of the suitability of the material description with KI and KD, the accuracy of the material, and supporting learning material. Given data was analyzed inductively with collected data, data reduction, data arrangement, data withdrawal, and verification of conclusion. Judging from data analysis, it can be concluded that the content of general anatomy textbook "RAUL", fourth edition, chapter three, Faculty of Medicine Sebelas Maret University, is very feasible with the value of 95% according to twelve points of the assessment aspects. It is hoped that this research can become a reference in evaluating the following textbook and contribute for anatomy learning as well.
@misc{ilyas2019analisis,
title = {Analisis Kelayakan Isi Buku Rangkuman Anatomi Umum Lengkap Edisi IV Semester 2 Bab 3 Fakultas Kedokteran UNS},
author = {Ilyas, Muhana Fawwazy},
howpublished = {OSF Preprints},
year = {2019},
month = {jun},
doi = {10.31227/osf.io/z6afn},
url = {https://doi.org/10.31227/osf.io/z6afn}
}